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The 5’ strand resection of DNA double strand breaks (DSBs) initiates 
homologous recombination (HR) and is critical for genomic stability. To date there is no 
quantitative method to measure single-stranded DNA (ssDNA) intermediates of resection 
in mammalian cells. In this study I develop a quantitative PCR (qPCR)-based assay to 
quantitate ssDNA intermediates, specifically, the 3’ ssDNA product of resection at 
specific DSBs induced by AsiSI restriction enzyme in human cells. I protect the large 
mammalian genome from shearing by embedding the cells in low-gelling-point agar 
during genomic DNA extraction, and measure the levels of ssDNA intermediates by 
qPCR following restriction enzyme digestion. This assay is more quantitative and precise 
compared with existing protein foci-based methods. Using this assay I quantitatively 
measure ssDNA intermediates of resection in human cells and find that the 5' strand at 
endonuclease-generated break sites is resected up to 3.5 kb in a cell cycle dependent 
manner. Depletion of CtIP, Mre11, Exo1, or SOSS1 blocks resection, while depletion of 
53BP1, Ku or DNA-dependent protein kinase catalytic subunit (DNA-PKcs) leads to 
increased resection as measured by this method. While 53BP1 negatively regulates DNA 
end processing, depletion of BRCA1 does not, suggesting that the role of BRCA1 in HR 
is primarily to promote RAD51 filament formation, not to regulate end resection. 
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Using direct measurement of resection in human cells and reconstituted assays of 
resection with purified proteins in vitro, I also show that DNA-PKcs, a classic non-
homologous end joining (NHEJ) factor, antagonizes DSB resection by blocking the 
recruitment of resection enzymes such as exonuclease 1 (Exo1). Autophosphorylation of 
DNA-PKcs promotes DNA-PKcs dissociation and consequently Exo1 binding. ATM 
kinase activity can compensate for DNA-PKcs autophosphorylation and promote 
resection under conditions where DNA-PKcs catalytic activity is inhibited. The 
Mre11/Rad50/Nbs1 (MRN) complex further stimulates resection in the presence of Ku 
and DNA-PKcs by recruiting Exo1 and enhancing DNA-PKcs autophosphorylation. This 
work suggests that, in addition to its key role in NHEJ, DNA-PKcs also acts in concert 
with MRN and ATM to regulate resection and thus DNA repair pathway choice. In 
addition, I find that MRN strongly suppresses DNA Ligase IV/XRCC4-mediated end 
rejoining, whereas it dramatically promotes DNA end ligation by the DNA Ligase 
III/XRCC1 complex. 
The Ataxia-Telangiectasia mutated (ATM) protein is a key regulator of 
checkpoint activation and HR in response to DSBs. The MRN complex acts as a DSB 
sensor and is essential for ATM recruitment to broken DNA ends and ATM activation. 
However, the precise mechanism for ATM activation upon DNA damage and ATM 
inactivation after DNA repair has remained poorly understood. Phosphorylation of ATM 
has been suggested to play important roles in this process. Autophosphorylation of ATM 
at four sites (S1981, S367, S1893, and S2996) has been shown to be essential for ATM 
activation and function in response to DNA damage in human cells. However, mutations 
at these four sites do not affect ATM kinase activity in vitro or in mouse models, 
suggesting that there are other mechanisms for regulation of ATM activity. Previous 
studies show that CDK5-mediated phosphorylation of ATM at Ser794 and EGFR-
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mediated phosphorylation of ATM at Tyr370 both positively regulate ATM activation 
upon DNA damage. In this study, I further propose that DNA-dependent protein kinase 
(DNA-PK) negatively regulates ATM activity through phosphorylation of ATM at 
multiple sites. ATM is hyperactive when DNA-PK activity is blocked by DNA-PK 
specific inhibitor or when the DNA-PKcs gene is deleted in cells. Pre-incubation of ATM 
protein with DNA-PK significantly inhibits ATM kinase activity in vitro. Using mass 
spectrometry analysis and site-directed mutagenesis, I characterized three clusters of 
sites: S85/T86, T372/T373 and T1985/S1987/S1988. The phospho-mimetic mutations at 
these residues repress ATM activation both in vitro and in cells. Overexpression of 
phospho-mimetic ATM mutants in ATM-deficient cells fails to restore cell survival, DSB 
end resection and G2/M checkpoint activation in response to DNA damage. In addition, I 
have observed that the phospho-blocking ATM mutants, T1985A/S1987A/S1988A and 
T86A/T373A, are resistant to DNA-PK pre-incubation in vitro and that overexpression of 
ATM T1985A/S1987A/S1988A mutant fails to respond to DNA-PK inhibition in 
comparison to wild-type ATM in cells. Taken together, my data suggests that the NHEJ 
factor DNA-PK suppresses the catalytic activity of ATM through phosphorylation and 
that the phosphorylation of a group of Ser/Thr residues on ATM negatively regulates 
ATM signaling upon DNA damage. Since ATM is known to promote the HR pathway, 
this may provide a novel mechanism for DNA repair pathway choice upon DNA damage 
as well as ATM inactivation after DNA repair. 
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CHAPTER 1: INTRODUCTION 
 
DNA DOUBLE-STRANDED BREAKS AND DNA DAMAGE RESPONSE 
The genome of all organisms is constantly subjected to attacks from both 
exogenous and endogenous DNA damaging agents, such as ultraviolet (UV) light, 
ionizing radiation (IR), radiomimetic chemicals, reactive oxygen species and replication 
errors, leading to a variety of DNA lesions. DNA double-strand breaks (DSBs) are one of 
the most deleterious genetic lesions in cells as failure of DSBs repair can result in cell 
death, while inappropriately repaired DSBs may lead to genetic aberrations, including 
mutations, translocations, deletions, duplications and even chromosome loss, all of which 
contribute to genomic instability and tumorigenesis. Although harmful by nature, DSBs 
are spontaneously induced by cells during several programmed cellular processes such as 
mating type switch in budding yeast, V(D)J recombination and class-switch 
recombination in lymphocytes, as well as mitotic and meiotic recombination. In response 
to DSBs, a massive signaling network called the DNA damage response (DDR) is 
initiated to coordinate damage recognition, signaling transduction, checkpoint activation, 
and ultimately DNA damage repair and cell cycle resumption (Davis et al, 2014; Shiloh, 
2014; Shiloh & Ziv, 2013). 
The DNA damage response is a highly organized cell signaling system in which 
the DNA damage signal is transferred from sensor proteins to transducers, and 
subsequently to downstream effectors which are directly implicated in regulation of 
checkpoint activation and DNA damage repair (Shiloh & Ziv, 2013). Sensor proteins, 
such as Ku70/80 heterodimer and Mre11/Rad50/Nbs1 (MRN) complex, are recruited to 
damage sites at early time points and further recruit and activate transducers, including 
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three members of the phosphatidylinositol 3 kinase-like kinase (PIKK) family: Ataxia-
Telangiectasia mutated (ATM), ATM Rad3-related protein (ATR) and DNA-dependent 
protein kinase catalytic subunit (DNA-PKcs). Transducer proteins in turn activate 
downstream effector proteins, such as KRAB associated protein 1 (KAP1), p53, 
Checkpoint kinase 2 (Chk2) and CTBP interacting protein (CtIP), via post translational 
modifications. All of these protein involved in DNA damage response will be further 
discussed in the following sections.  
With immunofluorescent staining or fluorescent protein tagging, the local 
accumulation/modification of DNA repair proteins at DSB sites can be microscopically 
visualized as distinct bright spots, which are termed DNA damage foci (also called DNA 
repair foci or (ionizing) radiation-induced foci (IRIF)) (Rogakou et al, 1999). The 
discovery of DNA damage foci has revolutionized the study of DNA repair because it 
enables researchers to “directly” observe DNA damage initiation and the repairing 
process, which provides a valuable tool for understanding the mechanisms of DNA 
repair. Many DNA damage response proteins have been shown to form foci at DSB sites, 
such as phosphorylated H2AX (γH2AX), autophosphorylated ATM (pS1981), DNA 
damage checkpoint protein 1 (MDC1), the Mre11/Rad50/Nbs1 (MRN) complex, p53-
binding protein 1 (53BP1), RPA and RAD51. The most prominent DNA damage foci are 
γH2AX foci, which are formed by ATM-mediated phosphorylation of histone variant 
H2AX at Ser139 in the vicinity of DSBs. γH2AX then facilitates the recruitment other 
DNA damage signaling factors such as MDC1 and 53BP1 which accumulate to form foci 
and subsequently contribute to DNA repair (Rothkamm et al, 2015). ATM pS1981 foci 
are formed by ATM autophosphorylated at S1981 at DSB ends. H2AX is also shown to 
be a target of DNA-PKcs in response to DSBs (Stiff et al, 2004), but a recent study 
showed that DNA-PKcs phosphorylation of H2AX is blocked by the MRN complex in 
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mouse cells, even when ATM kinase activity is inhibited by an ATM specific inhibitor 
(Hartlerode et al, 2015). Therefore, both γH2AX foci and ATM pS1981 foci serve as 
indicators for DNA damage as well as ATM activation (Bakkenist & Kastan, 2003; Paull 
et al, 2000). Compared with γH2AX foci and ATM pS1981 foci which are formed 
immediately after DNA damage, RPA foci and RAD51 foci appear at later time points 
and are widely used as markers for DSB end resection, a critical event for the 
homologous recombination (HR) repair (Polo & Jackson, 2011; Tomimatsu et al, 2012). 
 
DNA DOUBLE-STRAND BREAK REPAIR 
Two major pathways, non-homologous end joining (NHEJ) and homologous 
recombination (HR), are used to repair DSBs in eukaryotic cells (Figure 1.1). NHEJ is 
the predominant DNA repair pathway which is active in all cell cycle phases. Generally 
NHEJ is composed of three steps. First, the repair is initiated by the recognition and 
binding of DSB ends by the Ku70/80 heterodimer (Ku), followed by the recruitment of 
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) which binds to both DSB 
ends, forming a synaptic complex that tethers the two DNA ends together (DeFazio et al, 
2002; Weterings et al, 2003). Second, nonligatable DSB ends are processed by a variety 
of enzymes such as polynucleotide kinase/phosphatase (PNPK) and DNA polymerases 
mu/lambda. Lastly, DSB ends are religated by the DNA ligase IV/XRCC4 complex, 
which is promoted by the scaffold protein XLF. Overall, NHEJ is a relatively error-prone 
pathway because it is often associated with short range end processing before end 
rejoining (Davis et al, 2014; Jette & Lees-Miller, 2015; Radhakrishnan et al, 2014).  
In contrast, HR is a precise DNA repair pathway. HR is initiated with resection of 
5’ DSB ends to generate long 3’ single-stand DNA (ssDNA) overhangs, which requires 
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the action of many proteins including MRN, Exo1, CtIP and ATM (Symington, 2014). 
First, the ssDNA products of resection are coated by the ssDNA-binding protein RPA. 
RPA is then displaced by RAD51 recombinase with the help of BRCA2. Lastly, the 
RAD51 filaments guide the search for sequence homologies and mediate strand invasion 
into a sister chromatid, followed by the repair of the break using the homologous DNA as 
a template (Rothkamm et al, 2015). Although HR repair is more accurate than NHEJ 
repair, the activity of HR is generally limited to S and G2 cell phases due to the 
requirement for a sister chromotid as a homologous DNA template for HR repair (Davis 
et al, 2014). 
It should be noted that except for the two aforementioned canonical DSB repair 
pathways, there exist a few alternative DSB repair pathways conserved from yeast to 
mammalian cells, including alternative NHEJ (Alt-NHEJ, also called back-up NHEJ (B-
NHEJ) or microhomology-mediated end-joining (MMEJ)), single-stand annealing (SSA) 
and break-induced replication (BIR) (Sancar et al, 2004). Alt-NHEJ is even more error-
prone than DNA-PK-dependent NHEJ and it is initiated in the absence of classical NHEJ 
pathway, with the involvement of PARP-1, DNA ligase III and I, as well as XRCC1. 
However, Alt-NHEJ is gaining more and more attention because it is relatively more 
active in tumor cells which are often characterized by deficiency of canonical DNA 
damage response and repair (Betermier et al, 2014; Deriano & Roth, 2013). Both SSA 
and BIR belong to the category of HR. SSA repairs DSBs between two repeat sequences 
by using the repeat sequences in a single DNA molecule as the homologous sequence for 
repair, while BIR is often associated with replication and serves to repair broken 





Figure 1.1 Schematic diagram of DSB repair pathways 
In response to DSBs, the Ku heterodimer quickly binds to DNA ends and initiates the NHEJ repair 
pathway though recruitment of DNA-PKcs and other NHEJ factors. NHEJ is active throughout the 
cell cycle and is the predominant pathway for the repair of DSBs. An alternative NHEJ pathway 
mediated by PARP1, XRCC1 and DNA Ligase I or III may be initiated to compensate for the loss of 
classical NHEJ in cancer cells. The MRN complex can compete with Ku to bind to DNA ends, which 
leads to ATM activation and initiation of an ATM-dependent signaling cascade. MRN also initiates 5’ 
to 3’ DNA end resection in cooperation with CtIP to generate short 3’ overhangs, which are further 
resected by Exo1 and Dna2 to produce long 3’ overhangs that are coated by the ssDNA-binding 
protein RPA. Active ATM promotes resection though phosphorylation of multiple proteins involved 
in resection, while the 53BP1/RIF complex promotes NHEJ by blocking DSB end resection. The role 
of BRCA1 in DSB end resection remains controversial. The RPA-coated ssDNA activates ATR 
together with ATPIP, TOPBP1 and MRN, contributing to the activation of cell cycle checkpoint. RPA 
is then displaced by RAD51 to generate RAD51 filament, a process facilitated by BRCA2. RAD51 
coated ssDNA further mediates strand invasion and completion of HR repair. The activity of HR is 
limited to late S and G2 phases of the cell cycle. Adapted from (Davis et al, 2014; Radhakrishnan et al, 
2014). 
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PHOSPHATIDYLINOSITOL 3 KINASE-LIKE KINASE (PIKK) FAMILY 
As mentioned above, three members of the Phosphatidylinositol 3 kinase-like 
kinase (PIKK) family, including ATM, DNA-PKcs and ATR, are actively involved in 
DNA damage response and repair of DSBs. PIKK family consists of 6 Ser/Thr protein 
kinases with a preference for phosphorylating a serine or threonine followed by a 
glutamine (SQ/TQ). Other members of the PIKK family include the mammalian target of 
rapamycin (mTOR) which acts to sense nutrient and regulate metabolism, and the 
suppressor of morphogenesis in genitalia-1 (SMG-1) which is involved in the nonsense-
mediated mRNA decay, as well as the transformation/transcription domain-associated 
protein (TRRAP) which is a regulator of transcription (Baretic & Williams, 2014) (Figure 
1.2).  
The members of PIKK family all share a C-terminal kinase domain which shows 
homology to the Phosphatidylinositol 3 family of lipid kinases (PI3Ks), a group of 
enzymes that phosphorylate inositol phosphate molecules (Keith & Schreiber, 1995). 
However, the PIKK family members have only been implicated in phosphorylation of 
proteins but not phosphatidylinositol (Baretic & Williams, 2014). In addition to the 
kinase domain, a few other domains are also found to be conserved within the PIKK 
family. The FRAP-ATM-TRRAP (FAT) domain is N-terminal to the kinase domain, 
while the PIKK regulator domain (PRD) is C-terminal to the kinase domain, followed by 
the FAT C-terminal (FATC) domain (Figure 1.2). More and more evidence show that 
these three domains function together to regulate the catalytic activity of PIKK family 
members. For instance, the FAT and FATC domains of DNA-PKcs undergo large 
conformational changes when DNA-PKcs is recruited to DSB ends and activated by Ku 
(Spagnolo et al, 2006). A point mutation which truncates the last ten residues of the 
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FATC domain of ATM dramatically decreases ATM kinase activity (Guo et al, 2010b). 
Both DNA-PKcs and ATM have been shown to be autophosphorylated in the PRD, and 
these modifications are essential for the activation and function of both kinases, 
suggesting the importance of the PRD to PIKK family (Mordes et al, 2008). The N-
terminus of PIKK family member contains large HEAT repeats structure which may 
serve as a scaffold for the interactions among the kinase domain, the FAT domain, the 
FATC domain, as well as other proteins and DNA molecules, but the underlying 
mechanism remains elusive (Paull, 2015).  
 
 
Figure 1.2 Schematic representation of the functional domains of PIKK family members 
The colors represent domains: blue, HEAT repeats; yellow, FAT domain; red, PI3K-like kinase 
domain; green, PIKK regulatory domain; purple, FATC domain. The domains in ATM are as 
follows: HEAT repeats, 1-1,965; FAT domain, 1,966-2,566; PI3K-like kinase domain, 2,614-
2,960; PIKK regulatory domain, 2,961-3,024; FATC domain, 3,025-3,056. The domains in DNA-
PKcs are as follows: HEAT repeats, 1-2,883; FAT domain, 2,884-3,538; PI3K-like kinase 
domain, 3,565-4,013; PIKK regulatory domain, 4,012-4,096; FATC domain, 4,097-4,128. 
Adapted from (Paull, 2015). 
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In response to DNA damage, the action of ATM, ATR and DNA-PKcs requires 
distinct sensor proteins which activate the kinases in concert with different types of DNA. 
ATR is activated by RPA-coated ssDNA regions associated with stalled replication forks 
or DSB end resection through ATR-interacting protein (ATRIP), DNA topoisomerase II-
beta-binding protein 1 (TopBP1) and 9-1-1 complex. Once activated, ATR 
phosphorylates Chk1 to initiate a cellular signaling cascade that leads to cell cycle arrest 
(Cimprich & Cortez, 2008). Both ATM and DNA-PKcs are activated by DSBs, with 
requirement for MRN and Ku, respectively. Activated ATM regulates the initiation of 
DSB end resection that drives DNA repair to the HR pathway; meanwhile it mediates cell 
cycle checkpoint activation by phosphorylating Chk2 and p53 (Ditch & Paull, 2012). In 
contrast, activated DNA-PKcs primarily triggers DSB repair through the NHEJ pathway 
(Dobbs et al, 2010). Additionally, DNA-PKcs has also been implicated in regulation of 
replication stress checkpoint activation by facilitating the RPA-ATR-Chk1 signaling 
pathway (Ashley et al, 2014; Lin et al, 2014).  
Although great progress has been achieved on understanding the mechanisms to 
DNA repair during the past decades, the mechanism for the choice between ATM/MRN-
dependent HR pathway and DNA-PKcs/Ku-dependent NHEJ pathway in S/G2 phases are 
still not well understood. In this study, I mainly focus on the regulation of DNA damage 
response by ATM and DNA-PKcs, and how these two kinases coordinately regulate DSB 
end resection/rejoining, DNA damage signaling as well as DNA repair pathway choice, 
all of which will be further discussed in greater detail in the following sections. 
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ATAXIA TELANGIECTASIA MUTATED (ATM) 
ATM is named from a rare autosomal recessive neurodegeneration disease, 
ataxia-telangiectasia (A-T), which is caused by deficiency of ataxia-telangiectasia 
mutated (ATM) protein kinase. A-T is characterized by difficulties with movement and 
coordination (ataxia), blood vessel dilation (telangiectasia), immunodeficiency, 
hypersensitive to ionizing radiation, and high rate of tumorigenesis (Paull, 2015; Shiloh 
& Ziv, 2013). Most A-T patients lack functional ATM protein because of nonsense or 
missense mutations of in the ATM gene. The incidence of A-T is about 1 in 40,000 to 
100,000, which is not very high. However, approximately 1.4% of people are 
heterozygous with a mutant allele of ATM gene and they are likely to have higher risk for 
tumorigenesis (Athma et al, 1996; Khanna, 2000). Consistently, mouse models 
heterozygous for ATM mutation exhibit increased susceptibility to cancer after exposure 
to radiation (Spring et al, 2002). Most phenotypes of A-T patients, except 
neurodegeneration, are recapitulated in ATM knockout mice (Barlow et al, 1996). 
Surprisingly, mice homozygous for kinase-dead ATM die at an early embryonic stage, 
but the mechanism is not quite clear (Daniel et al, 2012; Yamamoto et al, 2012). 
 
ATM ACTIVATION AND ATM REGULATION OF DNA DAMAGE RESPONSE 
ATM exists as an inactive non-covalent dimer in resting cells (Bakkenist & 
Kastan, 2003). Upon DNA damage, ATM is recruited to break sites by the MRN 
complex through interaction with Nbs1 (Lee & Paull, 2005; You et al, 2005). ATM is 
also shown to interact with MR subunits in the MRN complex through an interface in 
Rad50 in vitro (Lee & Paull, 2004). At sites of double-strand breaks ATM is activated, 
characterized by ATM autophosphorylation at Ser1981 and transition from a non-
covalent dimer to a monomer (Bakkenist & Kastan, 2003) (Figure 1.3A). In response to 
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ionizing radiation (IR) treatment, ATM has been shown to mediate phosphorylation of 
more than 700 putative substrates involved in a variety of cellular processes, such as cell 
cycle regulation, chromatin reorganization, DNA repair, gene regulation and apoptosis 
(Matsuoka et al, 2007).  
G1/S checkpoint is activated by ATM phosphorylation of p53 at Ser15 and Chk2 
at Thr68 (Barlow et al, 1997; Matsuoka et al, 2000), while the intra-S checkpoint is 
regulated by ATM-mediated phosphorylation of structural maintenance of chromosome 1 
(SMC1) at Ser957 and Ser966 (Figure 1.3B). Interestingly, Nbs1 in the MRN complex is 
also phosphorylated by ATM at Ser278 and Ser343, and these phosphorylation events 
facilitate ATM phosphorylation of SMC1 (Kitagawa et al, 2004; Yazdi et al, 2002). ATM 
is also actively involved in G2/M checkpoint activation, which involves ATM-mediated 
phosphorylation of Chk2 and BRCA1 (Kurz & Lees-Miller, 2004) (Figure 1.3B). In 
addition, ATM signaling has been shown to facilitate repair of DSBs located in 
heterochromatin by phosphorylating the transcriptional corepressor Kruppel-associated 
box (KRAB)-associated protein-1 (KAP1) at Ser824, which temporarily perturbs 
heterochromatin, allowing the DNA repair machinery to enter the otherwise compacted 
chromatin (Goodarzi et al, 2008). In response to high dose to DNA damage which cannot 
be efficiently repaired by cells, ATM serves to promote apoptosis through 
phosphorylation of multiple apoptosis factors including p53 and E2F1 (Kurz & Lees-
Miller, 2004) (Figure 1.3B). In addition to its major role in DNA damage signaling and 
checkpoint activation, ATM also directly promotes HR repair by phosphorylating 
multiple proteins involved in DSB end resection, such as CtIP, MRN and human ssDNA-
binding protein 1 (hSSB1) (Figure 1.3B), which will be further discussed in the “DSB 
end resection” section. Notably, a recent study suggests that ATM is also involved in late 
stage of HR when DSB end resection and RAD51 filament formation are already 
 11 
finished, suggesting the requirement for ATM in both initiation and completion of HR 
(Bakr et al, 2015).  
The recruitment of ATM to DSB sites is critical for its function. In addition to the 
MRN complex, MDC1 was also shown to promote the binding of ATM to damage sites. 
MDC1 serves as a primary “reader” of γH2AX and it tightly binds to modified histone in 
the vicinity of DSBs. MDC1 can interact with ATM directly, although this interaction 
does not affect ATM autophosphorylation as MRN-ATM interaction does. MDC1 can 
also recruits ATM indirectly through association with Nbs1 in the MRN complex (Lou et 
al, 2006). Therefore, MDC1 strongly enhances ATM recruitment to DSB sites, which 
increases local concentrations of γH2AX, leading to chromatin binding of more MDC1 
and subsequently more MRN and ATM. This amplification loop acts to maintain the 
ATM signaling for a sustained DNA damage response. Similarly, a recent study revealed 
another amplification loop of ATM regulation involving ATM phosphorylation of Rad17. 
This event leads to increased Rad17-MRN interactions, which brings more ATM to DSB 






Figure 1.3 ATM activation and function 
(A) ATM exists as an inactive non-covalent dimer in resting cells (Bakkenist & Kastan, 2003). In 
the presence of DSBs, ATM dimers are recruited to DSB ends by MRN and converted to active 
monomers, with ATM autophosphorylation at Ser1981 being a marker of ATM activation in 
human cells. In the presence of oxidative stress, the inactive non-covalent ATM dimer becomes 
an active covalent dimer through formation of disulfide bonds at multiple sites, with the most 
critical one being Cys2991 (Guo et al, 2010b). (B) ATM regulates multiple cellular processes via 
phosphorylation of a variety of downstream effector proteins. Adapted from (Kurz & Lees-Miller, 
2004). 
 
ATM POST-TRANSLATIONAL MODIFICATIONS 
Like many other kinases, ATM is subjected to post-translational modifications 
which actively regulate ATM activity (Figure 1.4). One example is the acetylation of 
ATM at Lys3016 by the histone acetyltransferase Tip60 which is a prerequisite for ATM 
autophosphorylation and activation in response to DNA damage (Sun et al, 2005). Most 
strikingly, ATM has been shown to be autophosphorylated at four sites, including S1981, 
S367, S1893, and S2996, which is essential for ATM activation and function in response 
to DNA damage in human cells (Bakkenist & Kastan, 2003; Kozlov et al, 2011; Kozlov 
et al, 2006). ATM autophosphorylation at Ser367 and Ser1981 is important for the 
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sustained retention of ATM at DSB sites but not required for ATM recruitment 
(Bensimon et al, 2010; So et al, 2009). Phospho-blocking mutations at these sites prevent 
dimerization of ATM (Berkovich et al, 2007); however, these mutations do not affect 
ATM kinase activity in vitro or in mouse models (Daniel et al, 2008; Guo et al, 2010b; 
Lee & Paull, 2005; Pellegrini et al, 2006). It remains unresolved why humans and mice 
have totally different requirements for ATM autophosphorylation.  
In addition to autophosphorylation, ATM is also target of several other kinases. It 
has been shown that cyclin-dependent kinase 5 (CDK5) mediates phosphorylation of 
ATM at Ser794 upon DNA damage in neurons (Tian et al, 2009). Mutation of Ser794 to 
alanine in ATM impairs ATM autophosphorylation as well as the phosphorylation of 
ATM substrates, p53 and H2AX, suggesting that ATM Ser794 phosphorylation by CDK5 
is critical for ATM activation (Tian et al, 2009). A recent work suggests that the 
epidermal growth factor receptor (EGFR)-mediated phosphorylation of ATM at Tyr370 
also positively regulates ATM activation in the presence of DNA damage. Depletion or 
chemical inhibition of EGFR greatly impairs ATM activation, as shown by reduced foci 
formation; Chk2 phosphorylation and DNA repair efficiency (Lee et al, 2015). 
Interestingly, the chromosomal passenger protein kinase Aurora B has also been 
implicated in ATM activation in a DNA damage-independent manner during mitosis by 
phosphorylating ATM at Ser1403, which is essential for spindle assembly checkpoint 
activation upon nocodazole treatment (Yang et al, 2011).  
Dephosphorylation is also actively involved in regulation of ATM kinase activity. 
Several protein phosphatases, including PP2A, PP1 and wild-type p53-induced 
phosphatase 1 (Wip1), have been implicated in regulation of ATM activity in an 
inhibitory way. In the absence of DNA damage, both PP2A and PP1 constitutively 
interact with ATM, which represses ATM Ser1981 autophosphorylation. Upon DNA 
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damage, PP2A and PP1 dissociate from ATM, allowing the accumulation of 
autophosphorylated ATM and hence the initiation of the ATM signaling cascade 
(Goodarzi et al, 2004; Peng et al, 2010). Wip1 regulation of ATM is achieved though up-
regulation of Wip1 expression in a p53-dependent manner, which reduces ATM 
autophosphorylation after DNA damage (Shreeram et al, 2006). Therefore, PP2A and 
PP1 serve to repress ATM activation in the absence of DNA damage in resting cells 
where limited ATM activity is required, whereas Wip1 acts to inhibit ATM activation 
upon DNA damage, leading to impaired DNA repair and tumorigenesis. Conversely, the 
serine-threonine phosphatase 5 (PP5) stimulates ATM activation in response to DNA 
damage. The interaction between ATM and PP5 is induced by DNA damage, and 
depletion of PP5 impairs ATM autophosphorylation and activation, leading to reduced 
phosphorylation of ATM substrates and S-phase checkpoint defect (Ali et al, 2004). A 
possible model for PP5 stimulation of ATM activity in cells is that ATM kinase activity 
is normally inhibited by serine/threonine phosphorylation of certain sites, while PP5 
serves to remove these inhibitory phosphates upon DNA damage. Actually there is 
evidence showing the dephosphorylation events of ATM indeed occur after DNA damage 
(Kozlov et al, 2003). 
 
 
Figure 1.4 Post translational modification of ATM 
Sites associated with ATM activation are indicated. P, phosphorylation; S-S, disulfide bond 
formation; Ac, acetylation. Adapted from (Shiloh & Ziv, 2013). 
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ATM ACTIVATION BY OXIDATIVE STRESS 
Numerous observations have revealed a linkage between ATM and oxidative 
stress responses in cells. ATM-deficient cells are hypersensitive to oxidizing agents and 
have an impaired antioxidant response, while ATM-deficient mice show higher levels of 
reactive oxygen species (ROS) and oxidative stress in the cerebellum where 
neurodegeneration is found in A-T patients (Ditch & Paull, 2012). Interestingly, 
antioxidant treatment is able to restore cell proliferation and inhibits stress-associated 
signaling initiated by higher ROS in ATM-deficient cells (Ito et al, 2004; Kim & Wong, 
2009; Kurz et al, 2004). This evidence suggests that in addition to being activated by 
DNA damage in a MRN/DNA-dependent manner, ATM plays a key role in cellular 
response to oxidative stress as well. Biochemical studies showed ATM can be activated 
by hydrogen peroxide in the absence of MRN and DNA in vitro (Guo et al, 2010a; Guo et 
al, 2010b). Instead of undergoing monomerization in response to DNA damage, ATM 
forms an active covalent dimer through disulfide formation between the Cys2991 
residues of two ATM molecules in the presence of H2O2 (Figure 1.3A). Expression of the 
C2991L ATM mutant which cannot be activated by oxidative stress fails to induce 
apoptosis as wild-type ATM does in A-T cells upon H2O2 treatment. H2O2 is also found 
to induce disulfide bonds formation though a number of other cysteines of ATM in vitro, 
which don’t affect ATM activation but may help to stabilize the functionally important 
Cys2991 disulfide bond. Interestingly, the autophosphorylation-blocking ATM mutant 
S1981A can be normally activated by H2O2, indicating that autophosphorylation of ATM 
at Ser1981 is not required for oxidative stress-induced ATM activation. Notably, KAP1 
and H2AX which are targets of ATM in response to DNA damage are not phosphorylated 
by oxidative stress-activated ATM in cells, suggesting the substrate preference of ATM 
in different signaling pathways (Guo et al, 2010b). In addition, MRN/DNA-dependent 
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ATM activation is inhibited by hydrogen peroxide in vitro, presumably due to the 
impaired MRN binding to DNA in the presence of hydrogen peroxide (Guo et al, 2010a). 
This finding suggests that the activation of ATM by DNA damage might be repressed by 
high levels of ROS in cells. Since ionizing radiation (IR) treatment induces both DSBs 
and ROS production (Yamamori et al, 2012), MRN/DNA-dependent and oxidative stress-
dependent ATM activation should both be activated and influence ATM function in IR-
treated cells. 
 
DNA-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (DNA-PKCS) AND KU 
Another important PIKK member that directly regulates DNA repair is DNA-
dependent protein kinase catalytic subunit (DNA-PKcs). Cells lacking either DNA-PKcs 
or Ku are extremely sensitive to DNA damage agents while mice without DNA-PKcs or 
Ku are immune deficient (Jette & Lees-Miller, 2015). DNA-PKcs, together with the 
Ku70/80 heterodimer and DNA, form a holoenzyme referred to as “DNA-PK” which 
initiates NHEJ, the predominant pathway for the repair of IR-induced DSBs as well as 
programmed DSBs generated during V(D)J recombination in mammalian cells (Wang & 
Lees-Miller, 2013).  
Ku is a very abundant protein with high affinity to DNA ends in cells and the 
binding of Ku to DNA is sequence independent (Downs & Jackson, 2004). The Ku70 and 
Ku80 subunits form a ring-shaped structure which can slide on DNA in an ATP-
independent manner (Cary et al, 1997; Walker et al, 2001). Although in vitro studies 
show that naked DNA could be occupied by more than one Ku molecule, in vivo data 
suggests that each DSB end is generally bound by only one Ku heterodimer (Cary et al, 
1997; de Vries et al, 1989). Due to high protein abundance and DNA binding affinity, Ku 
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binds to DSB ends within a few seconds regardless of cell cycle phase (Britton et al, 
2013; Mari et al, 2006). On the one hand, Ku facilitates the recruitment of NHEJ 
machinery to DSB sites through direct or indirect interactions with multiple canonical 
NHEJ factors, including DNA-PKcs, DNA Ligase IV, XRCC4, XLF, Artemis and other 
DNA end processing enzymes (Davis et al, 2014; Radhakrishnan et al, 2014) (Figure 
1.1). It should be noted that the recruitment of various NHEJ factors is a dynamic process 
rather than occurring in a stepwise, sequential manner (Yano & Chen, 2008; Yano et al, 
2009). On the other hand, Ku serves to maintain the stability of broken DNA ends by 
protecting the ends from non-specific processing (Sun et al, 2012). Ku70/80 hetrodimer 
binds to DSBs with Ku70 being proximal to the end and Ku80 distal to the end (Walker 
et al, 2001).  
Ku is able to recruit DNA-PKcs efficiently through multi-site interaction between 
the two proteins (Rivera-Calzada et al, 2005; Rivera-Calzada et al, 2007; Spagnolo et al, 
2006). Ku-mediated recruitment of DNA-PKcs to DSB ends results in the inward 
translocation of Ku, which places DNA-PKcs at the extreme DNA end (Calsou et al, 
1999; Yoo & Dynan, 1999). DNA-PKcs binds to both DSB ends and forms a stable 
synaptic complex that holds the two broken ends together for subsequent end rejoining 
(DeFazio et al, 2002; Weterings & van Gent, 2004).  
 
ACTIVATION OF DNA-PKCS 
The kinase activity of DNA-PKcs is critical for regulation of NHEJ, as evidenced 
by the observations that chemical inhibition of DNA-PKcs and kinase-inactivating 
mutations of this kinase both lead to radiosensitivity and impaired DSB repair (Kienker et 
al, 2000; Kurimasa et al, 1999). DNA-PKcs by itself shows very limited basal kinase 
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activity, which is strongly stimulated by Ku and DNA in vitro (Chan & Lees-Miller, 
1996), but the mechanism remains unresolved. Evidence from low resolution structure 
shows that after binding to Ku at DNA ends, a conformational change occurs in the FAT 
and FATC domains of DNA-PKcs, which may alter the catalytic group in the kinase 
domain or the ATP binding pocket, leading to full activation of DNA-PKcs (Rivera-
Calzada et al, 2005; Rivera-Calzada et al, 2007; Spagnolo et al, 2006). The N-terminal 
HEAT repeats region of DNA-PKcs forms a central open cavity that threads DNA 
through the channel, leading to the formation of a very stable Ku/DNA-PKcs/DNA 
complex (Sibanda et al, 2010). Interestingly, deletion of the N-terminus of DNA-PKcs 
results in spontaneous activation of this kinase, suggesting that the N-terminal region also 
serves to repress the basal activity of DNA-PKcs (Davis et al, 2013; Meek et al, 2012).  
 
PHOSPHORYLATION OF DNA-PKCS 
DNA-PKcs is recruited to DSB ends by Ku within seconds after DNA damage 
(Uematsu et al, 2007). The active DNA-PK holoenzyme composed of Ku, DNA-PKcs 
and DNA mediates the phosphorylation of many other NHEJ factors as well as DNA-
PKcs and Ku themselves, although most of these phosphorylation events do not seem to 
affect the efficiency of NHEJ (Wang et al, 2013). DNA-PKcs has been shown to be 
phosphorylated on more than 40 sites, including several phosphorylation clusters which 
are critical for DNA-PKcs function (Dobbs et al, 2010) (Figure 1.5). Autophosphorylated 
DNA-PKcs undergoes a large conformational change that is thought to promote its 
dissociation from DNA ends, along with the inactivation of DNA-PKcs kinase activity 
(Ding et al, 2003; Dobbs et al, 2010; Merkle et al, 2002; Reddy et al, 2004; Shibata et al, 
2011). Of particular importance to this rearrangement, a cluster of 6 serines and 
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threonines in DNA-PKcs termed the ABCDE cluster are autophosphorylated (Meek et al, 
2007), and Thr2609 in this cluster were also shown to be target of ATM and ATR in the 
presence of DSBs and replication stress, respectively (Chen et al, 2007; Yajima et al, 
2006). Phospho-blocking mutations at the Thr2609 severely impaired DNA-PKcs 
mediated end-joining in vitro and cell survival upon radiation, suggesting that 
phosphorylation of the DNA-PKcs Thr2609 cluster is critical for NHEJ (Block et al, 
2004; Chan et al, 2002; Ding et al, 2003). DNA-PKcs Thr2609 cluster phosphorylation is 
also essential for recruitment of Artemis, which is required for V(D)J recombination after 
being phosphorylated by ATM (Goodarzi et al, 2006). Another DNA-PKcs 
phosphorylation cluster involved in the regulation of NHEJ is the Ser2056 cluster, which 
is likely to limit DNA end processing upon autophosphorylation. Conversely, 
phosphorylation of the Thr2609 cluster serves to promote DNA end processing (Meek et 
al, 2007). 
Interestingly, phospho-mimetic mutations of DNA-PKcs at three phosphorylation 
sites, including Ser3205 (ATM-dependent phosphorylation site) in the FAT domain as 
well as Ser56 and Ser72 (autophosphorylation sites) in the N-terminus, all lead to 
decreased catalytic activity, indicating that phosphorylation of DNA-PKcs at these sites 
may inactivate DNA-PKcs kinase activity (Neal et al, 2011). Similar to ATM, the 
catalytic activity of DNA-PKcs is also regulated by other kinases, such as EGFR and Akt, 
although this regulation is not mediated by direct phosphorylation of DNA-PKcs (Das et 




Figure 1.5 Phosphorylation of DNA-PKcs 
Diagram of DNA-PKcs phosphorylation sites and the corresponding upstream kinases as 
indicated. Adapted from (Davis et al, 2014). 
 
DNA-PKCS REGULATION OF HR AND OXIDATIVE STRESS RESPONSE 
Apart from its role in NHEJ, DNA-PKcs has also been implicated in regulation of 
HR (Allen et al, 2003; Convery et al, 2005; Cui et al, 2005; Neal et al, 2011; Shibata et 
al, 2011). It has been shown that the expression of exogenous DNA-PKcs in cells lacking 
this kinase inhibits HR in a Ku-dependent manner (Neal et al, 2011). Depletion of either 
Ku or DNA-PKcs leads to higher DSB end resection and hence HR, while overexpression 
of a DNA-PKcs mutant which has been disabled for phosphorylation of the Thr2609 
cluster results in delayed RAD51 foci formation (Shibata et al, 2011). However, there is 
still debate on how DNA-PKcs kinase activity affects DNA-PKcs regulation of HR and 
conflicting results have been reported on this issue (Allen et al, 2003; Davidson et al, 
2012; Neal et al, 2011). Additionally, previous studies have demonstrated that Ku inhibits 
5’ strand resection mediated by Exo1 or Dna2 in vitro, while MRN overcomes Ku 
inhibition of resection (Shim et al, 2010b; Yang et al, 2013), but it is not clear whether 
DNA-PKcs is also involved this process. It remains to be investigated whether DNA-
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PKcs directly affects resection and how its kinase activity and autophosphorylation 
function in this process.  
Notably, DNA-PKcs has also been implicated in the regulation of oxidative stress 
response in cells, although the detailed mechanism remains elusive (Li et al, 2014). 
DNA-PKcs deficiency leads to increased cellular level of ROS and decreased cell 
survival after treatment. It was found that ATM is hyperactive upon H2O2 treatment in 
DNA-PKcs-deficient cells, likely due to elevated ROS production as well as oxidatively 
damaged DNA accumulation, which both activate ATM. In contrast, this effect is not 
observed in DNA Ligase IV-deficient cells, indicating the hyperactivation of ATM in 
DNA-PKcs-deficient cells is not due to impaired NHEJ. Collectively, these results 
suggest that DNA-PKcs is a regulator of cellular redox homeostasis and serves to prevent 
ATM hyperactivation by reducing ROS in an NHEJ-independent manner (Li et al, 2014). 
 
THE MRE11/RAD50/NBS1 (MRN) COMPLEX 
The Mre11/Rad50/Nbs1 (Xrs2 in yeast) complex is conserved in all species and 
plays a key role in DSBs sensing, processing and repair. Nbs1(Xrs2) is lacking in 
prokaryotes but Mre11 and Rad50 are still present (Lamarche et al, 2010). MRN complex 
is essential for life, as deletion of any of the three components of MRN in mice leads to 
embryonic lethality, possibly due to HR deficiency caused by loss of functional MRN 
complex (Paull & Deshpande, 2014). Mre11 is characterized as a member of the Lambda 
phosphatase family of phosphodiesterases which possesses two metal ions in the active 
sites and mediates cleavage at phosphodiester or phosphomonoester bonds. Mre11 was 
shown to exhibits manganese-dependent 3’ to 5’ exonuclease activity on double-stranded 
DNA (dsDNA) as well as endonuclease activity on ssDNA/dsDNA junctions (Paull & 
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Gellert, 1998; Trujillo & Sung, 2001). Rad50 belongs to the structural maintenance of 
chromosomes (SMC) proteins family and has multiple activities, including ATP 
hydrolysis, adenylate kinase activity, as well as ATP-dependent DNA unwinding activity 
(Paull, 2015). The Rad50 protein has an extended structure with the Walker A ATP-
binding motif on the N-terminus and Walker B ATP-binding motif on the C-terminus 
contacting each other to form a globular ATP-binding domain, and a long coiled-coil in 
the middle of the protein extending away from the global domain (Paull, 2015) (Figure 
1.6A). Mre11 binds to Rad50 at the base of coiled-coil, forming the MR complex which 
exists as a dimer and functions to tether DNA ends together (de Jager et al, 2001). The 
intact MRN complex is formed by Mre11-mediated recruitment of Nbs1, which is 
essential for nuclear localization of the whole complex and MRN/DNA-dependent 
activation of ATM, as well as regulation of the DNA end unwinding activity and 
nuclease activity of MRN (Lee et al, 2003; Williams et al, 2010) (Figure 1.6B). MRX has 
been shown to promote NHEJ via interactions with Ku and DNA Ligase IV, although a 
similar effect is not observed for MRN (Lewis & Resnick, 2000). The major role of MRN 
in DNA repair is related to ATM activation and DNA end resection as discussed below. 
Hypomorphic mutations in the Mre11, Nbs1 and Rad50 genes lead to Ataxia-
Telanglectasia-Like Disorder (ATLD), Nijmegen breakage syndrome (NBS), and NBS‐
like disorder (NBSLD), respectively (Paull & Deshpande, 2014). Patients with these 
genetic diseases exhibit neurodegenerative and developmental disorders similar to A-T 
patients, suggesting the functional relationship between MRN and ATM (Paull, 2015). 
Deficiency of MRN results in failure of ATM activation upon DNA damage (Uziel et al, 
2003), further indicating that MRN functions upstream of ATM in response to DNA 
damage. Biochemistry studies using purified recombinant MRN and ATM proteins show 
that MRN strongly stimulate ATM activation in a DNA-dependent way in vitro (Lee & 
 23 
Paull, 2005). MRN binds to DNA ends tightly through multiple interfaces in the presence 
of ATP, recruits ATM through both ATM-Nbs1 interaction and ATM-MR interaction 
and promotes the monomerization and activation of ATM (Lee & Paull, 2005). It has 
been shown that this activation process requires ATP but not ATP hydrolysis (Lee et al, 
2013b). In the presence of ATP, MRN unwinds ~15 nt at DNA ends through the DNA 
unwinding activity of Rad50 (Cannon et al, 2013). Interestingly, ATM cannot be 
activated by MRN mutant with impaired DNA end unwinding activity in vitro, which can 
be complemented by using a DNA substrate with unwound ends (Lee & Paull, 2005), 
suggesting that MRN-mediated DNA end unwinding process is essential for ATM 
activation. This can also explain why MRN only activate ATM at DNA ends although it 
binds to internal DNA as well. In addition, the nuclease activity of MRN is not essential 
for ATM activation both in vitro and in cells (Hartlerode et al, 2015; Lee et al, 2013b). 
In addition to activating ATM and initiating the DNA damage signaling networks, 
MRN is also directly involved in DNA repair by regulating DSB end resection which is 
critical for HR. Studies in yeast and in vitro show that MRX initiates short-range of 
resection at 5’ strand in cooperation with the Sae2 endonuclease and promotes extensive 
resection by recruiting 5’ to 3’ exonucleases and helicases (Cejka et al, 2010; Mimitou & 
Symington, 2008; Nicolette et al, 2010; Nimonkar et al, 2011; Niu et al, 2010; Zhu et al, 
2008). Notably, the nuclease activity of MRX is not required for resection of 
enzymatically-generated “clean” DSBs but is essential for processing of DSB ends with 
covalently bound Spo11 protein during meiosis in budding yeast (Moreau et al, 1999).     
In agreement with these observations, in vitro reconstituted resection assays with purified 
human recombinant proteins suggest that the MRN complex can overcome Ku inhibition 
of DNA end resection by exonuclease 1 (Exo1) and enhance Dna2-mediated resection in 
cooperation with CtIP, and a nuclease-deficient MRN complex can promote DNA end 
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resection by Exo1 equally well as wild-type MRN in the presence of Ku (Makharashvili 
et al, 2014; Yang et al, 2013).  
 
 
Figure 1.6 Schematic representation of the MRN complex 
(A) The functional domains and important interaction sites in Mre11, Rad50 and Nbs1 are shown. 
(B) Schematic model for assembly of the MRN complex. Adapted from (Paull & Deshpande, 
2014). 
 
DNA END RESECTION AND DNA REPAIR PATHWAY CHOICE 
The first step of HR is the nucleolytic degradation of the 5’ strand to generate 
long 3’ ssDNA overhangs, a process termed DNA end resection. Many proteins are 
directly or indirectly involved in this complicated process, but the key task of resection is 
fulfilled by MRN (MRX in yeast), CtIP (Sae2 in Yeast), as well as two nucleases, Exo1 
and Dna2. MRN and CtIP initiate resection by mediating the endonucleolytic cleavage at 
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the 5’ strand end to generate a short 3’ ssDNA tail, which requires the endonuclease 
activity of MRN and CtIP and possibly the 3’ to 5’ exonuclease activity of MRN, 
followed by long-range resection through two parallel pathways which are dependent on 
the 5’ to 3’ exonuclease, Exo1, and the Dna2 endonuclease in concert with the 
Sgs1/BLM/Top2/Rmi1 complex, respectively (Symington, 2014) (Figure 1.7).  
 
 
Figure 1.7 Initiation of resection at DSB ends with protein adducts 
MRN and CtIP cooperatively generate a nick at a distance from DSB end, followed by 
bidirectional resection from the nick: 5’ to 3’ resection mediated by MRN and 3’ to 5’ resection 
mediated by Exo1. Adapted from (Symington, 2014). 
 
The initiation of DSB end resection is critical for DSB repair pathway choice in 
S/G2 cell cycle phases when both HR and NHEJ are active in eukaryotic cells, as 
extensively resected DSB ends cannot be religated by the NHEJ pathway. It has been 
shown that G1 arrest or chemical inhibition of cyclin-dependent kinases (CDKs) both lead 
to reduced resection, suggesting regulation of resection by cell cycle in a CDKs-
dependent manner (Ira et al, 2004). Further studies suggest that CDK actively regulates 
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resection through phosphorylation of multiple key proteins involved in DNA end 
resection, including CtIP, Exo1, as well as Nbs1 in the MRN complex. CtIP, a functional 
ortholog protein of yeast Sae2, is recruited to DSB sites and is indispensable for resection 
in human cells of S/G2 cell-cycle phases (Sartori et al, 2007). CDK-mediated 
phosphorylation of human CtIP at Thr847 (or Sae2 at Ser267) is essential for the 
initiation of resection (Huertas et al, 2008; Huertas & Jackson, 2009). Human Nbs1 in the 
MRN complex is also a target of CDKs. Phosphorylation of Nbs1 at Ser432 by CDKs has 
been shown to be essential for DSB end resection and HR repair (Falck et al, 2012), 
although conflicting results were obtained in another study regarding the role of Nbs1 
Ser432 phosphorylation in resection (Wohlbold et al, 2012). CDKs have also been 
implicated in regulation of long-range resection through phosphorylation of Exo1 at four 
S/TP sites on the C-terminus, including Ser369, Thr732, Ser815 and Thr824, in human 
cells (Tomimatsu et al, 2014). Phosphorylation of these sites by CDK1/2 promotes Exo1 
recruitment to DSB sites and hence stimulates long-range resection. In response to DNA 
damage, phospho-blocking mutations of Exo1 at the four CDKs sites block resection, 
leading to attenuated HR and cell survival, but increased NHEJ, whereas phospho-
mimetic mutations of Exo1 favour HR over NHEJ and render Exo1 constitutively active 
even in the presence of CDK inhibitor (Tomimatsu et al, 2014).  
As mentioned in previous sections, the ATM protein kinase is also actively 
involved in regulation of DNA end resection in addition to its critical role in cell cycle 
checkpoint activation upon DNA damage. On the one hand, ATM is required for end 
resection of DSBs locating in heterochromatin by facilitating the relaxation of 
heterochromatin via KAP1 phosphorylation. On the other hand, ATM directly 
phosphorylates a few DNA end resection factors and modulates their activities. 
Interestingly, CtIP, Exo1 and MRN are also targets of ATM. ATM-dependent 
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phosphorylation of CtIP at Ser664 and Ser745 has been shown to be critical for CtIP 
nuclease activity in vitro (Makharashvili et al, 2014). Upon DNA damage, CtIP is 
phosphorylated by ATR at Thr859, which enhances DNA end resection (Peterson et al, 
2013). But this site has also been shown to be phosphorylated by ATM, and this 
phosphorylation event requires CDKs-dependent CtIP phosphorylation and promotes 
CtIP recruitment, DSB end resection and HR repair (Wang et al, 2013). The single-
stranded DNA-binding protein hSSB1 has been shown to promote DNA end resection by 
Exo1 in vitro and is critical for genomic stability in cells (Richard et al, 2008; Yang et al, 
2013). Upon DNA damage, ATM-mediated phosphorylation of hSSB1 at Thr117 
stabilizes hSSB1 against proteasomal degradation and leads to hSSB1 accumulation in 
the nucleus where it functions to enhance resection and HR repair (Richard et al, 2008; 
Yang et al, 2013).  
Notably, in addition to promote the initiation of resection, ATM also functions to 
prevent excessive DSB end resection, which is unsuitable for RAD51 loading and HR 
and is essentially harmful for cells, by phosphorylating Exo1 at Ser714. This 
phosphorylation event occurs at some point after RPA loading to the ssDNA 
intermediates of resection but before RAD51 loading, and may attenuate Exo1 activity to 
prevent the destruction of RPA-loaded ssDNA substrates required for HR (Bolderson et 
al, 2010). Therefore, phosphorylation of Exo1 is a critical signal for termination of 
resection to provide an ssDNA substrate with optimal length for subsequent HR repair, 
although the mechanism for controlling the timing of this phosphorylation is unclear. 
Interestingly, a recent study showed that ATM-mediated phosphorylation of Mre11 at 
Ser676 and Ser678 is a prerequisite for ATM phosphorylation of Exo1 at Ser714 (Kijas et 
al, 2015). Cells expressing the phospho-blocking mutant Mre11 S676A/S678A show 
normal ATM activation but decreased survival after DNA damage. These cells also 
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exhibit excessive end resection at DSB sites and impaired HR, likely caused by the loss 
of ATM-mediated Exo1 Ser714 phosphorylation which is essential for controlling the 
extent of resection (Bolderson et al, 2010; Kijas et al, 2015).  
Recent evidence suggests that the NHEJ factor, Ku, is also involved in regulation 
of HR, presumably by repressing the activity of DNA end resection enzymes. Ku is a 
very abundant protein in cells and it has high affinity for DNA ends, which render Ku an 
excellent blocker for DSB end resection and meanwhile favour NHEJ repair. However, 
the HR factor, MRN/X, can compete with Ku for binding to DNA ends, presumably by 
removing Ku from the ends or pushing Ku inwards, promote the recruitment of resection 
enzymes and hence stimulate resection and HR repair (Langerak et al, 2011; Shim et al, 
2010a; Yang et al, 2013), which likely serves as a mechanism for DNA repair pathway 
choice. It should be noted that the DNA unwinding activity of MRN, rather than its 
nuclease activity, is required for overcoming Ku inhibition of Exo1-mediated DNA end 
resection in vitro (Cannon et al, 2013; Yang et al, 2013), supporting a model that MRN 
may function to push Ku away from DNA ends via Rad50-mediated unwinding of DNA 
ends rather than removing Ku from DNA ends through Mre11-mediated endonucleolytic 
cleavage of the ends. 
Another piece of regulatory mechanism for choice of DNA repair pathways is 
emerging from studies on the interplay between BRCA1 and 53BP1 in DSB repair. 
BRCA1 is a tumor suppressor which is implicated in efficient DSB repair via the HR 
pathway (Moynahan & Jasin, 2010), but the mechanistic basis of its role in HR remains 
elusive. Depletion or mutation of the BRCA1 gene has been shown by many groups to 
reduce RAD51 foci at sites of DSBs, but whether BRCA1 directly affects resection has 
been controversial (Aparicio et al, 2014; Symington & Gautier, 2011). A recent study 
using a novel technique to measure resection showed that BRCA1 accelerates, although 
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not essential for, CtIP-mediated resection (Cruz-Garcia et al, 2014). 53BP1 was shown to 
inhibit DSB end resection in concert with RIF1 in G1 (Bothmer et al, 2011; Di Virgilio et 
al, 2013; Zimmermann et al, 2013), but 53BP1 at DSB sites is removed and 53BP1 
inhibition of resection is antagonized in a BRCA1-dependent manner in S phase, which 
promotes HR repair (Bunting et al, 2010). Interestingly, the accumulation of 53BP1/RIF1 
and BRCA1 at DSB sites are mutually exclusive in different cell cycle phase, which 
makes a regulatory circuit for appropriate choice of DNA repair pathways as cell cycle 
proceeds. In G1 phase when NHEJ is favored, 53BP1 and RIF1 prevent BRCA1 
recruitment to DSB ends and block resection, which inhibits HR; in S/G2 phases when 
sister chromatids are available as homologous templates for HR pathway, BRCA1 
inhibits the accumulation of 53BP1 and RIF1 at DSB sites and functions to promote DSB 
end resection together with CtIP, allowing HR to occur (Escribano-Diaz et al, 2013; Feng 
et al, 2013).  
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HYPOTHESIS AND GOALS 
 
1. Development of a quantitative assay for measuring DNA end resection in cells 
The initiation of resection is a critical control point for the choice between HR 
and NHEJ, because this process commits the breaks for HR repair. Currently, DSB 
resection in mammalian cells is mostly assessed indirectly using RPA foci, RAD51 foci, 
or BrdU detection in ssDNA, all of which are with relatively low resolution and 
subjectively dependent on the immunofluorescence protocol and antibody used and 
cannot determine the length of resection from a DSB site. Conflicting results regarding 
the effects of some proteins/modifications, such as BRCA1 protein, DNA-PKcs 
autophosphorylation and CDKs-mediated phosphorylation of Nbs1 at Ser43, on DSB end 
resection, have obtained using the foci staining strategy. The discrepancies between these 
studies suggest the necessity of developing a new assay to accurately measure DSB 
resection in a more straightforward way.  
Here I describe an assay to measure levels of ssDNA intermediates of resection at 
specific DSB sites in human cells by utilizing the ER-AsiSI system in which the 
restriction enzyme AsiSI is fused to the estrogen receptor hormone-binding domain and 
can be induced to enter the nucleus and generate DSBs at sequence-specific sites upon 
treating the cells with 4-hydroxytamoxifen (4-OHT) (Iacovoni et al, 2010). This method 
is more quantitative and precise with respect to the extent and efficiency of resection. 
Using this method, I find that resection at endonuclease-induced breaks occurs up to 3.5 
kb from the break site and is more efficient in S/G2 phase cells compared to cells in G1 
phase. I also find that the MRN complex, Exo1, SOSS1, and CtIP promote the processing 
DSB ends into ssDNA, while depletion of Ku, DNA-PKcs, or 53BP1 leads to increased 
ssDNA formation at DSB sites, consistent with the idea that NHEJ factors inhibit 
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resection. Lastly, I find that BRCA1 depletion has little effect on resection although it 
strongly reduces RAD51 foci, suggesting that the effect of BRCA1 on homologous 
recombination may be specific to RAD51 filament formation, not directly on the 
processing of DSB ends. 
 
2. The cooperative regulation of DNA end resection by DNA-PKcs, ATM and MRN 
The NHEJ factor DNA-PKcs is a potential regulator of DNA repair pathway 
choice, since it has also been implicated in regulation of HR in addition to its critical role 
in NHEJ  (Allen et al, 2003; Convery et al, 2005; Cui et al, 2005; Neal et al, 2011; 
Shibata et al, 2011), but the underlying mechanism is not fully understood. Previous 
studies with purified recombinant human proteins have shown that Ku inhibits 5’ strand 
resection mediated by Exo1 or Dna2 in vitro, and the MRN complex overcomes Ku 
inhibition of resection (Shim et al, 2010b; Yang et al, 2013). But there is no direct 
evidence showing whether DNA-PKcs also directly regulates DNA end resection. The 
expression of exogenous DNA-PKcs in cells lacking the enzyme inhibits HR in a Ku-
dependent manner (Neal et al, 2011). However, there is still debate about how DNA-
PKcs kinase activity and phosphorylation affects DNA-PK regulation of HR and 
conflicting results have been reported on this issue (Allen et al, 2003; Convery et al, 
2005; Shrivastav et al, 2009). These studies are based on HR assays that measure the 
efficiency of HR repair by examining fluorescent protein expression or cell survival after 
DNA damage. However, these assays are indirect and provide little detailed information 
about DSB end resection, the critical initiating step of HR.  
Based on the effect of DNA-PKcs on HR, the observations that ATM 
phosphorylates DNA-PKcs and that MRN overcomes Ku inhibition of resection, I 
hypothesize that DNA-PKcs can directly inhibit resection in a Ku-dependent manner and 
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it can actively regulate resection in concert with MRN and ATM. I find that DNA-PK 
inhibitor treatment strongly stimulates DSB resection, although the interpretation of this 
result is complicated by the inhibitor-induced loss of DNA-PKcs protein in human cells. 
To characterize the role of DNA-PKcs catalytic activity directly, I reconstitute resection 
with purified recombinant proteins in vitro and investigate the effect of DNA-PKcs on 
Exo1-mediated resection. The results show that DNA-PKcs inhibits Exo1 activity, which 
can be overcome by the combined effects of MRN and the autophosphorylation of DNA-
PKcs. Phosphorylation of DNA-PKcs, either through autophosphorylation or 
phosphorylation by ATM, promotes the recruitment of Exo1 to DNA ends, suggesting 
that unphosphorylated DNA-PKcs presents a barrier to the recruitment of resection 
enzymes. Overall, I propose that DNA-PKcs directly represses DSB end resection, which 
can be overcome by MRN and ATM, and in this way affects DNA repair pathway choice. 
 
3. Negative regulation of ATM signaling by DNA-PKcs-mediated phosphorylation 
ATM and DNA-PKcs are both actively involved in DSB repair: DNA-PKcs plays 
a key role in NHEJ, while ATM controls checkpoint activation and the HR pathway. It is 
well recognized that the MRN complex acts as a DSB sensor and is essential for ATM 
recruitment to broken DNA ends and ATM activation. Similarly, DNA-PKcs is recruited 
to DSBs and activated by Ku. However, it is not well understood how the choice between 
ATM/MRN-dependent HR pathway and DNA-PKcs/Ku-dependent NHEJ pathway is 
made in S/G2 phases when both pathways are active. Increasing evidence shows that 
cross-talk occurs between DNA-PKcs and ATM and they may cooperatively initiate DSB 
repair signaling and regulate DSB repair pathway choice. For instance, the expression of 
ATM is dependent on DNA-PKcs (Peng et al, 2005). Conversely, DNA-PKcs are 
phosphorylated by ATM at Thr2609 and Thr2647 in the ABCDE cluster, and this 
 33 
phosphorylation event is essential for DSB repair (Chen et al, 2007). My previous study 
showed that DNA-PKcs strongly inhibits DSB end resection, and this inhibition can be 
partially overcome by ATM-mediated phosphorylation of DNA-PKcs, suggesting that 
DNA-PKcs and ATM coordinately regulates DSB end resection, a key event for choice 
between HR and NHEJ.  
In this study, I propose that DNA-PKcs negatively regulates ATM activity 
through phosphorylation of ATM at multiple sites. I find that ATM is hyperactive when 
DNA-PKcs activity is blocked by DNA-PKcs specific inhibitor treatment or when the 
DNA-PKcs gene is deleted in cells. Pre-incubation of ATM protein with DNA-PKcs 
significantly inhibits ATM kinase activity in vitro. Using mass spectrometry analysis and 
site-directed mutagenesis, I characterize three clusters of sites: S85/T86, T372/T373 and 
T1985/S1987/S1988. The phospho-mimetic mutations at these residues lead to impaired 
ATM-mediated DNA damage response. In addition, I have observed that the phospho-
blocking ATM mutants, T1985A/S1987A/S1988A and T86A/T373A, are resistant to 
DNA-PKcs pre-incubation in vitro and that overexpression of ATM 
T1985A/S1987A/S1988A mutant fails to respond to DNA-PKcs inhibition as wild-type 
ATM does in cells. Taken together, my data suggests that the NHEJ factor DNA-PKcs 
suppresses the catalytic activity of ATM through phosphorylation. Since ATM is known 
to promote the HR pathway and DNA-PKcs is a key NHEJ factor, this may provide 
another novel mechanism for DNA repair pathway choice upon DNA damage. 
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CHAPTER 2: MATERIALS AND METHODS 
 
CELL CULTURE, TRANSFECTION, AND SORTING 
ER-AsiSI U2OS cells and 293T cells were grown in Dulbecco's Modified Eagle 
Medium (Gibco) containing 10% fetal bovine serum (FBS)(Gibco). WT, Ku86 Flox/+, 
Ku86Flox/- and DNA-PKcs-/- HCT116 cells were provided by Dr. Eric Hendrickson and 
were grown in McCoy’s 5A medium (Gibco) supplemented with 10% FBS and 2 mM L-
glutamine (Gibco). siRNA transfection in ER-AsiSI U2OS cells was performed using 
Lipofectamine 2000 (Invitrogen) following manufacturer’s instructions. For purification 
of G1 and S/G2/M ER-AsiSI-293T cells using the FUCCI system (Sakaue-Sawano et al, 
2008), 15 μg pRetroX-G1-Red vector and 15 μg pRetroX-SG2M-Cyan vector were co-
transfected into 70% confluent ER-AsiSI-293T cells in 15-cm dish using 40 μl 1 mg/ml 
linear polyethyleneimine (MW 25,000, Polysciences). 10 dishes of transfected cells were 
harvested and subjected to cell sorting using BD FACSAria (BD Biosciences) 24 h post 
transfection. To analyze cell cycle, cells were fixed with 100% cold ethanol, stained with 
propidium iodide (Sigma) and subjected to flow cytometric analysis. 
HEK-293 cells expressing wild-type and 6A DNA-PKcs (T2609A/S2612A/ 
T2620A/S2624A/T2638A/T2647A)(Chen et al, 2007)(provided by Dr. David Chen) and 
ER-AsiSI U2OS cells (provided by Dr. Gaëlle Legube) were grown in Dulbecco's 
Modified Eagle Medium (Gibco) containing 10% fetal bovine serum (FBS)(Gibco). 293-
6E cells were provided by Dr. Yves Durocher and were grown in F17 medium (Gibco) 
supplemented with 4 mM L-Glutamine and 0.1% Pluronic F-68 (Gibco). 
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REAGENTS AND ANTIBODIES 
Protein kinase inhibitors used in this study were purchased from the following 
sources: DNA-PK inhibitor NU-7441 (Tocris Bioscience, 3712), DNA-PK inhibitor NU-
7026 (Sigma, N1537), ATM inhibitor KU-55933 (EMD Millipore, 80017-420). 4-
Hydroxytamoxifen (4-OHT) was purchased from Sigma (Catalog no. H7904). Antibodies 
for Western blotting are as follows: PARP-1 (Genetex, GTX75098), CtIP (Active Motif, 
61141), Mre11 (Genetex, GTX70212), SSB1 (Bethyl, A301-938A), Exo1 (Genetex, 
GTX109891), BRCA1 (Santa Cruz, sc-6954), 53BP1 (Cell Signaling, 4937), DNA-PKcs 
(Abcam, ab1832), HA Tag (Bethyl, A190-108A), phospho-(Ser) CDKs substrate (Cell 
Signaling, 2324), Ku86 (Santa Cruz, sc-5280), RPA (Genetex, GTX22175), phospho-
(T2609) DNA-PKcs (Genway, 18-785-210106), phospho-(S2056) DNA-PKcs (Abcam, 
ab18192), ATM (Santa Cruz, sc-135663), phospho-(S1981) ATM (Abcam, ab81292),  
Alexa Fluor® 488 Conjugate phospho-(S10) H3 (Cell Signaling, 9708S), phospho-(S15) 
p53 (Calbiochem, PC461),  and custom RAD51 antibody (Martin Gellert Lab). 
 
WESTERN BLOTTING 
Cells were lysed in Laemmli lysis buffer (10% glycerol, 2% (m/v) SDS, 64 mM 
Tris-HCl pH6.8), boiled for 5 min, and sonicated. Protein concentrations were measured 
using BCA protein assay kit (Pierce). Cell lysates were mixed with 5×SDS loading buffer 
and boiled for 5 min. Proteins were separated by 6-12% SDS-PAGE, transferred to 
PVDF-FL membrane (Millipore), and probed with primary antibodies listed above, 
followed by detection with IRdye 800 anti-mouse (Rockland, RL-610–132-121) or 
AlexaFluor 680 anti-rabbit (Invitrogen, A21076) secondary antibodies. Membranes were 
scanned using a Licor Odyssey scanner. 
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IMMUNOSTAINING 
Cells were fixed with 4% formaldehyde for 20 min, followed by permeabilization 
with cold methanol for 5 min, blocking with 8% BSA for 1 h, incubation with primary 
antibodies for 1 h and secondary antibodies (donkey anti-rabbit lgG Alexa Fluor 594 and 
donkey anti-mouse lgG Alexa Fluor 488 from Invitrogen) for 30 min at room 
temperature. For RPA staining, cells were pre-extracted with a buffer containing 20 mM 
Hepes (pH 7.5), 50 mM NaCl, 3 mM MgCl2, 300 mM Sucrose and 0.5% Triton X-100 
for 5 min on ice before fixation. For RAD51 staining, this step was performed after 
methanol permeabilization. 
 
GENOMIC DNA EXTRACTION 
ER-AsiSI U2OS cells were trypsinized, centrifuged and resuspended with 37 ˚C 
0.6% low-gelling point agarose (BD Biosciences) in PBS (Gibco) at a concentration of 
6×10
6
 cells/ml (For gDNA extraction in ER-AsiSI HCT116 cells and ER-AsiSI 293T 
cells, the concentration is 1.5×10
6
 cells/ml). A 50 μl cell suspension was dropped on a 
piece of Parafilm (Pechiney) to generate a solidified agar ball, which was then transferred 
to a 1.5 ml eppendorf tube. The agar ball was treated with 1ml ESP buffer (0.5 M EDTA, 
2% N-lauroylsarcosine, 1 mg/ml proteinase-K, 1 mM CaCl2, pH 8.0) for 20 h at 16 ˚C 
with rotation, followed by treatment with 1ml HS buffer (1.85 M NaCl, 0.15 M KCl, 5 
mM MgCl2, 2mM EDTA, 4 mM Tris, 0.5 % Triton X-100, pH 7.5) for 20 h at 16 ˚C with 
rotation. After washing with 1ml phosphate buffer (8 mM Na2HPO4, 1.5 mM KH2PO4, 
133 mM KCl, 0.8 mM MgCl2, pH 7.4) for 6×1h at 4˚C with rotation, the agar ball was 
melted by placing the tube in a 70˚C heat block for 10 min. The melted sample was 
diluted 15-fold with 70˚C ddH2O, mixed with equal volume of appropriate 2×NEB 
restriction enzyme buffer and stored at 4˚C for future use.  
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MEASUREMENT OF RESECTION IN MAMMALIAN CELLS  
The level of resection adjacent to specific DSBs was measured by qPCR using a 
modification of the original yeast method (Zierhut & Diffley, 2008). The sequences of 
qPCR primers and probes are shown in Supplementary Table S2. 20 μl genomic DNA 
sample (~140 ng in 1×NEB restriction enzyme buffer 4) was digested or mock digested 
with 20 units of restriction enzymes (BsrGI, BamHI-HF or HindIII-HF; New England 
Biolabs) at 37°C overnight. 3 μl digested or mock-digested samples (~20 ng) were used 
as templates in 25 μl qPCR reaction containing 12.5 μl 2×Taqman Universal PCR Master 
Mix (ABI), 0.5 μM of each primer and 0.2 μM probe using a ViiA™ 7 Real-Time PCR 
System (ABI). The percentage of ssDNA (ssDNA%) generated by resection at selected 
sites was determined as previously described (Nicolette et al, 2010). Briefly, for each 
sample, a △Ct was calculated by subtracting the Ct value of the mock-digested sample 
from the Ct value of the digested sample. The percentage of ssDNA was calculated with 
the following equation: ssDNA%=1/(2^(△Ct-1)+0.5)*100 (Zierhut & Diffley, 2008). 
 
ER-ASISI RETROVIRUS PACKING AND INFECTION 
ER-AsiSI retrovirus was generated in 293T cells cultured in 6-well plates. For 
each well, 2 μg pBABE-ER-AsiSI vector was co-transfected with two helper plasmids 
(1.8 μg pCS2-mGP(Cejka et al, 2010)and 0.2 μg pMD2G (D. Trono, Addgene plasmid 
12259)) into 95% confluent 293T cells. The cells were split into 6 cm dish 24 h after 
transfection. Supernatant containing retrovirus was collected and filtered with 0.45 μm 
syringe filter at 48 h and 72 h. The supernatant was aliquoted and stored at -80˚C for 
future use. For ER-AsiSI virus infection, WT, Ku86 Flox/+, Ku86Flox/-, DNA-PKcs-/- 
HCT116 cells and 293T cells were grown to ~50% confluency. The cells were cultured 
with virus-containing supernatant supplemented with 10 μg/ml polybrene (Fisher) 
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overnight. 48 h after infection, the cells were selected with 2 μg/ml puromycin (Clontech) 
for ~3 weeks to generate stable cell lines. To delete one allele of Ku86 from Ku86 
Flox/+, Ku86Flox/- cells, the cells were treated with Cre Adenovirus (Vectorbiolabs) for 
6 days.  
 
ATM SHRNA AND CONTROL SHRNA LENTIVIRUS PACKING 
ATM shRNA and control shRNA lentiviruses were packed in 293T cells cultured 
in 10-cm dishes. For each dish, 12.5 μg lentiviral vector was co-transfected with two 
envelope protein expressing vectors (7.5 μg pCMV-delta 8.9 and 5 μg VSV-G) into 95% 
confluent 293T cells. After ~12 h incubation, fresh medium was added to the dish. The 
medium containing lentivirus was collected and filtered with 0.45 μm syringe filter after 




Ku86 siRNA used in this study was purchased from Qiagen (Catalog no. 
SI2663773). All other siRNAs were purchased from Eurofins MWG Operon. siRNA 
sequences are as follows. siControl: AAUUCUCCGAACGUGUCACGUdTdT (Quennet 
et al, 2011); siCtIP: GCUAAAACAGGAACGAAUCdTdT (Huertas & Jackson, 2009); 
siMre11: ACAGGAGAAGAGAUCAACUdTdT (Quennet et al, 2011); siSOSS-A: CGU 
GAUGGCAUGAAUAUUGdTdT (Huang et al, 2009); siExo1: UAGUGUUUCAGGAU 
CAACAUCAUCUdTdT (Bolderson et al, 2010); siDNA-PKcs: CUUUAUGGUGGCCA 
UGGAGdTdT (Peng et al, 2002);siBRCA1: GGAACCUGUCT CCACAAAGdTdT (Lou 
et al, 2003); si53BP1: GGACUCCAGUGUUGUCAUUdTdT (Kachirskaia et al, 2008). 
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The efficiency of gene knockdown was examined by Western blotting and DSB resection 
was measured 48 h after transfection. 
 
CHIP ASSAY 
ChIP assays were carried out according to a previously described protocol 
(Iacovoni et al, 2010). DNA-PKcs ChIP was performed by immunoprecipitating 200 µg 
of chromatin using 2 µg of phospho-DNA-PKcs S2056 antibody (Abcam), or no 
antibody. Immunoprecipitated DNA and input DNA were analyzed by qPCR (primer 
sequences are as follows. DSB1 FW: GATTGGCTATGGGTGTGGAC, REV: CATCCT 
TGCAAACCAGTCCT; DSB2 FW: TTCCTGCAGCCTCATTTTCT, REV: TGATGAT 




The primers for ATM mutagenesis were all designed using the online 
QuickChange Primer Design Program provided by Agilent Technologies 
(http://www.genomics.agilent.com/primerDesignProgram.jsp?toggle=uploadTrans&_req
uestid=975663). The mutagenesis was performed using Quickchange XL site-directed 
mutagenesis kit from Stratagene using 300 ng wild-type ATM vector as template. The 
program for quickchange PCR is as follows: 95 °C, 1 min → (95 °C, 50 s→55 °C, 50 s
→68 °C, 30 min) × 18 cycles → 68 °C, 7 min →4 °C, ∞. The quickchange PCR 




ESTABLISHMENT OF ATM FLP-IN U2OS STABLE CELL LINES 
0.5 μg pcDNA5-Intron-ATM vector (the ATM gene is engineered such that it is 
resistant to ATM shRNA used in this study) was co-transfected with 4.5 μg of the pOG44 
Flp-Recombinase Expression Vector into U2OS Flp-In cells. (The pcDNA5-Intron 
vector, pOG44 vector and U2OS Flp-In cells are all kindly provided by Dr. Blerta 
Xhemalce. U2OS Flp-In cells are cultured with DMEM containing 10% FBS, 100 μg/ml 
zeocin and 15 μg /ml blasticidin). 48 h after transfection, cells were selected with 0.2 
mg/ml hygromycin in DMEM containing 10% Tet System Approved FBS (Clontech, Cat 
No. 631106) and 15 μg /ml blasticidin. To induce expression of the ATM gene, cells 
were treated with 5 μg /ml doxycycline for 3-5 days. 
 
CLOGENIC ASSAY 
Cells were seeded in 6-well plates at a concentration of 400 cells per well. Cells 
were treated with various amounts of drugs or ionzing radiation the next day and further 
cultured for 10-14 days, followed by staining the colonies with 0.5% crystal violet 
solution. The number of colonies in each well was quantitated and the survival fraction 
was calculated by comparing the number of colonies in treated wells with that in 
untreated wells. 
 
G2/M CHECKPOINT ASSAY 
After treatment (drugs, 1 h treatment; ionizing radiation, 1 h recovery after 
radiation), cells were incubated with 400 ng/ml nocodazole for 17 h, followed by fixation 
with 75% cold ethanol for > 24 h. Cells were washed with PBS and blocked with 2% 
BSA in PBST (PBS containing 0.1% Tween-20) for 30 min, followed by staining with 
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Alexa Fluor® 488 Conjugated phospho-H3 (S10) antibody (1:100 dilution in PBST) for 
2h at room temperature. After washing, cells were further stained with 40 µg/ml 
propidium iodide solution at 4 °C overnight and subjected to flow cytometric analysis. 
 
PROTEIN BINDING ASSAY 
Purified recombinant ATM protein was incubated with biotinylated MRN or MR 
for 30 min at 30 °C, followed by the addition of streptavitin dynabeads (Invitrogen) and 
0.1% CHAPS. The mixture was incubated at 4 °C for 15 min with rotation. The 
dynabeads were washed three times with buffer A (25 mM Tris pH 8.0, 100 mM NaCl, 
10% Glycerol, 1 mM DTT) containing 0.1% CHAPS. Proteins bound to the beads were 
eluted by 1% SDS loading solution and analyzed by Western blotting. 
 
PROTEIN EXPRESSION AND PURIFICATION 
WT and 6A DNA-PKcs/Ku complexes were purified from DNA-PKcs WT- and 
6A- HEK293 stable cell lines (Chen et al, 2007). Cells collected from sixty 15-cm dishes 
were resuspended in 40 ml cold lysis buffer (50 mM Tris-HCl pH 7.5, 125 mM NaCl, 5% 
glycerol, 0.2% NP40, 1.5 mM MgCl2) supplemented with protease inhibitor (Roche) and 
phosphatase inhibitors (1 mM glycerol 2-phosphate disodium salt hydrate, 0.5 mM 
sodium pyrophosphate tetrabasic and 1 mM sodium orthovanadate), homogenized, 
sonicated and clarified by centrifugation at 100,000 g for 30 min at 4°C. TAP-tagged WT 
and 6A DNA-PKcs were isolated from the supernatant using 1 ml rabbit lgG agarose 
beads (Sigma). The beads were washed twice with lysis buffer and twice with TEV 
cleavage buffer (50 mM Tris-HCl pH 8.0, 50 mM NaCl, 0.05 mM EDTA, 1 mM DTT 
and 0.1% NP40). DNA-PKcs protein was released from the beads in 1 ml TEV cleavage 
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buffer by incubation with 500 units TEV protease (Invitrogen) at 16 °C for 8 h, followed 
by a series of batch purification through SP Sepharose (GE), ssDNA cellulose (Sigma) 
and Q Sepharose Fast Flow resin (GE). The protein was eluted with high salt buffer 
containing 25 mM Tris-HCl pH 8.0, 500 mM KCl, 10% glycerol and 1 mM DTT, and 
stored at -80°C for future use. 
Ku, Exo1, Exo1(D78A/D173A), MRN, and M(H129L/D130V)RN recombinant 
proteins were expressed and purified as previously described (Yang et al, 2013). Wild-
type ATM and ATM mutants were expressed and purified from 293-6E cells (Durocher 
et al, 2002). 25 μg pTT5-flag-ATM vector (pTP2133) was transfected into 25 ml 293-6E 
cells at a density of ~1.7×10
6
/ml using Polyethyleneimine (Polysciences). Cells were 
harvested 72 h after transfection and ATM protein was purified as described previously 
(Lee & Paull, 2005). The individual DNA-PKcs protein was purified from Hela cells as 
previously described (Goodarzi & Lees-Miller, 2004) and was provided by Dr. Susan 
Lees-Miller. DNA Ligase IV/XRCC4 complex was provided by Dr. Dale Ramsden and 
was purified as previously described (Reddy et al, 2004). 
 
IN VITRO RESECTION ASSAY 
The in vitro DNA resection assay was performed as previously described 
(Nicolette et al, 2010; Yang et al, 2013). Briefly, the 4.4 kb pNO1 plasmid was linearized 
with SphI-HF (NEB) and incubated at 37°C for 1 h or 2 h in a 10 μl reaction containing 1 
ng DNA (37 pM), 25 mM MOPS pH 7.0, 1 mM dithiothreitol (DTT), 5 mM MgCl2, 1 
mM ATP, 50 μg/ml BSA, 60 mM NaCl, and proteins as indicated in the figure legends. 
The reaction was stopped by adding 1 μl solution containing 1% SDS and 100 mM 
EDTA and further treated with 0.1 mg/ml Proteinase K (Sigma) for 30 min at 37°C to 
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digest all proteins. Reaction products were separated by 0.7% native agarose gel and 
visualized directly by SYBR Green (Invitrogen) staining, followed by a non-denaturing 
Southern blot analysis using an RNA probe for a 1kb region of the 3’ strand. To directly 
measure DNA resection by qPCR, the reaction was stopped by adding 1 μl 0.05% SDS 
and further processed as previously described (Nicolette et al, 2010). To analyze the 
protein products of the resection assay, the reaction was stopped by adding 2.5 μl 5×SDS 
loading buffer and boiled for 3 min. Proteins were separated by 8% SDS-PAGE gel and 
visualized by silver staining and phosphorimaging (0.25 mM ATP and 2.5 μCi [γ-
32
P]-
ATP (NEN) were used instead of 1 mM ATP in the reaction) or Western blotting.  
 
COMBINED LIGATION AND RESECTION ASSAY 
The 4.4 kb linear pNO1 DNA (37 pM) was assayed with both DNA Ligase 
IV/XRCC4 and Exo1 in a 10 μl reaction containing 25 mM MOPS pH 7.0, 1 mM DTT, 5 
mM MgCl2, 1 mM ATP, 50 μg/ml BSA, 105 mM NaCl, 45 mM KCl and 10% 
polyethylene glycol. Before adding ATP, MgCl2, DNA Ligase IV/XRCC4 and Exo1, the 
mixture containing all other components was pre-incubated at 25°C for 10 min. The 
reaction was allowed to proceed at 37°C for 1 h and terminated by adding 1 μl 0.05% 
SDS. Half of the reaction was diluted 5-fold with ddH2O. DNA end ligation mediated by 
DNA Ligase IV/XRCC4 was measured by using 1 μl sample as template in a 25 μl qPCR 
reaction containing 12.5 μl SYBR Green PCR Master Mix (ABI) and 0.5 μM of each 
primer (5’ primer: CTTGTTTCGGCGTGGGTATG; 3’ primer: GAAGGAGCTGACTG 
GGTTGAAG). Another half of the reaction was diluted 10-fold with 1×NEBuffer 4 and 
used to measure Exo1-mediated DNA resection as previously described (Nicolette et al, 
2010). 
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IN VITRO ATM KINASE ASSAY 
To examine the activation of purified recombinant ATM protein by MRN and 
DNA, the ATM proteins (0.2 nM to 2 nM) were incubated at 37°C for 1 h in reaction 
buffer containing 25 mM MOPS, 1 mM DTT, 5 mM MgCl2, 1 mM ATP, 70 mM NaCl, 
50 μg/ml BSA and 1 ng 4.4 kb linearized DNA substrate (37 pM) in the presence of 20 
nM MRN and 100 nM GST-p53 substrate. To examine the activation of ATM by H2O2, 
ATM protein was incubated with 817 μM H2O2 at 37°C for 1 h in the absence of DTT 
and DNA. For the two-step kinase assay, the first incubation was performed at 37 °C for 
45 min, followed by a one hour second incubation at 37°C. 3.5 nM DNA-PKcs and 7 nM 
Ku were used to examine the effect of Ku/DNA-PKcs on ATM activity in these 
reactions. The kinase reaction product phosphorylated p53 (S15) was detected by 
Western blotting using phospho-p53 (S15) antibody (Calbiochem, PC461). 
 
DNA BINDING ASSAY 
A 717 bp DNA was generated by PCR with biotin on the 5' strand at one end and 
three azide groups on the 5' strand of the other end as previously described (Yang et al, 
2013) and conjugated to magnetic streptavidin beads (Invitrogen). The DNA binding 
assay was performed at 37°C for 30 min in a 15 μl reaction containing 1.2 nM DNA, 25 
mM MOPS pH 7.0, 1 mM DTT, 5 mM MgCl2, 1 mM ATP, 50 μg/ml BSA and 60 mM 
NaCl. Interacting DNA and protein were crosslinked by exposing the reaction solution to 
UV light (254 nm) for 5 min. The bead-DNA-protein complex was then isolated with a 
magnetic holder, washed 5 times with washing buffer (25 mM MOPS pH 7.0, 50 mM 
NaCl, 0.2% CHAPS, 2 mM DTT) and eluted in 1× SDS-PAGE loading buffer with 
boiling for 5 min. The samples were then subjected to Western blotting analysis using 
Exo1 antibody. 
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CHAPTER 3: QUANTITATION OF DNA DOUBLE-STRAND 




DNA double strand breaks (DSBs) are one of the most deleterious types of DNA 
damage that can lead to chromosome rearrangements, genomic instability and 
tumorigenesis if not repaired correctly (Ciccia & Elledge, 2010). Non-homologous end 
joining (NHEJ) and homologous recombination (HR) are the two major DSB repair 
pathways in eukaryotic cells. NHEJ is the primary pathway and is utilized throughout the 
cell cycle, while HR is active in S and G2 phases where sister chromatids are available as 
repair templates (Trovesi et al, 2013). HR is initiated with the resection of the 5’ strands 
to generate 3’ single-stranded DNA (ssDNA), which is required for RAD51 binding and  
 
Portions of this chapter have been published as follows: 
 Zhou Y, Caron P, Legube G, Paull TT (2014) Quantitation of DNA double-strand break resection 
intermediates in human cells. Nucleic Acids Res 42: e19. (Contributions: YZ and TP designed the 
research and wrote the manuscript; YZ performed most experiments; PC and GL provided the ER-
AsiSI U2OS cells and DNA-PKcs ChIP data.)  
 Zhou Y, Paull TT (2015) Direct measurement of DNA double-strand break end resection by 
quantitative PCR. Anal Biochem 479: 48-50. (Contributions: YZ and TP designed the research 
and wrote the manuscript; YZ performed all experiments.) 
 Makharashvili N, Tubbs AT, Yang SH, Wang H, Barton O, Zhou Y, Deshpande RA, Lee JH, 
Lobrich M, Sleckman BP, Wu X, Paull TT (2014) Catalytic and noncatalytic roles of the CtIP 
endonuclease in double-strand break end resection. Mol Cell 54: 1022-1033. (Contributions: NM 
and TP designed the research and wrote the manuscript; NM performed most experiments. YZ 
performed the CtIP resection experiment in cells. All other authors contributes to the research) 
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strand invasion. Therefore, the initiation of resection is thought to be a critical control 
point for the choice between HR and NHEJ, because this process commits the breaks for 
HR repair. 
The proteins required for 5’ strand resection at DSBs in eukaryotic cells include 
the Mre11/Rad50/Nbs1 (MRN) complex, which binds to DSBs and promotes resection 
by two independent endo/exonucleases: Exo1 and Dna2 (Mimitou & Symington, 2009). 
The CtIP protein also participates in this process and promotes long-range resection in 
conjunction with MRN (Huertas & Jackson, 2009). The Ataxia-Telangiectasia-Mutated 
(ATM) protein kinase has also been shown to be required for DSB resection (Kuhne et al, 
2004; Morrison et al, 2000; You et al, 2009) although its role in this process is not 
completely understood. 
The Ku70/80 heterodimer and DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs) are two key regulators of NHEJ. DNA-PKcs is recruited to Ku-bound DNA 
ends and forms a synaptic complex that tethers the broken DNA ends together for 
religation (DeFazio et al, 2002; Weterings & van Gent, 2004). Apart from its role in 
NHEJ, DNA-PKcs has also been implicated in regulation of HR (Allen et al, 2003; 
Convery et al, 2005; Cui et al, 2005; Neal et al, 2011; Shibata et al, 2011), but the 
underlying mechanism is not fully understood. Previous studies have demonstrated that 
the human Ku heterodimer inhibits 5’ strand resection mediated by Exo1 or Dna2, while 
MRN overcomes Ku inhibition of resection in vitro (Shim et al, 2010b; Yang et al, 2013), 
but it is not clear whether DNA-PKcs also regulates this process.  
Currently, DSB resection in mammalian cells is assessed indirectly using RPA 
foci, RAD51 foci, or BrdU detection in ssDNA, all of which are subjectively dependent 
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on the immunofluorescence protocol and antibody used and cannot determine the length 
of resection from a DSB site. Here I describe an assay to measure levels of ssDNA at 
specific DSB sites in human cells that is quantitative and precise with respect to the 
extent and efficiency of resection. Using this method, I find that resection at 
endonuclease-induced breaks occurs up to 3.5 kb from the break site and is more efficient 
in S/G2 phase cells compared to cells in G1 phase. I also find that the MRN complex, 
Exo1, SOSS1, and CtIP promote the processing DSB ends into ssDNA. In contrast, 
depletion of Ku, DNA-PKcs, or 53BP1 leads to increased ssDNA formation at DSB sites, 
consistent with the idea that NHEJ factors inhibit resection. Lastly, I find that BRCA1 
depletion has little effect on resection whereas it strongly reduces RAD51 foci, 
suggesting that the effect of BRCA1 on homologous recombination may be specific to 




Development of a quantitative resection assay using the ER-AsiSI system 
To quantitate ssDNA at sites of DSBs, I utilized the ER-AsiSI system in which the 
restriction enzyme AsiSI is fused to the estrogen receptor hormone-binding domain 
(Iacovoni et al, 2010). The AsiSI enzyme can be induced to enter the nucleus and 
generate DSBs at sequence-specific sites (5'-GCGATCGC-3') upon treating the cells with 
4-hydroxytamoxifen (4-OHT). The genomic DNA was extracted using a method 
modified from a previously described strategy (Stenerlow et al, 2003) in which cells are 
embedded in low-gelling point agar that protects the DNA from shearing and damage 
during extraction (Figure 3.1).  
 
 
Figure 3.1 Workflow of the procedure for genomic DNA extraction. 
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Almost all restriction enzymes cut double-stranded DNA (dsDNA) but not single-
stranded DNA (ssDNA). I exploit this feature of restriction enzymes to distinguish 
original dsDNA from ssDNA products of resection at specific sites (Figure 3.2A).To 
measure resection adjacent to specific DSBs, I chose two AsiSI sites on Chromosome 1 
("DSB1", Chr 1: 89231183; "DSB2", Chr 1: 109838221) that have been shown to be 
cleaved with high efficiency (Iacovoni et al, 2010; Miller et al, 2010). Three pairs of 
quantitative PCR (qPCR) primers were designed across BsrGI or BamHI restriction sites 
at various distances from each AsiSI site (Figure 3.2B). The restriction enzymes are 
specific for duplex DNA, thus can be used to distinguish between single-stranded and 
double-stranded DNA, as demonstrated previously in budding yeast (Zierhut & Diffley, 
2008). Another two pairs of primers were designed across the two AsiSI sites to monitor 
the percentage of double strand breaks (DSB%) present at the two sites, as well as a pair 
of primers at a site where there is no nearby AsiSI sequence on Chromosome 22 ("No 
DSB") which was used as a negative control (Figure 3.2B). The quality of Taqman qPCR 
primers/probes was tested by generating standard curves using non-digested genomic 
DNA as template (Figure 3.3). The percentage of ssDNA generated by resection at 
various sites was measured by qPCR as described (Nicolette et al, 2010)(see Materials 
and methods for details).  
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Figure 3.2 Schematic representation of the principle for ssDNA quantitation and the design of 
Taqman qPCR primers/probes for quantitation of ssDNA intermediates of resection. 
(A) To measure the amount of ssDNA, a restriction site in the DNA region of interest was 
selected (here shown with BsrGI for DSB1 and BamHI for DSB2). Digest or mock digests were 
performed with the DNA sample, followed by qPCR analysis of the digested DNA sample using 
primers across the restriction site. If the DNA remains double-stranded at the interested region 
(upper panel), it will be cut by the restriction enzyme and there will be no PCR amplification. In 
contrast, if the interested DNA region becomes single-stranded due to resection (bottom panel), it 
will not be cut by the restriction enzyme, and thus one strand of DNA remains intact, which will 
generate a PCR product. For each sample, a △Ct is calculated by subtracting the Ct value of the 
mock-digested sample from the Ct value of the digested sample. The percentage of ssDNA is 
calculated using this equation: ssDNA%=1/(2^(△Ct-1)+0.5)*100. (B) Schematic diagram of 
Taqman qPCR primers and probes design for measurement of DSB% at two selected AsiSI sites 
(“DSB1” and “DSB2”) located on Chromosome 1 and measurement of resection at sites adjacent 
to the two AsiSI sites. The primer pairs for measurement of DSB% at two selected AsiSI sites are 
marked by red arrows. The primer pair (purple arrows) on Chromosome 22 ("No DSB"), which is 
designed across a HindIII restriction site, is used as negative control. The primer pairs for 
measurement of resection at “DSB1” and “DSB2” are across BsrGI and BamHI restriction sites, 
and are marked by blue arrows and green arrows respectively. All Taqman probes, which are not 
shown in the diagram, contain a 5’ reporter group 6FAM and a 3’ quencher group TAMRA, and 
are designed at either side of the restriction site. See Table 3.1 for primer/probe sequences. 
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Table 3.1 Sequence of qPCR primers and probes used in this study 
 
DSB1-335 bp  
Primer FW GAATCGGATGTATGCGACTGATC 
Primer REV TTCCAAAGTTATTCCAACCCGAT 
Probe  6FAM-CACAGCTTGCCCATCCTTGCAAACC-TAMRA 
 
DSB1-1618 bp  
Primer FW TGAGGAGGTGACATTAGAACTCAGA 
Primer REV AGGACTCACTTACACGGCCTTT 
Probe  6FAM-TTGCAAGGCTGCTTCCTTACCATTCAA-TAMRA 
 
DSB1-3500 bp  
Primer FW TCCTAGCCAGATAATAATAGCTATACAAACA 
Primer REV TGAATAGACAGACAACAGATAAATGAGACA 
Probe  6FAM-ACCCTGATCAGCCTTTCCATGGGTTAAG-TAMRA 
 
DSB2-364 bp   
Primer FW CCAGCAGTAAAGGGGAGACAGA 
Primer REV CTGTTCAATCGTCTGCCCTTC 
Probe  6FAM-CCAGGCCCTCAAAATCCCTCCACTG-TAMRA 
 
DSB2-1754 bp  
Primer FW GAAGCCATCCTACTCTTCTCACCT 
Primer REV GCTGGAGATGATGAAGCCCA 
Probe  6FAM-CACTCCCTGTTCTTCTTCTGCTCCCGA-TAMRA 
 
DSB2-3564 bp  
Primer FW GCCCAGCTAAGATCTTCCTTCA 
Primer REV CTCCTTTGCCCTGAGAAGTGA 
Probe  6FAM-CTGCAGCCCTCAAGCCCGGAT-TAMRA 
 
No DSB  
Primer FW ATTGGGTATCTGCGTCTAGTGAGG 
Primer REV GACTCAATTACATCCCTGCAGCT 
Probe  6FAM-TCTCTGCACAGACCGGCTTCCCTTC-TAMRA 
 
Across DSB1  
Primer FW GATGTGGCCAGGGATTGG 
Primer REV CACTCAAGCCCAACCCGT 
Probe  6FAM-ATCGCGCGCCGTGAGTCACACT-TAMRA 
 
Across DSB2  
Primer FW GAGGAGCCTCTCCTGCAGC 
Primer REV GAACCAGACCTACCTCCAGGG 





Using this method, an increase in ssDNA upon 4-OHT treatment was observed 
adjacent to both DSB sites but not at the site lacking an AsiSI sequence in U2OS cells 
(Figure 3.4A). More ssDNA was observed at sites closer to DSBs and the extent of 
resection was as far as 3,500 nucleotides from the DSB end (Figure 3.4A), with higher 
levels of resection observed after longer 4-OHT treatment (Figure 3.4B). Using primers 
spanning the AsiSI sequence, it was determined that the percentage of DNA cleaved at 
the DSB1 and DSB2 sites was 21.0% and 8.8%, respectively, after 4 hours of 4-OHT 
exposure (Table 3.2). Considering the levels of ssDNA generated at ~350 nt from DSB1 
and DSB2 are ~4% and 2%, I conclude that approximately 20 to 26% of DNA ends are 
actually resected to an extent of 350 nt at both the DSB sites in asynchronously growing 
U2OS cells (Table 3.2). This may be a low estimate since rapidly repaired breaks would 
not be detected, but it can be used to estimate the efficiency of DSB resection at sites 
which are cut and not immediately religated.                                         
 
Figure 3.3 Test of Taqman qPCR primers/probes used in this study. 
Standard curves obtained using primers/probes (shown in Figure 3.2B and Table 3.1) and non-
digested genomic DNA (gDNA) from ER-AsiSI-U2OS cells. 
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Figure 3.4 Development of a quantitative DNA resection assay in human cells using the 
ER-AsiSI system. 
(A) ER-AsiSI U2OS cells were treated with 300 nM 4-OHT for 4 h or mock treated, genomic 
DNA (gDNA) was extracted and digested or mock digested with BsrGI, BamHI, or HindIII 
overnight. DNA end resection adjacent to DSB1, DSB2 and No DSB site was measured by qPCR 
as described in Materials and methods. The result is an average of three experiments with error 
bars showing standard deviation. (B) ER-AsiSI-U2OS cells were treated with 300 nM 4-OHT for 
2 h or 4 h, followed by genomic DNA extraction and measurement of resection as in (A). The 
result is an average of three experiments with error bars showing standard deviation. 
 
 
Table 3.2 Summary of the % ssDNA at DSB1 and DSB2, % DSBs, and the % DSBs 
resected (% ssDNA/%DSB) at the two selected AsiSI sites after 4 h of 4-OHT treatment. 
The percentage of DSB was measured by qPCR using undigested gDNA samples and two sets of 
primers across the two AsiSI sites. The “No DSB” primers were used to normalize the amount of 
gDNA in the qPCR reaction. DSB percentages at DSB1 and DSB2 sites in mock-treated cells 




Resection of DSBs is more efficient in S/G2 phases of the cell cycle 
Previous studies showed that DSB resection is cell cycle dependent and 
preferentially occurs in S and G2 phases due to a requirement for cyclin-dependent kinase 
(CDK) activity (Trovesi et al, 2013). To test this using the resection assay, I used CDK 
inhibitor roscovitine (CDKi) to inhibit CDK activity in the asynchronous ER-AsiSI U2OS 
cell culture (Figure 3.5A) and found that resection efficiency was reduced by roscovitine 
in a dose-dependent manner (Figure 3.5C). Roscovitine treatment slightly increased the 
percentage of cells in G1 phase (Figure 3.5B), consistent with the reported function of 
roscovitine in G1 arrest (Alessi et al, 1998). I also used the FUCCI system (Sakaue-
Sawano et al, 2008) for selection of cells in either G1 or S/G2 phases of the cell cycle in 
293T cells stably expressing ER-AsiSI (Figure 3.6A and B). Flow cytometry with 
propidium iodide (PI) staining was used to determine the percentage of cells in G1, S, and 
G2(/M) and the Scepter
™
 2.0 cell counter was utilized to examine cell size. The result 
suggested that cells expressing mCherry (Red) fluorescent protein were almost 
exclusively in G1 phase, while cells expressing Cyan (Green) fluorescent protein were 
mostly in S/G2(/M) phases (Figure 3.7A). As expected, the G1-Red cell populations were 
smaller in size that the S/G2(/M)-Green cell populations (Figure 3.6C), further confirming 
the success of cell sorting. Single-stranded DNA at DSB1 and DSB2 was measured in the 
G1-Red cells and the S/G2(/M)-Green cells, and compared to that of cells growing 
asynchronously (Unsorted cells) (Figure 3.7B). Higher levels of resection were observed 
in cells in S/G2(/M) phase compared to the asynchronous culture, and resection was 
strongly decreased in G1 cells, consistent with the observed effects of roscovitine. Low 
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levels of resection were still observed in G1 cells, however, suggesting that end 
processing does take place inefficiently and results in shorter resection tracks in G1 cells 
compared to cells in S or G2 phase. 
 
Figure 3.5 DSB end resection is inhibited by CDK inhibitor Roscovitine. 
ER-AsiSI U2OS cells were pretreated with 25 μM or 50 μM CDK inhibitor roscovitine (CDKi) 
for 1 h and then treated with 300 nM 4-OHT for 4 h, followed by (A) Western blotting analysis 
using antibodies directed against phospho-(Ser) CDKs substrates and PARP-1 as a loading 
control, or (B) flow cytometric analysis after propidium iodide staining or (C) measurement of 
DNA resection. Error bars indicate standard deviation calculated from three experiments. 
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The effects of known DNA repair factors on resection in human cells 
To further confirm the applicability of the resection assay, I measured resection in 
ER-AsiSI U2OS cells transfected with control siRNA or siRNAs directed against various 
genes involved in DNA repair. The Mre11/Rad50/Nbs1 (MRN) complex has been shown 
to bind to DSBs and promote resection by two independent endo/exonucleases: Exo1 and 
Dna2 (Mimitou & Symington, 2009; Nicolette et al, 2010; Yang et al, 2013). The CtIP 
protein also participates in this process and promotes long-range resection in conjunction 
with MRN (Sartori et al, 2007; You et al, 2009). Resection was dramatically decreased  
 
 
Figure 3.6 Purification of G1 and S/G2/M ER-AsiSI 293T cells using the FUCCI system. 
15 μg pRetroX-G1-Red vector and 15 μg pRetroX-SG2M-Cyan vector were co-transfected into 
70% confluent ER-AsiSI-293T cells in 15-cm dish using 40 μl 1 mg/ml Polyethyleneimine. The 
cells were treated or mock treated with 600 nM 4-OHT 24 h post transfection. 4 h later, 10 dishes 
of transfected cells were harvested and subjected to cell sorting using BD FACSAria (BD 
Biosciences). (A) Scatter plots of the flow cytometric analysis of the ER-AsiSI 293T negative 
control cells. (B) Scatter plots of the flow cytometric analysis of the ER-AsiSI 293T cells 
transfected with pRetroX-G1-Red and pRetroX-SG2M-Cyan Fucci vectors. G1-Red and S/G2/M-
Green cells were sorted from indicated gates (CFP+: Green; mCherry: Red). (C) Cell size 
analysis of unsorted, G1-Red and S/G2/M-Green ER-AsiSI 293T cells using Scepter
™
 2.0 cell 
counter (Millipore). 
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upon knockdown of CtIP or Mre11 (Figure 3.3A and B), consistent with previous 
observations (Sartori et al, 2007; Yamaguchi-Iwai et al, 1999). The SOSS1 single-
stranded DNA binding complex (comprised of hSSB1, SOSS-A, and SOSS-C) (Yang et 
al, 2013) was shown to be important for resection in human cells (Richard et al, 2008) 
and was recently shown to promote Exo1-mediated resection in vitro (Yang et al, 2013). 
Consistent with these observations, I found that depletion of  
 
 
Figure 3.7 Resection of DSBs is more efficient in S/G2 phases of the cell cycle. 
(A) ER-AsiSI 293T cells were transfected with FUCCI vectors (pRetroX-G1-Red and pRetroX-
SG2M-Cyan), induced with 600 nM 4-OHT for 4 h, and sorted for G1-Red and S/G2/M-Green 
cells. Part of the unsorted, G1-Red and S/G2/M-Green ER-AsiSI 293T cells were stained with 
propidium iodide (PI) and analyzed by flow cytometry to determine the percentage of cells in G1, 
S, and G2/M phases. (B) Measurement of DSB resection in unsorted, G1-Red and S/G2/M-Green 
ER-AsiSI 293T cells obtained in (A). The result is an average of three experiments with the error 
bars indicating standard deviation. 
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SOSS1 complex using siRNA directed against SOSS-A subunit led to reduced resection 
in U2OS cells, as did the depletion of Exo1 (Figure 3.3C and D), one of the two major 
exonucleases involved in long-range resection of DSB ends. There is some variability in 
the percentage of ssDNA at DSB1 and DSB2 between different experiments, which can 
be partially attributed to the variability in break formation by AsiSI (data not shown). 
 
Figure 3.8 The effects of known DNA repair factors (CtIP, Mre11, Exo1, SOSS1) on 
resection. 
Measurement of DSB resection in ER-AsiSI U2OS cells transfected with control siRNA or 
siRNAs directed against CtIP or Mre11 (A, B), Exo1or SOSS-A (C, D) as indicated using the 
resection assay established in Figure 3.2. The efficiency of knockdown was examined by Western 
blotting and PARP-1 was used as a loading control. The efficiency of SOSS1 depletion was 
examined by detecting the expression of hSSB1, another subunit of the SOSS-1 complex. 
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The BRCA1 protein is a tumor suppressor that is implicated in both homologous 
recombination and transcriptional regulation, but the mechanistic basis of its effects are 
not understood. Depletion or mutation of the BRCA1 gene has been shown by many 
groups to reduce RAD51 foci at sites of DSBs, but whether BRCA1 directly affects 
resection has been controversial (Symington & Gautier, 2011). Here I found that 
depletion of BRCA1 showed no significant effect on resection at either DSB1 or DSB2 
(Figure 3.9A and B). To confirm that the depletion was sufficient to affect the functions 
of BRCA1 under these conditions, I also examined RAD51 foci in the U2OS cells by 
conventional immunofluorescence and observed a clear deficiency in RAD51 filament 
formation (Figure 3.9C). In contrast, BRCA1 depletion had little effect on RPA 
accumulation at damage sites in U2OS cells (Figure 3.9C), consistent with a previous 
reports in chicken DT40 cells (Nakamura et al, 2010). These results suggest that BRCA1 
promotes HR at a step later than resection of 5' strands, perhaps more similar to the 
mechanism of BRCA2, which binds RAD51 directly and promotes RAD51 filament 
formation through its mediator activity (Holloman, 2011). The 53BP1 protein has been 
shown to promote NHEJ, and is related to BRCA1 function in that the deletion of 53BP1 
rescues the developmental lethality and cell cycle checkpoint defects in BRCA1-null 
mice and embryonic stem cells (Bouwman et al, 2010; Bunting et al, 2010). Consistent 
with the view that NHEJ and HR factors compete for DSB ends, here I found that 
depletion of 53BP1 results in increased resection (Figure 3.9A and B) as previously 
reported (Bunting et al, 2012). Depletion of 53BP1 also resulted in increased levels of 




Figure 3.9 The effects of known DNA repair factors (BRCA1, 53BP1) on resection. 
(A, B) Measurement of DSB resection in ER-AsiSI U2OS cells transfected with control siRNA or 
siRNAs directed against BRCA1 or 53BP1 using the resection assay established in Figure 3.2. 
The efficiency of knockdown was examined by Western blotting and PARP-1 was used as a 
loading control. (C) ER-AsiSI U2OS cells transfected with control siRNA or siRNAs directed 
against BRCA1 or 53BP1 were treated with 300 nM 4-OHT for 4 h, followed by immunostaining 
with RPA and RAD51 antibodies and counterstaining with DAPI. For RPA foci quantitation, 
cells with more than 10 RPA foci were counted (siControl N=354; siBRCA1 N=383; si53BP1 
N=356). For RAD51 foci quantitation, cell with more than 5 RAD51 foci were counted 
(siControl N=494; siBRCA1 N=583; si53BP1 N=570). 
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The nuclease activity of CtIP is dispensable for resection at restriction enzyme-
induced DSB ends in human cells 
It has been shown that CtIP interacts with BRCA1 and MRN, and may prevent 
the recruitment of 53BP1 in cooperation with BRCA1 in S/G2 phase, although the 
importance of CtIP-BRCA1interaction for resection remains controversial (Daley et al, 
2014). A previous study in the Paull laboratory suggests that the nuclease activity of CtIP 
is not essential for stimulation of Dna2-mediated resection in vitro. And a nuclease-
deficient CtIP mutant, N289A/H290A, could promote repair of DSBs equally well as 
wild-type CtIP in cells (Makharashvili et al, 2014). To test the role of CtIP nuclease 
activity in DSB end resection in cells, I directly examined the resection of DSBs by 
utilizing 293T cells that conditionally translocate the AsiSI restriction enzyme into the 
nucleus where it induces DSBs at specific site (Iacovoni et al, 2010). Endogenous CtIP 
was depleted in these cells, followed by expression of either wild-type or N289A/H290A 
CtIP. Single-stranded DNA intermediates generated by resection at two of the AsiSI sites 
was measured by quantitative PCR as described (Zhou et al, 2014; Zhou & Paull, 2015), 
which showed that CtIP is required for the production of ssDNA at these DSB sites, but 
that both the wild-type and nuclease-deficient mutant complement this deficiency (Figure 
3.10), suggesting that CtIP protein, but not its nuclease activity, is required for the 
resection of breaks induced by restriction enzyme cleavage in human cells. 
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Figure 3.10 Study of the effect of CtIP nuclease activity on DSB end resection using the 
established resection assay. 
Endogenous CtIP in ER-AsiSI-293T cells was depleted by shRNA treatment (KD) and 
transfected with vector (v), shRNA-resistant wild-type (wtCtIP) or N289A/H290A CtIP 
(CtIP(NA/HA)) plasmids 24 h before treatment with 600 nM 4-OHT, which induces nuclear 
translocation of the AsiSI enzyme. After 4 hrs, cells were harvested, genomic DNA was prepared, 
and either digested with restriction enzymes to distinguish between single-stranded and double-
stranded DNA, or mock-digested as described (Zhou et al, 2014; Zhou & Paull, 2015). (A) 
Quantitation of single-stranded DNA intermediates generated by resection at two selected AsiSI-
induced DSBs (“DSB1” and “DSB2”) was performed by real-time PCR. The percentage of 
ssDNA at various distances from the two DSBs (335 nt, 1618 nt and 3500 nt from DSB1; 364 nt, 
1754 nt and 3564 nt from DSB2) was measured. Background was examined by measuring 
%ssDNA at a site where there is no nearby AsiSI-induced break (“No DSB”). The average of two 
experiments is shown, with the qPCR performed in triplicate and the error bars showing standard 
deviation. (B) Western blot of CtIP with actin as a loading control. 
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The DNA-PK enzyme blocks DSB resection in human cells 
 
The most highly conserved NHEJ factor is the Ku heterodimer, which is present 
in all organisms that use NHEJ for DNA repair (Hiom, 2003). Ku is generally considered 
to be inhibitory of resection, but recent data from murine models suggests that the effect 
of the Ku heterodimer on resection may be minimal compared to 53BP1 (Bunting et al, 
2012). I used the ER-AsiSI U2OS system to address this question by depleting Ku86, a 
central factor in NHEJ (Figure 3.11A and B). Even partial depletion of Ku promotes 
ssDNA formation by ~1.4- to 2.2-fold in U2OS cells. I also performed the resection assay 
in HCT116 cells engineered to conditionally delete the Ku86 gene upon Cre expression 
(Fattah et al, 2010). Wild-type (WT), Ku86 Flox/+, and Ku86 Flox/- HCT116 cells were 
transduced with HA-ER-AsiSI retrovirus and Cre-mediated deletion of Ku86 was induced 
(Figure 3.11C and D). The results confirm that the Ku heterodimer blocks resection in 
human cells and that a Ku86 heterozygous cell line shows haploinsufficiency for this 
effect.  
DNA-PKcs binds to DSBs through the Ku heterodimer and is an important 
classical NHEJ factor. However, there is evidence showing that DNA-PKcs might be an 
active regulator of DSB repair pathway choice (Cui et al, 2005). To investigate whether 
DNA-PKcs affects DSB resection in human cells, I measured resection in AsiSI 
expressing U2OS cells transfected with control siRNA or siRNA directed against DNA-
PKcs. As in the case of Ku depletion, knockdown of DNA-PKcs led to increased 
resection (Figure 3.12A and B). As reported previously (Peng et al, 2005), DNA-PKcs 
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depletion also decreased the protein level of ATM, which is required for resection 
(Jazayeri et al, 2006; You et al, 2009).The increase in DSB resection upon DNA-PKcs 
knockdown in the background of ATM reduction suggests that DNA-PKcs strongly 
inhibits DSB resection in vivo. This conclusion was further confirmed by measuring 
resection in wild-type and DNA-PKcs-/- HCT116 cells expressing AsiSI, where DNA-
PKcs deficient cells exhibited ~2.4 to 3.3-fold higher levels of resection at DSB1 and 1.2 
to 1.7-fold higher levels of resection at DSB2 compared to wild-type cells, even though 
the expression of ATM was strongly reduced in DNA-PKcs-/- cells (Figure 3.12C, D).
 
Figure 3.11 Ku blocks DSB end resection. 
(A, B) Measurement of DSB resection in ER-AsiSI U2OS cells transfected with control siRNA or 
siRNAs directed against Ku86 as in Figure 3.8. (C, D) Measurement of DSB resection in wild 
type (WT), Ku86 heterozygous (Ku86 Flox/+) and Ku86 conditional HCT116 cells (Fattah et al, 
2010). WT, Ku86 Flox/+ and Ku86 Flox/- cells were transduced with ER-AsiSI retrovirus and 
deletion of one Ku86 allele in the Ku86 Flox/+ and Ku86 Flox/- cells was induced with Cre 
expression. The cells obtained were then treated with 600 nM 4-OHT for 4 h and resection was 
measured. The result is an average of four experiments with standard deviation. The expression of 
Ku86 and HA-ER-AsiSI was examined by Western blotting using anti-Ku86 and anti-HA 
antibodies, with PARP-1 as a loading control. 
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To verify that DNA-PKcs is indeed recruited to DSB1 and DSB2, we performed 
chromatin immunoprecipitation (ChIP) and observed a clear enrichment of phospho-
S2056 DNA-PKcs at both DSB sites (Figure 3.12E). We observed increased 
accumulation of DSBs upon 4-OHT treatment in Ku or DNA-PKcs deficient cells (data 
not shown), likely due to a failure of NHEJ, which provides more DSBs for resection. 
 
Figure 3.12 DNA-PKcs blocks DSB end resection. 
(A, B) Measurement of DSB resection in ER-AsiSI U2OS cells transfected with control siRNA or 
siRNAs directed against DNA-PKcs. (C, D) Measurement of DSB resection in wild type (WT) 
and DNA-PKcs-/- HCT116 cells (Ruis et al, 2008).The result is an average of four experiments 
with standard deviation. The expression of DNA-PKcs, ATM and HA-ER-AsiSI was examined 
by Western blotting using anti-DNA-PKcs, anti-ATM and anti-HA antibodies, respectively, with 
PARP-1 as a loading control. (E) ChIP experiments were performed in ER-AsiSI U2OS cells 
using either mock antibody or antibody directed against phospho-DNA-PKcs (S2056). ChIP 
efficiencies (as percent of input immunoprecipitated) were measured by qPCR at 80 bp from 
AsiSI induced DSBs. The results are shown as mean of five independent experiments with 
standard deviation. (ChIP data provided by Caron P and Legube G) 
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DISCUSSION 
In this study I have developed a qPCR based assay to directly measure DSB 
resection intermediates in human cells. In contrast to widely used assays which examine 
ssDNA generated by resection by indirectly detecting RPA, RAD51, or BrdU foci, the 
assay described here is quantitative and directly measures the level of ssDNA. In 
addition, it is possible to determine the length of resection from a specific DSB site using 
the new assay. I find that 5’ strands at a DSB in human cells are degraded up to 3.5 kb 
from break ends, which is similar to the length of resection measured using probes that 
detect ssDNA formation near break sites in budding yeast (Chung et al, 2010). The AsiSI 
expression system used here theoretically generates about 1,000 DSBs in the human 
genome, although not every site is cleaved upon 4-OHT exposure and translocation of 
AsiSI into the nucleus (Iacovoni et al, 2010). Approximately 150 DSBs can be actually 
induced by AsiSI enzyme in human cells (Massip et al, 2010). At the two AsiSI sites I 
have focused on, between 8 and 21% of the chromosomes incur a DSB in U2OS cells, 
based on qPCR across the break sites. This may be a low estimate since rapidly repaired 
breaks would not be detected, but it can be used to estimate the efficiency of DSB 
resection at sites which are cut and not immediately religated, which appears to be 
approximately 20%. This is lower than estimates of HR frequency determined from 
analysis of I-SceI-induced breaks in wild-type and repair-deficient cells which have 
suggested that HR accounts for 30 to 40% of repair events in human cells (Johnson & 
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Jasin, 2001), although the chromatin structure at each site as well as the cell cycle phase 
certainly affect the efficiency of end processing.  
Resection of DSBs has been shown to be efficient and extensive in the S and G2 
phases of the cell cycle, but limited in the G1 phases (Aylon et al, 2004; Huertas & 
Jackson, 2009; Ira et al, 2004). I also find this to be the case in the 293T mammalian cell 
system, with lower resection observed in G1 cells and higher levels of the ssDNA 
observed in S/G2(/M) cells compared to asynchronous cultures. Here I also find 
significant levels of resection in cultures that are predominantly in G1 phase, however, 
suggesting that processing of DNA ends into ssDNA does occur, albeit less efficiently, in 
G1 phase cells. My survey of enzymes known to be involved in end resection (MRN, 
Exo1, CtIP, SOSS1), confirms that these factors are acting directly at the level of end 
processing and validate this method in comparison to previous results. Furthermore, 
measurement of resection in CtIP-depleted 293T cells where either wild-type CtIP or 
nuclease-deficient CtIP mutant (N289A/H290A) suggests that CtIP protein, but not its 
nuclease activity, is required for the resection of breaks induced by restriction enzyme 
cleavage in human cells. 
The Ku heterodimer and DNA-PKcs are specifically required for NHEJ, but have 
also been suggested to regulate end processing (Allen et al, 2003; Convery et al, 2005; 
Cui et al, 2005; Neal et al, 2011; Shibata et al, 2011). Using the qPCR-based resection 
assay, I clearly show that the DNA-PKcs protein inhibits resection of DSB ends, the 
initiating step of HR. Consistent with previous reports (Allen et al, 2002; Neal et al, 
2011), I find that loss of DNA-PKcs or Ku dramatically increases the efficiency of DSB 
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resection, using both siRNA depletion and genetic deletion. This is expected considering 
the widely proposed competition between NHEJ and HR factors for DNA ends (Allen et 
al, 2003; Neal et al, 2011; Shrivastav et al, 2008) and evidence for Ku inhibition of 
resection in yeast (Clerici et al, 2008; Krishna et al, 2007; Lee et al, 1998; Zhang et al, 
2007). In addition, I observed increased accumulation of DSBs upon 4-OHT treatment in 
Ku or DNA-PKcs deficient cells, likely due to a failure of NHEJ repair. Notably, even 
though depletion of 53BP1 and depletion of Ku or DNA-PKcs have similar stimulatory 
effects on resection, only depletion of the DNA-PK holoenzyme components increases 
the apparent accumulation of unresolved DSBs (data not shown). This suggests that 
53BP1 is not involved in the initial fast process of religation but may affect pathway 
choice for the subset of breaks that goes through resection and HR.  
Recent observations showing that 53BP1 deletion rescues many of the defects 
seen in BRCA1-deficient cells (Bouwman et al, 2010; Bunting et al, 2010) suggest that 
BRCA1 function must be to antagonize 53BP1 in some way. Yet here I demonstrate that 
BRCA1 depletion has no effect on end processing under conditions where RAD51 
filament formation is clearly compromised. It is possible that RAD51 filaments in 
BRCA1-depleted cells are qualitatively different from those in wild-type cells, leading to 
differences in foci intensity, or perhaps BRCA1 affects resection at some genomic sites 
more than others. From the data I have collected, however, I suggest that the function of 
BRCA1 may be more similar to that of BRCA2, to promote RAD51 filament formation, 
whereas 53BP1 is antagonizing the end resection process directly.  
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In conclusion, I have developed a method to analyze the levels of ssDNA 
quantitatively in mammalian cells and have demonstrated the validity of this method. 
Here I have used it in the context of site-specific DSBs in order to measure end resection, 
but in theory this method can be used to quantitate ssDNA intermediates in any genomic 
context. Direct measurement of DSBs has obvious advantages over foci-based methods in 
that quantitative analysis of the actual resection products can be performed; however, we 
note that this is limited by the requirement for sequence specificity of the cut site. Other 
methods such as RPA ChIP-Seq have also been utilized to address the need for resection 
assays at random or unknown DNA damage sites in the mammalian genome (Yamane et 
al, 2011; Yamane et al, 2013). A combination of these methods may be necessary to 










CHAPTER 4: DNA-DEPENDENT PROTEIN KINASE REGULATES 
DNA END RESECTION IN CONCERT WITH MRE11-RAD50-NBS1 




DNA double strand breaks (DSBs) are caused by replication fork collapse, ionizing 
radiation, chemotherapeutic drugs, and reactive oxygen products of metabolism, and can 
lead to chromosome rearrangements, genomic instability and tumorigenesis if not 
repaired correctly (Ciccia & Elledge, 2010). Eukaryotic cells have developed two major 
pathways to repair DSBs: Non-homologous end joining (NHEJ) and homologous 
recombination (HR). NHEJ is active throughout the cell cycle while the activity of HR is 
limited to S and G2 phases (Trovesi et al, 2013). When NHEJ and HR are both active, 5’ 
to 3’ resection of DSBs is thought to be a critical control point for the choice between the 
two repair pathways, because the 3’ single-strand DNA (ssDNA) generated by extensive 
resection serves to inhibit NHEJ but is required for RAD51 filament formation and strand 
invasion during HR (Huertas, 2010; Symington & Gautier, 2011).  
 
Portions of this chapter have been published as follows: 
 Zhou Y, Paull TT (2013) DNA-dependent Protein Kinase Regulates DNA End Resection in 
Concert with Mre11-Rad50-Nbs1 (MRN) and Ataxia Telangiectasia-mutated (ATM). J Biol Chem 
288: 37112-37125. (Contributions: YZ and TP designed the research and wrote the manuscript; 
YZ performed all experiments.) 
 Della-Maria J, Zhou Y, Tsai MS, Kuhnlein J, Carney JP, Paull TT, Tomkinson AE (2011) Human 
Mre11/human Rad50/Nbs1 and DNA ligase IIIalpha/XRCC1 protein complexes act together in an 
alternative nonhomologous end joining pathway. J Biol Chem 286: 33845-33853. (Contributions: 
JD, YZ, TP and AT designed the research and wrote the manuscript; JD and YZ performed most 
experiments. All other authors contributes to the research) 
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Many proteins have been implicated in the regulation of DSB resection in 
eukaryotic cells. The Mre11/Rad50/Nbs1 (MRN) complex has been shown to promote 
resection by two independent endo/exonucleases: Exo1 and Dna2 (Cejka et al, 2010; 
Mimitou & Symington, 2008; Nicolette et al, 2010; Niu et al, 2010; Zhu et al, 2008). 
MRN recruits Exo1 to DSBs and promotes resection in conjunction with CtIP (Chen et 
al, 2008; Dodson et al, 2010; Eid et al, 2010; Huertas & Jackson, 2009; Quennet et al, 
2011; Yuan & Chen, 2009). The Ataxia-Telangiectasia-Mutated (ATM) protein kinase is 
activated via MRN and is also required for efficient DSB resection (Kuhne et al, 2004; 
Morrison et al, 2000; You et al, 2009) although its role in this process is not completely 
understood. 
The Ku70/80 heterodimer and DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs) coordinate the process of NHEJ. After binding of Ku and subsequent 
recruitment of DNA-PKcs to DSBs, an active DNA-PK holoenzyme is formed that 
mediates the phosphorylation of DNA-PKcs itself as well as other NHEJ factors (Wang 
et al, 2013). Autophosphorylated DNA-PKcs undergoes a large conformational change 
that is thought to promote its dissociation from DNA ends (Ding et al, 2003; Dobbs et al, 
2010; Merkle et al, 2002; Reddy et al, 2004; Shibata et al, 2011). Of particular 
importance to this rearrangement, a cluster of 6 serines and threonines in DNA-PKcs 
termed the ABCDE cluster are autophosphorylated (Meek et al, 2007), and T2609 and 
T2647 in this cluster were also shown to be targets of ATM (Chen et al, 2007).  
Apart from its role in NHEJ, DNA-PKcs has also been implicated in regulation of 
HR (Allen et al, 2003; Convery et al, 2005; Cui et al, 2005; Neal et al, 2011; Shibata et 
al, 2011), but the underlying mechanism is not fully understood. It has been shown that 
the expression of exogenous DNA-PKcs in cells lacking the enzyme inhibits HR in a Ku-
dependent manner (Neal et al, 2011). However, there is still debate about how DNA-PK 
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kinase activity affects DNA-PK regulation of HR and conflicting results have been 
reported on this issue (Allen et al, 2003; Davidson et al, 2012; Neal et al, 2011). It 
remains to be investigated whether DNA-PKcs directly affects resection and how its 
kinase activity functions in this process. 
In this study, I examine how chemical inhibition of DNA-PKcs affects DSB 
resection using a resection assay for mammalian cells that I have developed (Zhou et al, 
2014). I find that DNA-PK inhibitor treatment strongly stimulates DSB resection, 
although the interpretation of this result is complicated by the inhibitor-induced loss of 
DNA-PKcs protein in human cells. To characterize the role of DNA-PKcs catalytic 
activity directly, I reconstitute resection with purified recombinant proteins in vitro and 
investigate the effect of DNA-PKcs on Exo1-mediated resection. The results show that 
DNA-PKcs inhibits Exo1 activity, which can be overcome by the combined effects of 
MRN and the autophosphorylation of DNA-PKcs. Phosphorylation of DNA-PKcs, either 
through autophosphorylation or phosphorylation by ATM, promotes the recruitment of 
Exo1 to DNA ends, suggesting that unphosphorylated DNA-PKcs presents a barrier to 
the recruitment of resection enzymes. Overall, I propose that in conjunction with MRN 






Chemical inhibition of DNA-PK stimulates DSB resection in human cells 
I have established a quantitative PCR (qPCR) assay for accurate measurement of 
DSB resection in human cells using a U2OS cell line (ER-AsiSI U2OS) which expresses 
the restriction enzyme AsiSI fused to the estrogen receptor (ER) hormone-binding 
domain (Iacovoni et al, 2010). Approximately 150 DSBs can be induced at sequence-
specific sites after treating the cells with 4-hydroxytamoxifen (4-OHT) which induces 
translocation of the ER-AsiSI protein into the nucleus (Massip et al, 2010). To accurately 
measure ssDNA generated by resection adjacent to specific AsiSI-induced DSBs, I 
focused on two AsiSI sites on Chromosome 1 ("DSB1", Chr 1: 89231183; "DSB2", Chr 
1: 109838221)(Iacovoni et al, 2010) and designed three pairs of qPCR primers across 
BsrGI (DSB1) or BamHI (DSB2) restriction sites located various distances from each 
AsiSI site (DSB1: 335 bp, 1618 bp and 3500 bp; DSB2: 364 bp, 1754 bp and 3564 bp) 
(Zhou et al, 2014). The restriction enzymes can be used to distinguish between ssDNA 
generated by resection and unresected dsDNA because they can only cut duplex DNA. 
As a negative control, I designed a pair of primers at a site where there is no nearby AsiSI 
sequence on Chromosome 22 ("No DSB") (Miller et al, 2010). After extracting the 
genomic DNA, the percentage of ssDNA (ssDNA%) at various sites adjacent to DSB1 
and DSB2 was measured by qPCR (Nicolette et al, 2010) and the percentage of double 
strand breaks (DSB%) present at the two AsiSI sites was also examined using two pairs 
of primers across the AsiSI sites. 
DNA-PKcs is an important classical NHEJ factor but may also be involved in 
regulation of HR (Neal et al, 2011; Shibata et al, 2011). Our previous study measuring 
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resection in human cells showed that depletion of DNA-PKcs significantly increased 
resection (Zhou et al, 2014). This is expected considering the widely accepted model, 
where NHEJ and HR factors compete for DNA ends (Allen et al, 2003; Neal et al, 2011; 
Shrivastav et al, 2008), but it remains unclear how the kinase activity and 
phosphorylation of DNA-PKcs affects DSB resection. Several studies have shown that 
phosphorylation of DNA-PKcs promotes release of DNA-PKcs from DNA and that 
blocking DNA-PKcs phosphorylation using small molecule inhibitors or mutations in the 
phosphorylation sites results in reduced rates of DSB repair and reduced survival after 
ionizing radiation (Chan et al, 2002; Ding et al, 2003; Merkle et al, 2002). At least a 
subset of the effects of blocked autophosphorylation occurs through inhibition of NHEJ, 
since loss of catalytic activity has been shown to impede the ligation step of joining 
(Block et al, 2004; Reddy et al, 2004). However, the effect of chemical inhibition of 
DNA-PK on HR remains controversial (Allen et al, 2003; Davidson et al, 2012; Neal et 
al, 2011). I examined this by performing the DNA resection assay in the presence of a 
DNA-PK inhibitor NU-7441 (DNA-PKi) or vehicle (DMSO). For comparison, cells were 
also treated with the ATM inhibitor KU-55933 (ATMi). As expected, inhibition of ATM 
kinase activity led to decreased resection at various sites adjacent to DSB1 and DSB2 
(Figure 4.1A), indicating that ATM promotes resection in human cells. In contrast, 
inhibition of DNA-PK catalytic activity strongly stimulated DSB resection (Figure 4.1A). 
Strikingly, the accumulation of DSBs at both DSB1 and DSB2 sites was not affected by 
ATMi, but was dramatically increased by DNA-PKi (Figure 4.1B), probably due to 
DNA-PKi inhibition of NHEJ-mediated repair. DNA-PKi treatment thus provides more 
DSB ends for resection, at least in part explaining why inhibition of DNA-PK kinase 




Figure 4.1 Chemical inhibition of DNA-PK stimulates DSB resection in human cells. 
(A) ER-AsiSI U2OS cells were pre-treated with 10 μM ATM inhibitor KU-55933 (ATMi) or 10 
μM DNA-PK inhibitor NU-7441 (DNA-PKi) for 1 h, followed by induction or mock-induction of 
DSBs with 300 nM 4-OHT for 4 h and measurement of DNA resection. (B) Percentages of DSBs 
at the two selected AsiSI sites were measured by qPCR using undigested gDNA samples from 
(A) and two sets of primers across the two AsiSI sites. The “No DSB” primers were used to 
normalize the amount of gDNA in the qPCR reaction. DSB percentages at DSB1 and DSB2 sites 
in mock-induced cells were both set to zero. 
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I also examined whether the protein level of DNA-PKcs was affected by DNA-
PK inhibitor upon DNA damage, because some inhibitors have been implicated in the 
degradation of their target proteins (Long et al, 2012). I found that NU-7441 treatment 
indeed led to decrease of DNA-PKcs protein level by ~40%, and another widely used 
DNA-PK inhibitor, NU-7026, had the same effect (Figure 4.2A). Interestingly, treating 
the cells with both DNA-PK inhibitor and ATM inhibitor further decreased the protein 
level of DNA-PKcs, and ATM protein levels also were reduced upon decrease of DNA-
PKcs (Figure 4.2A and B), consistent with the reported effect of DNA-PKcs depletion on 
ATM expression (Peng et al, 2005). In the absence of ATM inhibitor, both NU-7441 and 
NU-7026 dramatically increased DNA resection, whereas the ATM inhibitor significantly 
attenuated this effect (Figure 4.2C), even though the level of DNA-PKcs protein was 
further reduced (Figure 4.2A and B). Taken together, these data suggest that chemical 
inhibition of DNA-PKcs may stimulate DSB resection in human cells via a least two 
mechanisms: 1) DNA-PK inhibition reduces NHEJ repair and provides more DSB ends 
for resection; 2) DNA-PK inhibition decreases DNA-PKcs protein levels, which 
enhances resection. However, the loss of DNA-PKcs protein and inhibition of NHEJ 
repair with inhibitor treatment complicates the interpretation of the effect of DNA-PKcs 











Figure 4.2 The effects of DNA-PK inhibitor and ATM inhibitor on DNA-PKcs protein 
level and DSB end resection. 
(A) ER-AsiSI U2OS cells were pre-treated with 10 μM ATM inhibitor KU-55933 (ATMi), 10 
μM DNA-PK inhibitor NU-7441 or 20μM DNA-PK inhibitor NU-7026 as indicated for 1 h, 
followed by induction of DSBs with 300 nM 4-OHT for 4 h. Cell lysates were analyzed by 
Western blot using antibodies against DNA-PKcs, phospho-DNA-PKcs S2056, ATM and 
phospho-ATM S1981, with PARP-1 as a loading control. (B) Quantitation of DNA-PKcs band in 
(A), average of 3 quantitations is shown with standard deviation. (C) ER-AsiSI U2OS cells were 





DNA-PKcs inhibits DNA end resection by Exo1 in vitro 
Our study of resection in human cells showed that loss of DNA-PKcs protein 
stimulates DNA resection, but was inconclusive with respect to the role of DNA-PKcs 
kinase activity. It is also not clear whether DNA-PKcs indirectly regulates DSB resection 
by promoting NHEJ repair and limiting the availability of DSB ends for resection, or 
whether it can also directly affect the activity of DNA resection enzymes. In addition, it 
remains to be investigated how the kinase-inactive DNA-PKcs is released from DSB ends 
in the presence of DNA-PK inhibitor (Neal et al, 2011). 
To answer these questions, I performed reconstituted resection assays in vitro 
with purified human Exo1, Ku70/80 heterodimer, DNA-PKcs, and other proteins 
involved in DNA damage sensing and repair (Figure 4.3). I tested the activity of Exo1 in 
the presence of Ku or DNA-PKcs on a 4.4 kb linearized plasmid DNA and visualized the 
reaction products by SYBR Green staining and by non-denaturing Southern blot, probing 
for a 1 kb region of the 3’ strand at one end of the linearized plasmid DNA (Figure 4.4A). 
Exo1 alone completely degraded the DNA substrate, while Ku reduced the percentage of 
resected DNA molecules and the extent of resection by Exo1 (Figure 4.4B). DNA-PKcs 
by itself showed little effect on the activity of Exo1 (Figure 4.4B, lane 4); however, 
resection was strongly inhibited in the presence of both Ku and DNA-PKcs (Figure 4.4B, 
lane 3), showing that the effect of Ku and DNA-PKcs on resection is cooperative. 
Remarkably, the resection was completely blocked when ATP was eliminated from the 
reaction (Figure 4.4C, lane 5), suggesting that phosphorylation events mediated by DNA-






Figure 4.3 Purified recombinant proteins used in this study. 
Exo1, Ku, DNA-PKcs, wild-type MRN (WT) and nuclease-deficient MRN (H129L/D130V), 
ATM, and DNA Ligase IV/XRCC4 were stained with Coomassie Blue after SDS-PAGE. The 
Ku-associated wild-type (WT) DNA-PKcs and T2609 cluster phospho-blocking DNA-PKcs 
mutant (6A) were separated by SDS-PAGE followed by silver staining. *Asterisk indicates 










Figure 4.4 DNA-PK inhibits Exo1-mediated resection in vitro. 
(A) Schematic diagram of the resection assay in which 4.4 kb linear plasmid DNA is incubated 
with Exo1 and other factors in the reaction, which leads to either no resection, short resection 
tracks, or medium to long resection tracks (shown with resection initiating from both DNA ends). 
The reaction products are visualized with SYBR green (filled circle), which recognizes duplex 
DNA, or by non-denaturing Southern blot analysis using an RNA probe (line with asterisks) for a 
1 kb region of the 3' strand. (B) A reconstituted DSB resection assay was performed in the 
presence of 0.5 nM Exo1, 14 nM Ku, 7 nM DNA-PKcs and 37 pM linear DNA at 37°C for one 
hour. Reaction products were separated by 0.7% native agarose gel and visualized as described in 
(A) by SYBR Green staining (top), followed by a non-denaturing Southern blot analysis using an 
RNA probe for a 1 kb region of the 3' strand (bottom). (C) DNA resection assays were performed 
as in (B) in the presence or absence of ATP. 
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DNA-PKcs autophosphorylation overcomes DNA-PKcs inhibition of resection 
To further characterize the effect of DNA-PKcs on resection, I performed a time 
course experiment in the presence or absence of ATP. A one-hour reaction was sufficient 
for Exo1 to completely degrade the DNA substrate (Figure 4.5A, compare lanes 2 and 3), 
and ATP was not required for Exo1 to fulfill its function (lane 4), which was also the case 
in the presence of Ku (lanes 5-7). However, with both Ku and DNA-PKcs in the assay, a 
two-hour reaction led to 2.8-fold higher levels of resection than the one-hour reaction 
based on Southern blot signal (compare lanes 8 and 9), suggesting the inhibition of Exo1 
by DNA-PKcs is a reversible process in the presence of ATP. DNA-PKcs was previously 
shown to release from DNA ends upon autophosphorylation in the central domain of the 
kinase (Merkle et al, 2002), suggesting that DNA-PKcs inhibition of resection is released 
as more DNA-PKcs molecules are autophosphorylated in a longer reaction. Without 
ATP, even a two-hour reaction results in no resection (lane 10), further confirming that 
autophosphorylation of DNA-PKcs is critical for resection in the presence of Ku and 
DNA-PKcs. 
Autophosphorylation of DNA-PKcs at the ABCDE cluster has been suggested to 
be functionally important for DNA end processing, both in NHEJ and in HR (Ding et al, 
2003; Reddy et al, 2004; Shibata et al, 2011). To examine if this phosphorylation event 
affects Exo1-mediated DNA resection, I purified a DNA-PKcs/Ku complex where all six 
sites in the DNA-PKcs ABCDE cluster had been mutated (6A), and tested it in a time-
course experiment in comparison to a wild-type DNA-PKcs/Ku complex (WT). In a one-
hour reaction, the 6A complex showed slightly more inhibition of Exo1 activity than WT 
(Figure 4.5B, compare lanes 1 and 4). However, in a two-hour reaction, 3.5-fold higher 
levels of resection products were generated by Exo1 with WT DNA-PKcs compared to 
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the 6A mutant, as measured by the intensity of Southern blot signal (Figure 4.5B, 
bottom). These data suggest that autophosphorylation of the ABCDE cluster sites 
decreases DNA-PKcs inhibition of Exo1-mediated resection, presumably by promoting 
the release of DNA-PKcs from DNA ends and allowing Exo1 recruitment. Of note, ATP 
still promoted resection in the presence of 6A DNA-PKcs although always to a lesser 
extent than WT DNA-PKcs, consistent with reports that autophosphorylation of DNA-
PKcs at sites other than the ABCDE cluster sites can also promote DNA-PKcs release 
(Ding et al, 2003; Reddy et al, 2004). Taken together, these data suggest that 
autophosphorylation of DNA-PKcs at the ABCDE cluster sites and other sites can 
actively release the inhibition of Exo1-mediated resection.  
 
 
Figure 4.5 DNA-PKcs autophosphorylation overcomes DNA-PKcs inhibition of 
resection. 
(A) DNA resection assays were performed as in Figure 4.4C but were stopped after one or two 
hours as indicated. (B) DNA resection assays were performed for one or two hours with 0.35 nM 
wild-type (WT) DNA-PKcs or a T2609 cluster sites phospho-blocking DNA-PKcs mutant (6A) in 
the presence of 1.9 nM Ku, 0.1 nM Exo1, and 37 pM 4.4 kb linear DNA. 
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MRN overcomes DNA-PKcs inhibition of Exo1 activity 
MR and Mre11/Rad50/Nbs1(Xrs2) complexes have been implicated in DSB 
resection in vivo and in extracts (Costanzo, 2011; Mimitou & Symington, 2008; Zhu et al, 
2008). In vitro studies with purified proteins have also shown that MR and MRN(X) 
complexes recruit long-range exo/endo-nucleases and also help to block the inhibitory 
effects of Ku (Hopkins & Paull, 2008; Nicolette et al, 2010; Nimonkar et al, 2011; Niu et 
al, 2010; Yang et al, 2013). Here I found that MRN strongly promotes DNA resection by 
Exo1 in the presence of both Ku and DNA-PKcs in a dose-dependent manner (Figure 
4.6A). MRN was also able to stimulate resection with 6A DNA-PKcs, but the 6A DNA-
PKcs still showed more inhibition of Exo1 activity than wild-type DNA-PKcs in the 
presence of MRN (Figure 4.6B). A nuclease-deficient MRN mutant 
(M(H129L/D130V)RN)(Della-Maria et al, 2011) exhibited similar stimulation of Exo1 
activity as wild-type MRN (Figure 4.6C), which was confirmed by qPCR, measuring the 
percentage of ssDNA at 29 nt and 1025 nt from the DNA end Figure 4.6D) (Nicolette et 
al, 2010; Yang et al, 2013). This data suggests that the nuclease activity of MRN is not 
essential for stimulation of Exo1 in the presence of Ku and DNA-PKcs. In addition, the 3' 
to 5' exonuclease activity of Mre11 is not active under these reaction conditions (in the 
absence of manganese) (Paull & Gellert, 1998). In contrast to the stimulatory effect of 
MRN on resection in the presence of 6A DNA-PKcs, MRN could not overcome DNA-
PKcs inhibition of resection in the absence of ATP or in the presence of DNA-PK 
inhibitor NU-7026 (DNA-PKi) (Figure 4.6C). Thus, in the presence of DNA-PKcs, MRN 





Figure 4.6 MRN overcomes DNA-PKcs inhibition of Exo1-mediated resection. 
(A) DNA resection assays were performed in the presence of 0.5 nM Exo1, 14 nM Ku, 7 nM 
DNA-PKcs, 37 pM 4.4 kb linear DNA, with MRN added as indicated (6, 12, or 24 nM). (B) DNA 
resection assays were performed in the presence of 0.35 nM wild-type (WT) DNA-PKcs or a 
T2609 cluster sites phospho-blocking DNA-PKcs mutant (6A), 1.9 nM Ku, 0.1 nM Exo1, and 37 
pM 4.4 kb linear DNA with or without 9.5 nM MRN complex for one hour. (C) DNA resection 
assays as in Figure 3A were performed with 24 nM or 72 nM MRN or nuclease-deficient MRN 
mutant (M(H129L/D130V)RN) in the absence of ATP or in the presence of 200 μM DNA-PK 
inhibitor NU7026 (DNA-PKi). (D) Part of the DNA products in (C) were digested or mock 
digested with NciI at 37 °C overnight and resection was measured by qPCR as described in 
Experimental Procedures. A representative experiment is shown. 
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ATM promotes Exo1-mediated resection in the presence of Ku and DNA-PKcs by 
phosphorylating DNA-PKcs 
The fact that ATM kinase activity potentiates the stimulatory effect of DNA-PK 
inhibitor on DNA resection in cells (Figure 4.2C) suggested there might be an important 
role for ATM in regulating DNA-PKcs inhibition of resection. At least two of the 
phosphorylation sites in the ABCDE cluster, T2609 and T2647, have been identified as 
ATM target sites in human cells (Chen et al, 2007), and ATM activity has been shown to 
be required for resection of DBSs in Xenopus extracts (You et al, 2009) and for a subset 
of HR in human cells (Beucher et al, 2009). Here I found that ATM could further 
alleviate DNA-PKcs inhibition of resection in the presence of MRN (Figure 4.7A, lane 
6). To further examine whether ATM-mediated phosphorylation of DNA-PKcs affects 
resection, I performed in vitro resection assays in the presence or absence of the DNA-
PK specific inhibitor NU7026 (DNA-PKi). The result again clearly shows that blocking 
the kinase activity of DNA-PKcs dramatically inhibits DSB resection in the presence of 
MRN (lane 7). In contrast, eliminating DNA-PKcs protein from a resection reaction 
dramatically increases DSB resection (Figure 4.7B, compare lane 5 with 4), similar to our 
observations in human cells (Zhou et al, 2014). Interestingly, the addition of ATM largely 
restores resection in the presence of DNA-PK inhibitor, and this rescued resection was 
inhibited again when ATM inhibitor was present (Figure 4.7A, lanes 8 and 9). With Ku 
alone, ATM did not further promote resection in the presence of MRN; rather, it showed 
slight inhibitory effect on resection (Figure 4.7B, compare lanes 5 and 7), possibly due to 
the reported inhibitory effect of ATM phosphorylation on Exo1 ser714 (Bolderson et al, 
2010). To confirm this, I performed a titration of Ku and observed similar inhibition of 
Exo1 activity by ATM (Figure 4.7C, lanes 5 and 8), where this inhibitory effect could be 
overcome by inhibition of ATM kinase activity (Figure 4.7C, compare lanes 5 with 9 and  
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Figure 4.7 ATM promotes Exo1-mediated resection in the presence of Ku and DNA-
PKcs. 
(A) DNA resection assays were performed in the presence of 0.5 nM Exo1, 14 nM Ku, 7 nM 
DNA-PKcs, 37 pM 4.4 kb linear DNA, 24 nM MRN, 0.1 nM ATM, 20 μM ATM specific 
inhibitor KU-55933 (ATMi) and 200 μM DNA-PK specific inhibitor NU7026 (DNA-PKi). 
Reaction products were visualized by SYBR Green staining (top) and Southern blot analysis 
(bottom). (B) DNA resection assays were performed as in (A) using indicated proteins. (C) DNA 
resection assays were performed as in (A) with 0.5 nM Exo1, 56 nM (+) or 112 nM (++) Ku, 24 
nM MRN and 0.1 nM ATM in the presence or absence of 20 μM ATM specific inhibitor KU-
55933 (ATMi).  
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lanes 8 with 10). These data suggest that ATM stimulation of resection in the presence of 
both Ku and DNA-PKcs is specific to DNA-PKcs and might be achieved by 
phosphorylation of DNA-PKcs autophosphorylation sites, as previously suggested (Chen 
et al, 2007).                                                         
To test this hypothesis, I monitored the phosphorylation status of DNA-PKcs by 
using [γ-
32
P]-ATP in the reaction (Figure 4.8A). DNA-PKcs showed a faint 
autophosphorylation band when incubated in the presence of Ku (lane 4). Remarkably, 
MRN promotes DNA-PKcs autophosphorylation (lane 5), which might promote DNA-
PKcs dissociation and contribute to the stimulatory effect of MRN on Exo1 activity in the 
presence of DNA-PKcs. As expected, addition of ATM further increased the level of 
DNA-PKcs phosphorylation (lane 6). The phosphorylation of DNA-PKcs in the presence 
of MRN was blocked by DNA-PK inhibitor (lane 7), confirming this as 
autophosphorylation. Addition of ATM to this reaction restored DNA-PKcs 
phosphorylation, which in this case was blocked by ATM inhibitor (lanes 8-9), 
confirming that ATM indeed phosphorylates DNA-PKcs. In addition, use of phospho-
specific antibodies showed that both T2609 and S2056 of DNA-PKcs could be 
phosphorylated by ATM when autophosphorylation of DNA-PKcs is suppressed by 
DNA-PK inhibitor in vitro (Figure 4.8B). In the presence of DNA-PKcs, the level of 
Exo1-mediated resection correlates well with the phosphorylation level of DNA-PKcs 
(Figure 4.7A and Figure 4.8A). These data suggest that ATM can promote resection by 
increasing the phosphorylation level of DNA-PKcs, which could be a novel mechanism 
by which ATM promotes HR. In addition, ATM kinase activity can compensate for 
DNA-PKcs autophosphorylation and restore resection upon inhibition of DNA-PKcs. 
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Figure 4.8 ATM kinase activity compensates for DNA-PKcs autophosphorylation upon 
chemical inhibition of DNA-PKcs. 
(A) Resection assays were performed as in Figure 4.7A in the presence of 0.5 nM Exo1, 14 nM 
Ku, 7 nM DNA-PKcs, 37 pM 4.4 kb linear DNA, 24 nM MRN, 0.1 nM ATM, 20 μM ATM 
specific inhibitor KU-55933 (ATMi), 200 μM DNA-PK specific inhibitor NU7026 (DNA-PKi) 
and 2.5 μCi [γ-
32
P]-ATP, except that the protein products were visualized by silver staining (top) 
and phosphorimaging (bottom). (B) 14 nM Ku, 7 nM DNA-PKcs, 24 nM MRN, 0.1 nM ATM, 
and 1 ng 4.4 kb linear DNA were incubated at 37°C for one hour in resection reaction buffer in 
the presence of 200 μM DNA-PK inhibitor NU7026 (DNA-PKi). 50 nM GST-p53 substrate was 
also included in the reaction to monitor kinase activity. Western blotting analysis was performed 
using DNA-PKcs antibody, DNA-PKcs phospho-specific antibodies (T2609 and S2056), as well 
as p53 phospho S15 antibody. 
 
DNA-PKcs inhibits the recruitment of Exo1 to DNA ends in vitro 
In accordance with my findings with Exo1, previous studies also showed that 
DNA-PK inhibited the digestion of DNA by exonuclease V and that autophosphorylation 
of DNA-PKcs overcame this inhibition (Reddy et al, 2004; Weterings et al, 2003). It is 
possible that DNA-PKcs inhibits Exo1-mediated resection in the presence of Ku simply 
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by blocking DNA ends and preventing Exo1 binding. To test this hypothesis, I performed 
a DNA pull-down assay using a 717 bp biotinylated DNA substrate which was 
conjugated to magnetic streptavidin beads as previously described (Yang et al, 2013). A 
nuclease-deficient Exo1 mutant (Exo1(D78A/D173A)) was used for this experiment to 
prevent degradation of the DNA by Exo1. The DNA-protein complex was crosslinked 
with UV light and isolated for Western blotting analysis using Exo1 antibody. Exo1 alone 
showed low affinity for DNA ends (Figure 4.9A, lane 1). Our previous work showed that 
MRX was able to promote the recruitment of yeast Exo1 to DNA ends (Nicolette et al, 
2010). Similarly, I found that MRN greatly improves the binding of human Exo1 to the 
DNA substrate (lane 2). Exo1 recruitment was significantly reduced in the presence of 
Ku and DNA-PKcs, and was almost completely blocked when ATP was not included in 
the reaction (lanes 3 and 4). Similar to DNA-PKcs phosphorylation, Exo1 recruitment 
was inhibited by DNA-PK inhibitor and restored by ATM kinase activity (Figure 4.9B), 
suggesting that ATM acts to remove the kinase-inactive DNA-PK complex from DSBs. 
In this experiment I also monitored binding of DNA-PKcs to the DNA and confirmed 
that inhibition of DNA-PKcs activity stabilizes the kinase on DNA, whereas ATM 
catalytic activity helps to remove DNA-PKcs (Figure 4.9B). Taken together, these data 
suggests that DNA-PKcs inhibits Exo1-mediated resection by blocking DNA ends, and 
that autophosphorylation or ATM-mediated phosphorylation of DNA-PKcs overcomes 
this inhibitory effect by promoting DNA-PKcs dissociation and Exo1 recruitment. 
 
Opposing effects of DNA-PKcs and MRN regulate DNA Ligase IV-mediated end 
ligation and Exo1-mediated resection 
Previous studies showed that DNA-PKcs autophosphorylation promotes DNA 
end-joining by the DNA Ligase IV/XRCC4 complex (LigIV/XRCC4)(Reddy et al, 2004). 
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Here I examined how DNA-PKcs and MRN regulate NHEJ and resection with both 
LigIV/XRCC4 and Exo1 in the same reaction. I measured ligation of the cohesive ends of 
the linearized plasmid substrate by qPCR using a pair of primers across the restriction site 
and simultaneously measured resection as previously described (Nicolette et al, 2010; 
Yang et al, 2013). As expected, when LigIV/XRCC4 or Exo1 were present individually, 
DNA ligation was stimulated by Ku and DNA-PKcs, whereas resection was inhibited by 
Ku and DNA-PKcs (Figure 4.10A and B). However, with both LigIV/XRCC4 and Exo1 
in the assay, ligation was largely blocked (Figure 4.10A and B), possibly because the 
DNA ends were quickly resected by Exo1 and became poor substrates for ligation in the  
 
 
Figure 4.9 Blocking the activity of DNA-PKcs inhibits the recruitment of Exo1 to DNA 
ends and promotes stabilization of DNA-PKcs.  
(A) A DNA binding assay was performed with 110 nM nuclease-deficient Exo1(D78A/D173A), 
24 nM MRN, 28 nM Ku, 14 nM DNA-PKcs and 1.2 nM of a 717 bp biotinylated DNA substrate 
(containing three azide crosslinker groups on the 5’ strand) conjugated to magnetic streptavidin 
beads. The Dynabead-DNA-protein complex was crosslinked with UV light, washed and pulled 
down for Western blotting analysis using Exo1 antibody. (B) DNA binding assay as in (A) was 
performed in the presence of 110 nM Exo1 (D78A/D173A), 2.5 nM ATM, 20 μM ATM specific 
inhibitor KU-55933 (ATMi) and 200 μM DNA-PK specific inhibitor NU7026 (DNA-PKi) and 
probed for both Exo1 and DNA-PKcs. 
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Figure 4.10 Opposing effects of DNA-PKcs and MRN regulate DNA Ligase IV-mediated 
end ligation and Exo1-mediated resection.  
(A) 37 pM 4.4 kb SphI-linearized DNA was assayed in the presence of 0.5 nM Exo1, 0.5 nM 
DNA Ligase IV/XRCC4 complex, 2.5 nM Ku, 5 nM DNA-PKcs and 24 nM MRN. DNA ligation 
and resection were both measured by qPCR as described in Methods. Ligation level in the 
presence of LigIV/XRCC1 alone was set to one. A representative experiment is shown. (B) 
Combined DNA ligation and resection assays were performed as in (A) in the presence or 
absence of 200 μM DNA-PK inhibitor NU7026 (DNA-PKi). (C) DNA ligation assay was 
performed as in (A) with 4 nM or 100 nM wild-type MRN or nuclease-deficient MRN complex 
(M(H129L/D130V)RN). 
 
       
 92 
in vitro assay. In vivo the presence of other NHEJ factors and other regulators of HR 
likely are responsible for the high efficiency of NHEJ (Dobbs et al, 2010; Shrivastav et 
al, 2008). In the presence of DNA-PK inhibitor, both ligation and resection were blocked 
(Figure 4.10B, lanes 3 and 6), further indicating that autophosphorylation of DNA-PKcs 
is important for both NHEJ and HR. Unexpectedly, although MRN overcomes DNA-
PKcs inhibition of resection (Figure 4.10A, lane 9), it strongly inhibits DNA ligation in 
the presence of Ku/DNA-PKcs (Figure 4.10A, lane 5). This inhibition does not require 
the nuclease activity of MRN (Figure 4.10C), suggesting that the inhibitory effect is not 
simply due to short range processing of DNA ends by MRN. 
 
MRN stimulates DNA ligase III/XRCC1-mediated end rejoining 
I also tested the effect of MRN complex on DNA end ligation mediated by DNA 
ligase III/XRCC1, a ligase involved in the completion of DSB repair by the alternative 
NHEJ pathway (Della-Maria et al, 2011). As shown in Figure 4.11A, MRN significantly 
promoted intermolecular joining of compatible DNA ends, whereas MR slightly 
promoted ligation and Nbs1 did not show much effect. I found that DNA Ligase 
III/XRCC1 could also mediate ligation of incompatible DNA ends (Figure 4.11B), which 
was enhanced by MRN or MR, but not by Nbs1. This stimulation was presumably caused 
by the end-tethering activity of MRN and MR (de Jager et al, 2001). Because the 
nuclease activity of Mre11 has been shown to be active in the presence of Mg
2+ 
(Hopkins 
& Paull, 2008), we hypothesized that short range of end processing by the MRN complex 
may contribute to the ligation of incompatible DNA ends. To test this hypothesis, the 
effects of wild-type MRN or nuclease-deficient MRN mutant (M(H129L/D130V)RN) on 
DNA end ligation by ligase III/XRCC1 were compared using linear DNA substrate with 
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compatible or incompatible ends. As expected, both the wild-type and nuclease-dead 
MRN complexes stimulated the ligation of compatible DNA ends (Figure 4.12A), with 
the mutant MRN showing clearly stronger stimulatory effect. In contrast, ligation of 
incompatible DNA ends was only stimulated by the wild-type MRN complex but not by 
the mutant (Figure 4.12B), indicating that MRN nuclease activity promotes the joining of  
 
 
Figure 4.11 MRN stimulates compatible and incompatible DNA end ligation by DNA 
ligase III/XRCC1. 
(A) Linear plasmid DNA with compatible ends (digested by PstI) was incubated with 1.4 fmol of 
DNA ligase III/XRCC1 in the presence or absence of MRN (312.5 fmol, 625 fmol), MR (312.5 
fmol, 625 fmol), Nbs1 (425 fmol, 850 fmol). DNA bands were quantified using ImageQuant TL 
version 2005 software, and the amount of multimeric ligated products was calculated as a 
percentage of the total DNA in the reaction. (B) Linear plasmid DNA (lane 1, 20 fmol) with 
incompatible, nonpalindromic ends (digested by BglI and EcoNI) was incubated with 180 fmol of 
DNA ligase III_/XRCC1 in the presence of no addition (lane 2), 625 fmol of MRN (lane 3), 1.25 
pmol of MRN (lane 4), 625 fmol of MR (lane 6), 1.25 pmol of MR (lane 7), 850 fmol of Nbs1 
(lane 9), 1.7 pmol of Nbs1 (lane 10). Lane 5, 1.25 pmol of MRN; lane 8, 1.25 pmol of MR; and 
lane 11, 1.7 pmol of Nbs1. DNA bands were quantified, and the percentage of ligation product 





incompatible DNA ends. Taken together, these results suggest that the MRN complex 
stimulates ligase III/XRCC1 mediated DNA end ligation through its end-tethering 
activity. The nuclease activity of MRN is essential for enhancing ligation of incompatible 




Figure 4.12 MRN nuclease activity is not required for stimulating compatible DNA end 
ligation but enhances incompatible DNA end ligation. 
(A) Linear plasmid DNA (lane 1, 16 fmol) with compatible ends (PstI) was incubated with 1.4 
fmol of DNA ligase III_/XRCC1 in the presence of no addition (lane 2), 312.5 fmol of wild-type 
MRN(lane 3), 625 fmol of wild-type MRN(lane 4), 312.5 fmol of nuclease-deficient MRN (lane 
6), 625 fmol of nuclease-deficient MRN (lane 7). Lane 5, 625 fmol of wild-type MRN; lane 8, 
625 fmol of nuclease-deficient MRN. DNA bands were quantified using ImageQuant TL version 
2005 software, and the amount of multimeric ligated products was calculated as a percentage of 
the total DNA in the reaction. (B) Linear plasmid DNA (lane 1, 20 fmol) with incompatible, 
nonpalindromic ends (BglI and EcoNI) was incubated with 180 fmol of DNA ligase III/XRCC1 
in the presence of no addition (lane 2), 625 fmol of wild-type MRN (lane 3), 1.25 pmol of wild-
type MRN (lane 4), 625 fmol of nuclease-deficient MRN (lane 6), 1.25 pmol of nuclease-
deficient MRN (lane 7). Lane 5, 1.25 pmol of wild-type MRN; lane 8, 1.25 pmol of nuclease-




DNA-PKcs has been shown to possess dual functions in the regulation of both 
NHEJ and HR (Allen et al, 2003; Convery et al, 2005; Cui et al, 2005; Neal et al, 2011; 
Shibata et al, 2011), but the mechanism by which HR is regulated by DNA-PKcs is not 
well understood. Our previous study using the cellular resection assay clearly showed 
that loss of DNA-PKcs leads to increased DSB resection (Zhou et al, 2014), consistent 
with the observation that complementation of DNA-PKcs in V3 DNA-PKcs null CHO 
cells decreases RAD51 foci formation upon DNA damage (Shibata et al, 2011). I also 
observed increased accumulation of DSBs in DNA-PKcs deficient cells compared to 
wild-type cells (Zhou et al, 2014), likely due to a failure of NHEJ, thus more DSB ends 
are available for resection in the absence of DNA-PKcs. Here I investigated the effects of 
small-molecule inhibition of DNA-PKcs and found that this also simulates resection in 
cells. However, interpretation of these results are complicated by an inhibitor-dependent 
reduction of DNA-PKcs protein by as much as 40% (Figure 4.1D, E), in effect depleting 
DNA-PKcs by another means. In addition, loss of DNA-PKcs also leads to loss of ATM 
(Figure 4.1D)(Peng et al, 2005).  
In contrast, our in vitro reconstituted resection assay clearly shows that a 
catalytically inactive DNA-PK complex generates a strong barrier to resection, such that 
it cannot be relieved by MRN (Figure 4.3C). The end result of blocking DNA-PKcs 
activity is an inability to load Exo1 on DSB ends, consistent with the idea that 
autophosphorylation of DNA-PKcs helps to release it from ends and allow access of 
other repair factors (Dobbs et al, 2010; Uematsu et al, 2007). In cells, the effects of DNA-
PKcs inhibitors on DNA-PKcs protein levels and NHEJ efficiency, as well as the 
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phosphorylation of DNA-PKcs by ATM, likely mask the stimulatory effects of DNA-
PKcs catalytic activity on resection and yield conflicting observations (Allen et al, 2003; 
Davidson et al, 2012; Neal et al, 2011; Shrivastav et al, 2009). Our results in vitro are 
consistent with previous observations that loss of DNA-PKcs catalytic activity (through 
truncation of the catalytic domain, chemical inhibition, or mutation of 
autophosphorylation sites) actually inhibits HR (Allen et al, 2003; Convery et al, 2005). 
Other reports have shown that ATM actively regulates HR (Jazayeri et al, 2006; 
You et al, 2009), and I also observe here that inhibition of ATM leads to lower rate of 
resection (Figure 4.1B). Phosphorylation of resection-related factors likely account for 
this; for instance, ATM-mediated phosphorylation of CtIP is critical for CtIP stimulation 
of resection (Li et al, 2000; Wang et al, 2013). The stabilization of the SOSS1 single-
stranded DNA binding complex by ATM-mediated phosphorylation of hSSB1 (Richard 
et al, 2008) serves as another mechanism by which ATM promotes resection, because 
SOSS1 has been shown to promote resection both in vitro (Yang et al, 2013) and in 
human cells (Zhou et al, 2014). It has also been reported that ATM also phosphorylates 
DNA-PKcs (Chen et al, 2007), which I show here in vitro promotes DSB resection and 
rescues Exo1 resection activity when DNA-PKcs catalytic activity is inhibited. ATM 
phosphorylates the T2609 cluster of DNA-PKcs autophosphorylation sites in cells 
expressing wild-type and kinase-deficient alleles of DNA-PKcs (Chen et al, 2007), 
indicating that these sites are bona fide ATM target sites. Unlike the loss of DNA-PKcs 
protein, blocking DNA-PKcs catalytic activity clearly is inhibitory to DSB resection, but 
this block can be removed by ATM-mediated phosphorylation of DNA-PKcs. Similar 
cross-talk between DNA-PKcs and ATM has been observed in V(D)J recombination. A 
recent study in mouse pre-B cells showed that coding joint formation during V(D)J 
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recombination was blocked by loss of DNA-PKcs protein, while it was not affected by 
inhibition of DNA-PKcs kinase activity when active ATM is present (Lee et al, 2013a). 
I also find that MRN stimulates DNA-PKcs autophosphorylation, possibly 
mediated by the end-tethering activity of MRN (de Jager et al, 2001), which in turn might 
promote DNA-PKcs kinase activity. The DNA ends tethered together by MRN are likely 
to be good substrates for DNA-PKcs autophosphorylation in trans which facilitates end 
processing (Meek et al, 2007).  
I observed in this study that MRN partially alleviates the inhibition of Exo1-
mediated resection, similar to our previous observations with yeast MRX, yeast Ku, and 
yeast Exo1 (Nicolette et al, 2010). With the human proteins in the presence of DNA-
PKcs, I observed an even stronger block to resection imposed by Ku, and a complete 
block in the absence of ATP. The primary effect of MRN on this reaction is to increase 
the number of ends accessed by Exo1, consistent with our hypothesis that the role of 
MRN is to stimulate the initiation of resection by Exo1. However, Ku also appears to 
reduce the extent of Exo1 resection, which is partially suppressed by MRN. It is possible 
that Ku accumulates internally on the DNA and in this way restrains the progression of 
Exo1, but further experiments are required to test this idea.  
My experiments measuring ligation and resection in the same reaction showed 
that MRN blocks end joining mediated by DNA Ligase IV/XRCC4. This result is 
unexpected because MRX promotes Ku-mediated end joining in budding yeast (Boulton 
& Jackson, 1998; Moore & Haber, 1996) and MRN strongly stimulates DNA ligation by 
DNA Ligase III/XRCC1 by mediating DNA end tethering in vitro (Figure 4.11-
12)(Della-Maria et al, 2011). It is possible that human MRN-mediated end synapsis 
promotes the activity of Ligase III/XRCC1, but does not provide a configuration of ends 
that is favorable for the Ligase IV/XRCC4 complex. In addition, this synapsis might also 
 98 
promote the in trans autophosphorylation of DNA-PKcs, which may lead to premature 
dissociation of DNA-PKcs and inhibit end rejoining. Moreover, MRN may interfere with 
the formation of DNA-PKcs-mediated intermolecular DNA end synapsis which 
contributes to DNA ligation (Weterings et al, 2003). 
In summary, using both in vivo resection assays and in vitro reconstituted 
reactions, I have demonstrated that the NHEJ factor DNA-PKcs has the ability to actively 
regulate HR via at least two mechanisms: 1) DNA-PKcs indirectly affects DSB resection 
by promoting NHEJ repair, which decreases the amount of DSBs available for resection; 
2) DNA-PKcs directly inhibits DSB resection by actively blocking DSB ends. Both 
autophosphorylation and ATM-mediated phosphorylation of DNA-PKcs can overcome 
DNA-PKcs inhibition of resection by enhancing DNA-PKcs dissociation and Exo1 
recruitment. The MRN complex promotes resection in the presence of Ku/DNA-PKcs by 
recruiting Exo1 and enhancing DNA-PKcs autophosphorylation, but inhibits end 
rejoining which is stimulated by Ku and DNA-PKcs. It is important to note that the in 
vitro reactions shown here are a reconstitution of the enzymatic reactions that are thought 
to occur in vivo; the magnitude of the DNA-PK-mediated inhibition of Exo1 and other 
enzymes as well as the efficiency of MRN/ATM mediated suppression will vary 
depending on the concentration of these factors in cells. Nevertheless, the suppression of 
DNA-PKcs inhibition of resection by ATM shown here, and the opposing effects of 
DNA-PKcs and MRN in DNA end resection and ligation, suggest that DNA-PKcs, ATM 











DNA double-strand breaks (DSBs) can be induced by multiple external and 
internal factors, including ionizing radiation, radiomimetic chemicals, reactive oxygen 
species and replication errors, and are the most deleterious genetic lesions in cells as 
failure of DSBs repair may lead to cell death, genomic instability and tumorigenesis. 
Mammalian cells utilize two major pathways, non-homologous end joining (NHEJ) and 
homologous recombination (HR), to repair DSBs, which involves the activation of a 
complex signaling network called the DNA damage response (DDR). Proper activation of 
the DDR coordinates cell cycle checkpoint activation, choice of DNA repair pathways, 
damage repair and subsequent resumption of normal cell cycle progression. In contrast, 
impeding appropriate DDR will lead to chromosomal deletion and translocation that can 
contribute to malignant transformation (Bensimon et al, 2011). DDR is a highly 
organized signal transduction system in which the DNA damage signal is sensed by 
sensor proteins, transferred to transducers, and finally conveyed to downstream effectors 
which are directly involved in checkpoint activation and DNA damage repair (Shiloh & 
Ziv, 2013). Sensor proteins, such as Ku70/80 heterodimer and Mre11/Rad50/Nbs1 
(MRN) complex, are recruited to damage sites promptly and further promote recruitment 
and activation of transducers, including Ataxia-Telangiectasia mutated (ATM), ATM 
Rad3-related protein (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-
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PKcs). Transducer proteins in turn activate downstream effector proteins, such as KAP1, 
p53, Chk2 and CtIP, via post translational modifications. 
ATM is a serine/threonine protein kinase belonging to the phosphoinositide 3-
kinase like kinase (PIKK) family. Another member of the PIKK family, the DNA-
dependent protein kinase catalytic subunit (DNA-PKcs), associates with the Ku70/80 
heterodimer (Ku) to form the holoenzyme DNA-PK. DNA-PKcs and ATM are both 
actively involved in DSB repair: DNA-PKcs plays a key role in NHEJ, the prominent 
pathway for repair of DSBs in human cells, while ATM protein kinase is a master 
regulator of checkpoint activation and HR pathway. It is well recognized that the MRN 
complex acts as a DSB sensor and is essential for ATM recruitment to broken DNA ends 
and ATM activation. Similarly, DNA-PKcs is recruited to DSBs and activated by Ku. 
However, it is not clear how cells make choice between ATM/MRN-dependent HR 
pathway and DNA-PKcs/Ku-dependent NHEJ pathway.  
Recent evidence shows that cross-talk occurs between DNA-PKcs and ATM and 
that these two kinases may cooperatively initiate DSB repair signaling and regulate DSB 
repair pathway choice. On the one hand, DNA-PKcs is phosphorylated by ATM at 
residues T2609 and T2647 in the ABCDE cluster in response to DNA damage. This 
phosphorylation event is essential for the repair of DSBs by NHEJ (Chen et al, 2007). In 
addition, ATM-mediated phosphorylation of DNA-PKcs overcomes Ku/DNA-PKcs 
inhibition of resection in vitro (Zhou & Paull, 2013). On the other hand, the expression of 
ATM is DNA-PKcs-dependent. ATM protein level is decreased in DNA-PKcs-deficient 
cells or cells expressing siRNA directed against DNA-PKcs (Peng et al, 2005).  
The precise mechanism for ATM activation upon DNA damage and ATM 
inactivation after DNA repair has remained elusive. Phosphorylation of ATM has been 
suggested to play critical roles in this process. Autophosphorylation of ATM at four sites 
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(S1981, S367, S1893, and S2996) has been shown to be essential for ATM activation and 
function in response to DNA damage in human cells (Bakkenist & Kastan, 2003; Kozlov 
et al, 2011; Kozlov et al, 2006). However, phospho-blocking mutations at these four sites 
do not affect ATM kinase activity in vitro or in mouse models (Daniel et al, 2008; Guo et 
al, 2010b; Lee & Paull, 2005; Pellegrini et al, 2006), suggesting that there are other 
mechanisms for regulation of ATM activity. Previous studies show that CDK5-mediated 
phosphorylation of ATM at Ser794 and EGFR-mediated phosphorylation of ATM at 
Tyr370 both positively regulate ATM activation upon DNA damage (Lee et al, 2015; 
Tian et al, 2009), whereas Aurora B stimulates ATM activation in a DNA damage-
independent manner during mitosis by phosphorylating ATM at Ser1403 (Yang et al, 
2011).  
In this study, I propose that DNA-PKcs negatively regulates ATM activity 
through phosphorylation of ATM at multiple sites. ATM is hyperactive in human cells 
when DNA-PKcs activity is blocked by DNA-PK specific inhibitor treatment or when the 
DNA-PKcs gene is deleted. Pre-incubation of ATM protein with DNA-PKcs significantly 
inhibits ATM kinase activity in vitro. Using mass spectrometry analysis and site-directed 
mutagenesis, I characterized three clusters of sites: S85/T86, T372/T373 and 
T1985/S1987/S1988. The phospho-mimetic mutations at these residues repress ATM 
activation both in vitro and in cells with induction of DNA damage. Overexpression of 
phospho-mimetic ATM mutants in ATM-deficient cells fails to restore cell survival, DSB 
end resection and G2/M checkpoint activation in response to DNA damage. In addition, I 
have observed that the phospho-blocking ATM mutants, T1985A/S1987A/S1988A and 
T86A/T373A, are resistant to DNA-PKcs pre-incubation in vitro and that overexpression 
of ATM T1985A/S1987A/S1988A mutant fails to respond to DNA-PKcs inhibition as 
wild-type ATM does in cells. Taken together, my data suggests that the NHEJ factor 
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DNA-PKcs suppresses the catalytic activity of ATM through phosphorylation and that 
the phosphorylation of a group of Ser/Thr residues on ATM negatively regulates ATM 
signaling pathway upon DNA damage. Since ATM is known to promote the HR 
pathway, this may provide a novel mechanism for DNA repair pathway choice upon 





ATM is more active when DNA-PKcs kinase activity is blocked by DNA-PK 
inhibitor or when the DNA-PKcs gene is deleted in human cells 
I previously examined the effect of DNA-PKcs catalytic activity on DSB end 
resection using the ER-AsiSI system in U2OS cells in which DSBs can be induced by 
hydroxytamoxifen (4-OHT) treatment (Zhou & Paull, 2013). I found that chemical 
inhibition of DNA-PKcs kinase activity stimulates ATM activation, as shown by the 
increased ATM S1981 foci and γH2AX foci formation after inducing DNA damage 
(Figure 5.1A), which is confirmed by examining the phosphorylation levels of ATM at 
Ser1981 using Western blotting and ChIP analysis (data not shown). A similar effect is 
observed when the NHEJ factors DNA Ligase IV and XRCC4 are depleted (Figure 5.1A, 
B), suggesting the increased ATM activation is not simply due to chemical inhibition of 
the NHEJ DNA repair pathway which may provide more DSB ends for ATM binding and 
activation. In agreement with these findings, more ATM S1981 foci and γH2AX foci are 
observed after DNA damage in human HCT116 cells where DNA-PKcs gene is depleted 
(Figure 5.1C). The phosphorylation levels of two ATM targets, KAP1 and Chk2, are also 
increased in the absence of DNA-PKcs when the cells are treated with H2O2 or ionizing 
radiation (Figure 5.1D). The inhibition of phosphorylation signal by ATM inhibitor 
(ATMi) confirms that the phosphorylation levels of KAP1 and Chk2 serve as good 
markers for ATM activation. Taken together, these results suggest that DNA-PKcs 





Figure 5.1. ATM is more active when DNA-PKcs kinase activity is blocked by DNA-PK 
inhibitor or when the DNA-PKcs gene is deleted in human cells.  
(A) ER-AsiSI U2OS cells were transfected with control siRNA (siCtrl), siRNA against the NHEJ 
factors DNA Ligase IV (siLigIV), siRNA against the NHEJ factors XRCC4 (siXRCC4), or 
siRNAs against both Ligase IV and XRCC4 (siLigIV/siXRCC4). In the presence or absence of 
DNA-PK inhibitor NU7441, DSBs were introduced by treating cells with 4-OHT, which induces 
nuclear translocation of the restriction enzyme AsiSI and subsequent cleavage of chromosome 
DNA at specific locations (Iacovoni et al, 2010). Cells were fixed and stained with phospho-ATM 
S1981 antibody and γH2AX antibody. The number of phospho-ATM S1981 foci (upper panel) 
and γH2AX foci (bottom panel) per cell was quantitated. Error bars represent standard deviation 
of three independent experiments. (B) Cells from (A) were lysed and subjected to western 
blotting analysis for DNA Ligase IV and XRCC4. PARP1 was used as a loading control. (C) WT 
and DNA-PKcs-/- ER-AsiSI HCT116 cells were treated with various concentrations of 4-OHT. 
Cells were fixed and stained with phospho-ATM S1981 antibody and γH2AX antibody. The 
number of phospho-ATM S1981 foci (upper panel) and γH2AX foci (bottom panel) per cell was 
quantitated. Error bars represent standard deviation of three independent experiments. (D) WT 
and DNA-PKcs-/- HCT116 cells were treated with 250 μM H2O2 or 5 Gy ionizing radiation (IR) 
in the presence or absence of ATM inhibitor (10 μM), followed by western blotting analysis for 
the phosphorylation status of two ATM targets (KAP1 and Chk2). 
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DNA-PKcs phosphorylates ATM in vitro      
Since DNA-PKcs is a protein kinase, it is reasonable to hypothesize that DNA-PK 
may regulate ATM kinase activity through phosphorylation of ATM. To test this 
hypothesis, I performed an in vitro kinase assay with [γ-
32
P]-ATP. As shown in Figure 
5.2A, ATM is autophosphorylated in the presence of MRN, and the phosphorylation level 
of ATM is increased by the addition of Ku/DNA-PKcs. Addition of ATM inhibitor to the 
reaction completely blocks ATM autophosphorylation, but DNA-PKcs can mediate 
phosphorylation of ATM even in the absence of ATM kinase activity. However, ATM is 
barely phosphorylated by DNA-PKcs in the absence of MRN, likely due to the low 
DNA-binding affinity of ATM by itself (Lee & Paull, 2005). In addition, the MRN 
complex is also strongly phosphorylated by both ATM and DNA-PK in vitro. These 
results suggest that ATM is phosphorylated by DNA-PKcs in vitro and that MRN 
promotes this phosphorylation event, presumably by recruiting ATM to DNA ends where 
DNA-PKcs is located. 
 
DNA-PKcs-mediated phosphorylation of ATM inhibits ATM kinase activity in vitro 
Next, I asked whether DNA-PKcs mediated phosphorylation of ATM and MRN 
has any effect on ATM kinase activity. To answer this question, I performed in vitro 
reconstituted kinase assays using GST-p53 as a substrate as previously described (Lee & 
Paull, 2005). Because p53 can be phosphorylated by both ATM and DNA-PKcs in vitro, 
I designed a two-step experiment in which the phosphorylation of ATM and MRN by 
DNA-PKcs and the phosphorylation of p53 substrate by ATM were separated. During the 
first incubation, ATM was incubated with DNA-PK, MRN and DNA in the presence or 
absence of DNA-PK inhibitor (DNA-PKi). In reactions where DNA-PKi was added, 
DNA-PK-mediated phosphorylation of ATM and MRN was blocked. During the second 
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incubation, p53 substrate was added to all reactions and DNA-PKi was added to those 
reactions where it was not added during the first incubation, ensuring that p53 substrate 
could not be phosphorylated by DNA-PKcs in any of the reactions. As shown in Figure 
5.2B, DNA-PKcs kinase activity is completely blocked by DNA-PKi, whenever the 
inhibitor is added to the reaction. Notably, pre-incubation of ATM with active DNA-PK 
complex in the first step dramatically decreases ATM kinase activity, as shown by the 
decreased phosphorylation level of p53 substrate compared with the reaction in which 
DNA-PKcs kinase activity is blocked by DNA-PKi during the first incubation (lane 3). 
This effect is most likely to be mediated by active DNA-PK complex, as pre-incubation 
of ATM with DNA-PKi itself or Ku alone doesn’t affect ATM activity (Figure 5.2C). 
I further examined if this effect is caused by DNA-PK mediated phosphorylation 
events. As phosphorylation requires ATP, the two-step kinase assay was performed with 
ATP being added to the first incubation or to the second incubation. The result clearly 
shows that elimination of ATP during the first incubation overcomes the inhibitory effect 
of DNA-PK on ATM activity (Figure 5.2D), suggesting that this effect is indeed related 
to DNA-PK mediated phosphorylation events occurring in the first incubation. Since both 
MRN and ATM can be phosphorylated by DNA-PK (Figure 5.2A), I asked which 
phosphorylation event actually leads to the DNA-PK inhibition of ATM activity. In order 
to address this question, DNA-PK, MRN or ATM was eliminated from the first 
incubation. As expected, DNA-PK doesn’t show any effect on ATM activity when it is 
only added to the second incubation (Figure 5.2E, lane 12). No decrease of ATM 
activation is observed when ATM protein is not present in the first incubation (Figure 
5.2E, lane 9), suggesting that the effect is not caused by DNA-PK-mediated 
phosphorylation of MRN. Interestingly, inhibition of ATM activity is also not observed 
when MRN is absent in the first incubation (Figure 5.2E, lane 6), likely due to the fact 
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that ATM is barely phosphorylated by DNA-PKcs in the absence of MRN (Figure 5.2A, 
lane 7).  
To determine conclusively whether the presence of MRN is essential for the 
inhibitory effects of DNA-PK, we made use of the fact that high levels of ATM kinase by 
itself yield some basal activity in vitro when the substrate concentration is also very high 
(data not shown). Based on this observation, a kinase assay was performed with high 
concentrations of both ATM and GST-p53 substrate in the absence of MRN. The result 
clearly shows that DNA-PK is still able to inhibit ATM activity without addition of MRN 
(Figure 5.2F), suggesting that inhibition of ATM kinase activity by DNA-PK is caused 
by DNA-PK-mediated phosphorylation of ATM, although MRN strongly promotes this 
effect in a dose-dependent manner (presumably by enhancing ATM phosphorylation by 
DNA-PK) (Figure 5.3A). The nuclease activity of MRN is not required for DNA-PK 
inhibition of ATM, because a nuclease-deficient mutant M(H129N)RN shows similar 
effect as wild-type MRN (Figure 5.3B). I also performed a DNA titration experiment and 
found that the decrease of ATM activity is less obvious with increased amounts of 
linearized DNA in the reaction (Figure 5.4A), which is presumably due to the fact that 
DNA-PK-mediated phosphorylation of ATM is not higher with more DNA (Figure 
5.4B), because ATM and DNA-PK are binding to different DNA molecules and are less 
likely to contact each other in the presence of more DNA ends.  
The role of ATM autophosphorylation in ATM function has remained 
controversial (Paull, 2015). I hypothesized that autophosphorylation of ATM might 
repress DNA-PK-mediated phosphorylation and hence overcome DNA-PK inhibition of 
ATM activity, as it is not a rare case that one phosphorylation event inhibits further 
phosphorylation of the same protein in cellular signaling network. An 
autophosphorylation-mimic ATM mutant (S367D/S1893D/S1981D/S2996D) was 
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purified and tested in the kinase assay in comparison with wild-type ATM protein. The 
results clearly show that DNA-PK can still phosphorylate this ATM mutant and inhibit its 
kinase activity (Figure 5.5), suggesting that ATM autophosphorylation at the four 
identified sites (S367/S1893/S1981/S2996) does not affect DNA-PK phosphorylation of 
ATM or inhibition of ATM activity. Notably, the ATM (S367D/S1893D/S1981D/ 
S2996D) can still undergo autophosphorylation to a similar level as wild-type ATM, 
demonstrating the existence of other uncharacterized autophosphorylation sites in ATM. 
 
Figure 5.2. DNA-PK-mediated phosphorylation of ATM inhibits ATM kinase activity in 
vitro. 
(A) Purified recombinant ATM protein was incubated with DNA-PK, MRN, linearized DNA, [γ-
32
P]-ATP in the presence or absence of ATM inhibitor (ATMi). The protein products were 
separated on SDS-PAGE and visualized by phosphorimaging. (B) Two-step in vitro ATM kinase 
assay in which DNA-PK-mediated phosphorylation events (Incubation 1,) and the 
phosphorylation of p53 substrate by ATM (Incubation 2) were separated. Inc., Incubation. (C) 
Similar experiment was performed as in (B), with various components being added at different 
steps of reaction. (D) Similar experiment was performed as in (B), with ATP being added before 
1st (reactions 1, 2 and 3) or 2nd incubation (reaction 4). (E) Similar experiment was performed as 
in (B), with various components being added at different steps of reaction. (F) Basal activity of 
ATM was examined with high concentration of ATM protein and GST-p53 substrate in the 
absence of MRN. 
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Figure 5.3. Inhibition of ATM kinase activity by DNA-PK is promoted by MRN protein 
but not affected by MRN nuclease activity. 
(A) Two-step in vitro ATM kinase assay as in Figure 5.2B, with a titration of purified 
recombinant MRN in the assay.(B) Two-step in vitro ATM kinase assay as in Figure 5.2B, using 
purified recombinant wild-type MRN complex (WT) or nuclease-deficient MRN mutant (H129N) 
in the assay.  
 
Figure 5.4. The inhibitory effect of DNA-PK on ATM kinase activity is stronger with 
limited amount of DNA ends. 
(A) Two-step in vitro ATM kinase assay as in Figure 5.2B, with a titration of linearized DNA in 
the experiment. (B) Purified recombinant ATM protein was incubation with DNA-PK, MRN, 
linearized DNA, [γ-
32
P]-ATP in the presence or absence of ATM inhibitor (ATMi). The protein 
products were separated on SDS-PAGE and visualized by phosphorimaging. 
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Figure 5.5. ATM autophosphorylation at S367/S1893/S1981/S2996 cannot overcome 
DNA-PK inhibition of ATM activity. 
(A) Two-step in vitro ATM kinase assay as in Figure 5.2B, using purified recombinant wild-type 
ATM (WT) or autophospho-mimetic ATM mutant S367D/S1893D/S1981D/S2996D. (B) Purified 
recombinant wild-type ATM (WT) or autophospho-mimetic ATM mutant 
S367D/S1893D/S1981D/S2996D was incubation with DNA-PK, MRN, linearized DNA, [γ-
32
P]-ATP in the presence or absence of 20 μM ATM inhibitor (ATMi). The protein products were 
separated on SDS-PAGE and visualized by phosphorimaging.  
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The inhibitory effect of DNA-PK on ATM activity was further confirmed by 
using an ATP analog-sensitive ATM mutant Y2755A, which has a cavity within the 
ATP-binding pocket and can utilize bulky ATP analog N6-(furfuryl)-ATP for 
phosphorylation of p53 substrate (Figure 5.6A) (Lee et al, 2013b). Since the ATP analog 
is labeled with 
32
P, ATM-mediated phosphorylation of p53 can be observed directly by 
phosphorimaging while p53 phosphorylation by DNA-PK will not be 
32
P-labeled. As 
shown in Figure 5.5B, ATM(Y2755A) strongly phosphorylates p53 using the radioactive 
bulky ATP analog as a phosphate donor, while DNA-PK can barely use this analog for 
p53 phosphorylation. Consistent with results obtained from two-step kinase assays 
(Figure 5.2B-E), incubation of ATM(Y2755A) with active DNA-PK complex 
dramatically reduces ATM(Y2755A)-mediated phosphorylation of p53 substrate (Figure 
5.6B). Taken together, these results demonstrate that DNA-PK negatively regulates ATM 
kinase activity by phosphorylating ATM protein in vitro.   
 
Figure 5.6. DNA-PK inhibits ATM kinase activity in vitro. 
(A) Schematic diagram of ATM Y2755A mutation generating analog-sensitive ATM mutant. (B) 
In vitro kinase assay with analog-sensitive ATM mutant (Y2755A) in the presence of [γ-
32
P]-
labeled bulky ATP analog γ-N6-Fu-ATP. The protein products were separated on SDS-PAGE 
and visualized by phosphorimaging. 
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Identification of target site(s) responsible for the inhibitory effect of DNA-PK on 
ATM kinase activity      
To identify target ATM site(s) responsible for DNA-PK inhibition of ATM 
activity, purified recombinant ATM protein was incubated with MRN and DNA in the 
presence or absence of DNA-PK protein and subjected to mass spectrometry (MS) 
analysis. Based on the MS results (Table 5.1, Table 5.2), as well as the preference of 
DNA-PKcs for phosphorylation of S/TQ sites, I made a series of phospho-blocking (S/T
→A) and phospho-mimetic (S→D, T→E) ATM mutants and tested their kinase activities 
in vitro (Table 5.3).   
The screening led to the identification of three clusters of sites with potential 
interest: S85/T86, T372/T373 and S1985/T1987/T1988, all of which are conserved in 
mammalian species (Figure 5.7A). Phospho-mimetic mutations at these sites (S85D, 
T86E, T372E, T373E, S1985D, T1987E, T1988E) all result in decreased ATM kinase 
activity in the presence of MRN/DNA, while phospho-blocking mutations (alanine 
substitutions) at the same sites barely affect ATM activation (Table 5.3). Combinations of 
adjacent phospho-mimetic mutations render ATM more deficient in MRN/DNA-
dependent activation (Table 5.3, Figure 5.7B-E). Both the S85D/T86E mutant and the 
S1985D/T1987E/T1988E mutant show dramatically decreased activity compared with 
wild-type ATM or corresponding phospho-blocking mutants (S85A/T86A and 
S1985A/T1987A/T1988A, respectively) (Figure 5.7B, E). In contrast, the activation of 
T372E/T373E mutant is less severely impaired (Figure 5.7C). Considering the similar 
amino acid sequence pattern of S85/T86 cluster and T372/T373 cluster (ST/Q and TT/Q, 
respectively), I also introduced S85/T372 and T86/T373 combination mutations into 
ATM. As expected, the MRN/DNA-dependent activity of both S85D/T372E and 
T86E/T373E mutants are much lower than wild-type ATM or corresponding phospho-
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blocking mutants (S85A/T372A and T86A/T373A, respectively) (Table 5.3 and Figure 
5.7D).  
Table 5.1. Mass spectrometry analysis of recombinant ATM protein (purified from 
HEK293 cells) treated or mock-treated with DNA-PK. 
 
Table 5.2. Mass spectrometry analysis of recombinant ATM protein (purified from 
HEK293-6E cells) treated or mock-treated with DNA-PK. 
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Table 5.3. Summary of all ATM mutants made in this study regarding kinase activity and 
resistance to DNA-PKcs. 
 
* The kinase activity of each ATM mutants in the presence of MRN/DNA is tested in comparison to 
activity of wild-type (WT) ATM as in Figure 5.7. “=”, activity similar to WT; “↓”, decreased activity 
compared with WT. 
#
 The effect of DNA-PKcs on the kinase activity of some ATM mutants is examined by kinase assay as in 
Figure 5.10. The S/TQ residues are highlighted in red. 
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Figure 5.7. Screening for phospho-mimetic ATM mutants possessing decreased kinase 
activity. 
(A) Alignment of ATM partial sequences from mammalian species. The highlighted residues 
which are mutated in this study are conserved. (B) In vitro kinase assay was performed with 
purified recombinant wild-type ATM (WT), phospho-mimetic ATM mutant S85D/T86E, or 
phospho-blocking ATM mutant S85A/T86A, in the presence of (MRN + linearized DNA) or 
H2O2. (C) In vitro kinase assay was performed with purified recombinant wild-type ATM (WT), 
phospho-mimetic ATM mutant T372E/T373E, or phospho-blocking ATM mutant T372A/T373A, 
in the presence of (MRN + linearized DNA) or H2O2. (D) In vitro kinase assay was performed 
with purified recombinant wild-type ATM (WT), phospho-mimetic ATM mutant T86E/T373E, or 
phospho-blocking ATM mutant T86A/T373A, in the presence of (MRN + linearized DNA) or 
H2O2. (E) In vitro kinase assay was performed with purified recombinant wild-type ATM (WT), 
phospho-mimetic ATM mutant T1985E/S1987D/S1988D, or phospho-blocking ATM mutant 
T1985A/S1987A/S1988A, in the presence of (MRN + linearized DNA) or H2O2.  
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Another important pathway of ATM activation is dependent on oxidative stress 
(Guo et al, 2010b). I also examined H2O2-induced ATM activation for the mutants 
mentioned above. Interestingly, S85D/T86E, T372E/T373E and T86E/373E are all 
activated normally by H2O2, whereas T1985E/S1987D/S1988D is also deficient in the 
presence of H2O2 (Figure 5.7C-E).  
The regulation of ATM activation by phosphorylation at the identified sites (S85, 
T86, T372, T373, T1985, S1987, S1988) was furthered examined in 293T cells in which 
the endogenous ATM was partially depleted by shRNA while shRNA-resistant wild-type 
ATM or phospho-blocking/mimetic ATM mutants were transiently over-expressed. The 
cells were treated with bleomycin to induce DSBs or H2O2 to induce oxidative stress, 
followed by detection of the phosphorylation levels of ATM targets, including KAP1, 
Chk2 and p53, by western blotting. Consistent with the in vitro data, cells expressing the 
S85D/T86E, T86E/T373E or T1985E/S1987D/S1988D mutants clearly show decreased 
phosphorylation levels of ATM substrates as well as ATM autophosphorylation at S1981 
upon bleomycin treatment, while the activity of T372E/T373E is only slightly decreased 
in cells (Figure 5.8). These data confirms that ATM activation is impaired by 
phosphorylation of the identified sites upon DNA damage. With H2O2 treatment, 
S85D/T86E, T372E/T373E and T86E/T373E are all similar to wild-type ATM and the 
corresponding phospho-blocking mutants (Figure 5.9). The T1985E/S1987D/S1988D 
ATM mutant could also be normally activated by H2O2 in cells (Figure 5.9B), which is 
inconsistent with the in vitro data, possibly due to the action of other ATM stimulators 
such as AIMIN and NKX3.1 in cells (Bowen et al, 2013; Kanu & Behrens, 2007). 
The potential sites that are responsible for the inhibitory effect of DNA-PKcs on 
ATM kinase activity should meet two criteria: 1) the phospho-mimetic mutant should 
have decreased kinase activity, and 2) the corresponding phospho-blocking mutant 
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should be resistant to DNA-PKcs pre-incubation in vitro. Therefore, I further tested the 
phospho-blocking ATM mutants in the two-step experiment with DNA-PKcs pre-
incubation. Neither the S85A/T86A mutant nor the T372A/T373A mutant shows 
resistance to DNA-PKcs in this assay (Figure 5.10A, B). Interestingly, however, the 
combined mutant T86A/T373A is clearly resistant to DNA-PKcs pre-incubation, while 
S85A/T372A is not (Figure 5.10C, Table 5.3). In addition, the triple ATM mutant 
T1985A/S1987A/S1988A is completely resistant to DNA-PKcs as well (Figure 5.10D).  
 
 
Figure 5.8. Examination of ATM activation in the presence of bleomycin-induced DSBs 
in 293T cells. 
(A) Wild-type ATM (WT), phospho-mimetic ATM mutant S85D/T86E, and phospho-blocking 
ATM mutant S85A/T86A are transiently overexpressed in 293T cells with endogenous ATM 
being depleted by shRNA. Cells were treated with bleomycin to induce DNA damage, followed 
by western blotting analysis for the phosphorylation status of three ATM targets (KAP1, p53 and 
Chk2). shCtrl, control shRNA; shATM, ATM shRNA. (B) Similar experiment was performed as 
in (A) for wild-type ATM (WT), phospho-mimetic ATM mutant T373E/T373E, and phospho-
blocking ATM mutant T372A/T373A. (C) Similar experiment was performed as in (A) for Wild-
type ATM (WT), phospho-mimetic ATM mutant T86E/T373E, and phospho-blocking ATM 
mutant T86A/T373A. (D) Similar experiment was performed as in (A) for wild-type ATM (WT), 





Figure 5.9. Examination of ATM activation in the presence of H2O2-induced oxidative 
stress in 293T cells. 
(A) Wild-type ATM (WT), phospho-mimetic ATM mutant S85D/T86E, and phospho-blocking 
ATM mutant S85A/T86A are transiently overexpressed in 293T cells with endogenous ATM 
being depleted by shRNA. Cells were treated with H2O2 to induce oxidative stress, followed by 
western blotting analysis for the phosphorylation status of three ATM targets (KAP1, p53 and 
Chk2). shCtrl, control shRNA; shATM, ATM shRNA. (B) Similar experiment was performed as 
in (A) for Wild-type ATM (WT), phospho-mimetic ATM mutant T373E/T373E, phospho-
blocking ATM mutant T372A/T373A, phospho-mimetic ATM mutant T1985E/S1987D/S1988D, 
and phospho-blocking ATM mutant T1985A/S1987A/S1988A. (C) Similar experiment was 
performed as in (A) for Wild-type ATM (WT), phospho-mimetic ATM mutant T86E/T373E, and 




Figure 5.10. Identification of sites responsible for the inhibitory effect of DNA-PK on 
ATM kinase activity. 
(A) Two-step in vitro ATM kinase assay as in Figure 5.2B, using purified recombinant wild-type 
ATM (WT) or phospho-blocking ATM mutant S85A/T86A. (B) Two-step in vitro ATM kinase 
assay as in Figure 5.2B, using purified recombinant wild-type ATM (WT) or phospho-blocking 
ATM mutant T372A/T373A. (C) Two-step in vitro ATM kinase assay as in Figure 5.2B, using 
purified recombinant wild-type ATM (WT) or phospho-blocking ATM mutant T86A/T373A. (D) 
Two-step in vitro ATM kinase assay as in Figure 5.2B, using purified recombinant wild-type 
ATM (WT) or phospho-blocking ATM mutant T1985A/S1987A/S1988A. 
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Phosphorylation of ATM at S85/T86, T86/T373, T1985/S1987/S1988 impairs the 
interaction between ATM and MR      
The binding of ATM to the MRN complex is essential for ATM activation (Lee & 
Paull, 2004). Since ATM S85D/T86E mutant cannot be activated by MRN/DNA, I 
speculated that the ATM-MRN interaction might be impaired by the phospho-mimetic 
mutations. To test this idea, I performed a pull-down assay using purified recombinant 
MRN complex with biotin tag. Surprisingly, ATM S85D/T86E mutant can interact 
normally with the MRN complex, as compared with wild-type ATM and ATM 
S85A/T86A mutant (Figure 5.11A). A similar result is observed in 293T cells (Figure 
5.11B). It is well recognized that the interaction between ATM and Nbs1 in the MRN 
complex is essential for ATM activation (Lee & Paull, 2007). But ATM was also shown 
to interact with MR through an interface in Rad50 in vitro (Lee & Paull, 2004). 
Therefore, I performed pull down assays with either GST-Nbs1 or Biotinylated MR 
complex and found that S85D/T86E mutant interacts with Nbs1 normally (Figure 5.11C), 
but its interaction with MR is significantly impaired compared with wild-type ATM and 
S85A/T86A mutant (Figure 5.11D). These results suggest that S85 and T86 
phosphorylation of ATM impairs ATM-MR interaction but not ATM-Nbs1 interaction. 
Considering the greatly decreased activity of the phospho-mimetic ATM mutant 
S85D/T86E, I can conclude that ATM-MR interaction and ATM-Nbs1 interaction are 
both essential for ATM full activation. Furthermore, I examined the interaction between 
biotin-MR and other ATM mutants, including T86A/T373A, T86E/T373E, 
T1985A/S1987A/S1988A, and T1985E/S1987D/S1988D. As expected, the kinase-
deficient phospho-mimetic ATM mutants (T86E/T373E and T1985E/S1987D/S1988D) 
both show decreased binding to MR (Figure 5.11E), suggesting that phosphorylation of 
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ATM at these sites may cause a conformational change of the protein and hence lead to 
decreased affinity to MR in the MRN complex. 
 
 
Figure 5.11. Phospho-mimic mutations of ATM at S85/T86, T86/T373, T1985/S1987/ 
S1988 impair the interaction between ATM and MR. 
(A) In vitro immunoprecipitation (IP) experiment with Bio-MRN, wild-type ATM (WT), 
S85AT86A and S85DT86E. Magnetic streptavidin beads were used to pull down Bio-MRN and 
associated ATM protein. (B) Flag-tagged wild-type ATM (WT), or ATM mutants S85AT86A 
and S85DT86E, was over-expressed in 293T cells with endogenous ATM being depleted by 
shRNA. Flag IP was performed and the IP products were analyzed by western blotting using 
antibodies against ATM, Mre11, Rad50 and Nbs1. (C) Similar experiment was performed as in 
(A), using Bio-MR instead of Bio-MRN. (D) Similar experiment was performed as in (C), using 
GST-Nbs1 instead of Bio-MR. (E) Similar experiment was performed as in (A) for other ATM 
mutants: T86A/T373A, T86E/T373E, T1985A/S1987A/S1988A and T1985E/S1987D/S1988D.  
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Phospho-mimic ATM mutants at DNA-PKcs sites are deficient in activation of the 
DNA damage response in human cells      
I further examined the function of the ATM mutants in U2OS Flp-In cells in 
which endogenous ATM is depleted by shRNA and wild-type ATM or ATM phospho-
blocking/mimetic mutants can be induced to express from a single genomic locus upon 
doxycycline treatment (O'Gorman et al, 1991)(Figure 5.12A). In agreement with previous 
data obtained in vitro and in 293T cells (Figure 5.7 and Figure 5.8), the activation of 
ATM S85D/T86E and T1985E/S1987D/S1988D by camptothecin (CPT)-induced DSBs 
is deficient in comparison to wild-type ATM, as shown by the reduced phosphorylation 
of ATM targets as well as ATM S1981 autophosphorylation (Figure 5.12A). Next I 
performed cell survival assays (clonogenic assays) using this system. Consistent with the 
critical regulatory roles of ATM in DNA damage repair and oxidative stress response, 
depletion of ATM dramatically decreases cell survival when the cells are treated with 
CPT, ionizing radiation (IR) or H2O2 (Figure 5.12B-D). With CPT or IR treatment, the 
phospho-mimetic ATM mutants S85D/T86E and T1985E/S1987D/S1988D both fail to 
restore cell survival as wild-type ATM while the corresponding phospho-blocking ATM 
mutants (S85A/T86A, T1985A/S1987A/S1988A) restore ATM function (Figure 5.12B, 
C). In contrast, both S85D/T86E and T1985E/S1987D/S1988D successfully recover cell 
survival upon H2O2 treatment (Figure 5.12D), suggesting that ATM phosphorylation at 
these sites does not affect ATM function in oxidative stress regulation. Similar effects on 
cell survival are also observed for the combination mutants T86A/T373A and 
T86E/T373E (data not shown). 
The effects of phospho-blocking and phospho-mimic mutations of ATM on DSB 
end resection was examined using the method described in Chapter 3. Consistent with 
inhibition of ATM activity, depletion of ATM leads to decreased resection, which can be  
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Figure 5.12. Kinase-deficient phospho-mimetic ATM mutants are deficient in DNA 
damage response in human cells. 
(A) Expression of WT ATM and ATM mutants as indicated were induced by doxycycline in Flp-
In T-Rex U2OS cells in which endogenous ATM was depleted by shRNA. Cells were treated 
with camptothecin (CPT) and the phosphorylation status of two ATM targets (KAP1 and Chk2) 
was examined by western blotting. AA, S85A/T86A; DE, S85D/T86E; AAA, T1985A/S1987A/ 
S1988A; EDD, T1985E/S1987D/S1988D. (B) Cells as grown in (A) were subjected to survival 
analysis (clonogenic assay) after 1 h treatment with various concentration of camptothecin (CPT). 
(C) Cells as grown in (A) were subjected to survival analysis (clonogenic assay) after various 
doses of ionizing radiation (IR) treatment. (D) Cells as grown in (A) were subjected to survival 
analysis (clonogenic assay) after various doses of H2O2 treatment. (E) The effects of different 
ATM mutations on DSB end resection are examined by measuring ssDNA intermediates of 
resection at various locations adjacent to two DSBs (DSB1 and DSB2) generated by the AsiSI 
restriction enzyme in Flp-In T-Rex U2OS cells. (F) Cells as grown in (A) were subjected to G2/M 
checkpoint analysis after CPT treatment. 
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rescued by WT ATM or phospho-blocking ATM mutants (S85A/T86A, T1985A/S1987A 
/S1988A), but not by phospho-mimic ATM mutants (S85D/T86E, T1985E/S1987D/ 
S1988D) (Figure 5.12E), indicating that phosphorylation of these sites leads to reduced 
DSB end resection and may inhibit HR. 
ATM activation is essential for cell cycle checkpoint activation upon DNA 
damage. As anticipated, cells expressing the kinase-deficient phospho-mimic ATM 
mutants (S85D/T86E, T1985E/S1987D/ S1988D) fail to activate G2/M checkpoint after 
CPT treatment (Figure 5.12F). 
 
The phospho-blocking ATM mutant T1985A/S1987A/S1988A fails to respond to 
DNA-PK chemical inhibition as wild-type ATM does in human cells      
Chemical inhibition of DNA-PK leads to hyperactivation of ATM, as suggested 
by increased γH2AX foci formation and ATM autophosphorylation in cells (Figure 
5.1A). Since the recombinant ATM mutant T1985A/S1987A/S1988A is resistant to 
DNA-PK pre-incubation in vitro (Figure 5.10), I tested whether this is also the case in 
human cells. I used γH2AX foci as readout of ATM activation in the presence or absence 
of DNA-PK inhibitor. As shown in Figure 5.13, cells expressing ATM 
T1985A/S1987A/S1988A mutant fails to respond to DNA-PK inhibition, while the 





Figure 5.13. Phospho-blocking ATM mutant T1985A/S1987A/S1988A fails to response to 
DNA-PK chemical inhibition as wild-type ATM does in human cells. 
Expression of WT ATM and ATM mutants as indicated were induced by doxycycline in Flp-In 
T-Rex U2OS cells in which endogenous ATM was depleted by shRNA. Cells were treated with 5 
Gy IR. After 1 h recovery, cells were fixed and stained with phospho-ATM S1981 antibody and 
γH2AX antibody. The number of phospho-ATM S1981 foci (upper panel) and γH2AX foci per 




As a central player in the DNA damage response, the ATM protein kinase 
phosphorylates more than 700 substrates which act in many cellular processes including 
cell cycle regulation, DNA damage repair, transcriptional regulation and programmed 
cell death (Matsuoka et al, 2007). However, the mechanism for activation and regulation 
of ATM is far from clear. ATM is a large protein with 3,056 amino acids. There are very 
few distinct domains in ATM except for the PI3K kinase domain, which accounts for 
10% of the protein, and several regulatory and interaction domains that are located within 
a framework of more than 40 HEAT repeats (Perry & Kleckner, 2003) and are not well 
defined. Lack of structural information currently prohibits full understanding of ATM 
activation and how this process is regulated by the regulatory domains (Paull, 2015).  
Numerous biochemical and cellular studies have revealed the importance of post-
translational modifications (PTMs) for ATM activation, in which phosphorylation is one 
of the most important modifications. ATM has been shown to be autophosphorylated at 
four sites upon DNA damage, including Ser367, Ser1893, Ser1981 and Ser2996 
(Bakkenist & Kastan, 2003; Kozlov et al, 2011; Kozlov et al, 2006). The functional 
importance of ATM autophosphorylation remains controversial because 
autophosphorylation of ATM is not essential for ATM activation in vitro or in mouse 
models (Daniel et al, 2008; Guo et al, 2010b; Lee & Paull, 2005; Pellegrini et al, 2006), 
while in human cells ATM autophosphorylation is functionally important, presumably by 
promoting the retention of ATM at DSB sites (Bensimon et al, 2010; So et al, 2009). 
Phosphorylation of ATM by other kinases, including CDK5, EGFR and Aurora B, has 
also been implicated in regulation of ATM activation upon DNA damage or mitosis (Lee 
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et al, 2015; Tian et al, 2009; Yang et al, 2011). However, no phosphorylation events that 
negatively regulate ATM kinase activity have been reported so far. 
DNA-PKcs has been shown to be a phosphorylation target of ATM and ATM-
mediated phosphorylation of DNA-PKcs at Thr2609 is critical for DNA-PKcs function in 
DNA repair (Chen et al, 2007). Interestingly, my study here provides evidence showing 
that ATM is also phosphorylated by DNA-PK in vitro, which is not surprising because 
both kinases are recruited to DSB ends where they may contact and phosphorylate each 
other. The inhibitory effect of DNA-PKcs on ATM kinase activity is stronger with 
limited amount of DNA ends than with excess DNA ends (Figure5.4), probably because 
DNA-PKcs has to colocalize with ATM in order to regulate ATM activity, and the 
presence of excess DNA substrate is likely to reduce DNA-PK/ATM colocalization. 
However, it is not clear how DNA-PKcs and ATM are simultaneously activated at the 
same DSB end, because a widely accepted model suggests that the Ku70/80 heterodimer, 
which recruits and activates DNA-PKcs, and the MRN complex, which recruits and 
activate ATM, compete with each other for DSB binding (Paull, 2010). It is also quite 
unexpected that chemical inhibition of DNA-PKcs doesn’t seem to block MRN binding 
to DSB ends and subsequent activation of ATM (Figure 5.2B), as kinase-inhibited DNA-
PKcs has been shown to strongly inhibit the activity of other DNA repair factors on DSB 
ends, such as Exo1-mediated resection (Zhou & Paull, 2013) and Rad50-mediated ATP 
hydrolysis (Deshpande & Paull, unpublished data).   
The mechanisms for choice between NHEJ and HR in S/G2 phase are not fully 
understood. Evidence from other laboratories suggests that the NHEJ factor DNA-PKcs 
and HR factor ATM may coordinately regulate the choice for DNA repair pathways. 
ATM-dependent phosphorylation of DNA-PKcs at Thr2609 cluster has been shown to be 
critical for efficient DSB repair through the NHEJ pathway (Chen et al, 2007). In 
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addition, ATM is also implicated in regulation of NHEJ through phosphorylation of 
Artemis, a nuclease required for end processing in the NHEJ pathway (Riballo et al, 
2004). My previous study showed that DNA-PKcs inhibits DSB end resection by Exo1 
while ATM and MRN overcome this inhibition by phosphorylating DNA-PKcs and 
promoting DNA-PKcs dissociation from DNA ends (Zhou & Paull, 2013). The current 
study demonstrates that DNA-PKcs can also directly phosphorylate ATM at multiple 
sites and hence inhibit ATM kinase activity, which provides a novel regulatory 
mechanism for pathway choice as decreased activation of ATM impairs DSB end 
resection and HR (Zhou & Paull, 2013).  
Seven sites of interest are identified in ATM in the current study, including S85, 
T86, T372, T373, T1985, S1987 and S1988. Phospho-mimetic mutations at these sites all 
reduce ATM catalytic activity by varying degrees, and hence lead to impaired DNA 
damage response in cells. Notably, the phospho-mimetic mutants bind normally to the 
intact MRN complex but show decreased affinity to MR, suggesting that ATM needs to 
interact with both Nbs1 and MR to be activated. This can also explain why the phospho-
mimetic mutants are deficient in the MRN/DNA pathway but efficiently activated by 
oxidative stress. Actually MS analysis has previously identified phosphorylation of ATM 
at S85, T86, T373 and S1985 upon DNA damage in human cells (Kettenbach et al, 2011; 
Lee et al, 2015; Matsuoka et al, 2007; Sharma et al, 2014), suggesting that ATM is 
indeed phosphorylated at these sites in cells. Unfortunately, attempts to generate 
antibodies against S85/T86 or T372/T373 sites have not been successful.  
The S85/T86 and T372/T373 are both located in N-terminal HEAT repeats, and 
they have similar amino acid pattern: STQ and TTQ. I have also tested another two 
clusters of sites with similar pattern: S474/S475(Q) and S2591/S2592(Q). Phospho-
mimetic mutations at S475 and S2592 have no effect on ATM activation, although 
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phosphorylation of both sites has been identified in MS (this study and (Lee et al, 2015)). 
The cluster of T1985/S1987/S1988 is localized in the FAT domain and sits very close to 
the ATM autophosphorylation site S1981. In cells expressing the phospho-mimetic 
T1985/S1987/S1988 allele there is reduced S1981 phosphorylation in the presence of 
DNA damage. But it remains to be investigated whether the phospho-mimetic mutations 
directly inhibits S1981 phosphorylation and hence represses ATM activation, or the 
opposite. The fact that mutations in all of the autophosphorylation sites fail to affect 
inhibition of ATM activity by DNA-PKcs does suggest that these sites act independently 
from the sites identified in this work. 
My study reveals a complex mechanism for regulation of ATM activation by 
DNA-PK. Multiple sites of ATM might be phosphorylated in a DNA-PK-dependent 
manner, such as T86, T373, T1985, S1987 and S1988. Interestingly, both T86A and 
T373A are not resistant to DNA-PK pre-incubation while T86A/T373A double mutant is, 
suggesting the necessity of phosphorylation at both sites for DNA-PK regulation of ATM 
activity. In addition, T86A/T373A and T1985A/S1987A/S1988A both show resistance to 
DNA-PK, suggesting that phosphorylation of these two clusters can regulate ATM 
activity independently from each other.  
In summary, this study shows that DNA-PK, a key NHEJ factor, negatively 
regulates ATM activity upon DNA damage by phosphorylating ATM at multiple sites. 
Considering the critical role of ATM in HR, this study has provided a novel mechanism 






CHAPTER 6: DISCUSSION  
 
Measurement of resection in human cells     
DNA double strand breaks (DSBs) are primarily repaired by non-homologous end 
joining (NHEJ) and homologous recombination (HR) in mammalian cells. NHEJ is active 
throughout the cell cycle while the activity of HR is limited to S/G2 phases when sister 
chromatids are available as homologous repair templates. The resection of 5’ strand DNA 
at DSB sites is the initial step of HR and is critical for the choice between HR and NHEJ, 
as extensively resected DSB ends cannot be rejoined through the NHEJ pathway. 
Therefore, the detection of DSB end resection is important for understanding the 
mechanism of DNA repair. Currently the resection of DSB ends in mammalian cells is 
mostly examined by indirect methods such as checking the formation of RPA foci, 
RAD51 foci, or BrdU, which can provide a global estimate for the level of resection. But 
these methods are subjectively dependent on the quality of antibody used and the 
immunofluorescent staining procedure, and cannot determine the length of resection from 
a DSB site.  
Previously a quantitative PCR (qPCR)-based assay was established to quantitate 
the single-strand DNA (ssDNA) intermediates of resection at an HO endonuclease-
induced DSB in budding yeast (Zierhut & Diffley, 2008). However, to date there is no 
quantitative method to measure resection in mammalian cells due to the difficulty of 
extracting the large genomic DNA from mammalian cells without introducing shearing 
damage. Based on the resection assay in budding yeast (Zierhut & Diffley, 2008), I 
developed a similar assay based on qPCR to directly measure DNA end resection at 
DSBs induced by the AsiSI restriction enzyme in human cells. To protect the large 
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mammalian genome from shearing, I embedded the cells in low-gelling-point agar during 
genomic DNA extraction, and avoided pipetting or centrifugation during the extraction 
process. The AsiSI expression system used here theoretically generates about 1,000 
DSBs in the human genome, but only about 150 DSBs can be actually induced by the 
AsiSI enzyme in human cells and the cleavage efficiency of different AsiSI restriction 
sites are variable (Massip et al, 2010). Compared with the current foci-based methods, the 
assay developed in this study is more quantitative and precise, and it can directly measure 
the extent of resection. 
 
Regulation of resection by CtIP and BRCA1 
I find that the 5’ strands at a DSB are resected up to 3.5 kb from break ends in 
human cells, which is similar to the length of resection near break sites in budding yeast 
(Chung et al, 2010). Consistent with previous reports (Aylon et al, 2004; Huertas & 
Jackson, 2009; Ira et al, 2004), my study shows that DNA end resection is much lower in 
G1 cells compared to asynchronous cultures, whereas higher levels of the ssDNA 
intermediates of resection are observed in late S/G2 cells. However, significant levels of 
resection are indeed observed in cell cultures that are predominantly in G1 phase, 
suggesting that resection of DNA ends does occur in G1 phase cells. In agreement with 
this, a recent study showed CtIP-dependent resection of DNA ends at complex DSBs in 
G1, which requires the phosphorylation CtIP by Plk3 (Barton et al, 2014).  
CtIP has been shown to be an endonuclease with specificity for 5’ flaps of 
branched DNA structures, and this activity is required for processing of “dirty” DNA 
ends with topoisomerase adducts or other modifications (Makharashvili et al, 2014). 
However, assessment of resection in CtIP-depleted cells expressing either wild-type CtIP 
 132 
or nuclease-deficient CtIP mutant (N289A/H290A) using the resection assay established 
in this study suggests that the CtIP protein, but not its nuclease activity, is required for the 
resection of “clean” DSB ends induced by restriction enzyme cleavage in human cells 
(Makharashvili et al, 2014), likely due to the requirement of both the CtIP protein and the 
MRN complex for Exo1 localization to DSBs (Eid et al, 2010). Thus, CtIP has two 
distinct roles in DSB end resection: processing of complex DSB ends through its 
endonuclease activity, and recruitment of other proteins involved in DNA end resection 
through protein-protein interactions (Makharashvili & Paull, 2015). Similarly, the 
endonuclease activity of MRX has been implicated in processing of DSB ends with 
covalently bound Spo11 protein during meiosis but is not required for resection of 
enzymatically-genereated “clean” DSBs in budding yeast (Moreau et al, 1999). In vitro 
studies also show that the MRN complex can overcome the inhibitory effects of Ku and 
DNA-PKcs on resection of linearized DNA substrate, which does not require MRN 
nuclease activity (Yang et al, 2013; Zhou & Paull, 2013). CtIP interacts with the MRN 
complex through the FHA domain and BRCT domains of Nbs1, and this interaction is 
facilitated by CDK-mediated phosphorylation of CtIP (Wang et al, 2013). Although it is 
well recognized that CtIP and MRN cooperatively initiate DSB end resection, it remains 
elusive why the endonuclease activities of CtIP and MRN are both required for the 
processing of complex DNA lesions resulted from inverted DNA repeats, topoisomerase 
poisons, or ionizing radiation.  
CtIP also binds to the BRCT phospho-peptide binding domain of BRCA1, which 
requires the phosphorylation of CtIP at Ser327 (Yu & Chen, 2004). It is suggested that 
CtIP may prevent the recruitment of 53BP1 in cooperation with BRCA1 in S/G2 phase, 
but the importance of CtIP-BRCA1 interaction for resection remains controversial (Daley 
et al, 2014), and inconsistent effects of BRCA depletion on DSB end resection have been 
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reported in different studies (Symington & Gautier, 2011). In this study I demonstrate 
that BRCA1 depletion has no significant effect on DNA end resection at the two selected 
DSB sites although it compromises the overall RAD51 foci formation in cells. However, 
I cannot rule out the possibility that RAD51 filaments in BRCA1-depleted cells are 
qualitatively different from those in wild-type cells, leading to differences in foci 
intensity, or that BRCA1 depletion may affect resection at some genomic sites more than 
others.  
A recent study in the Legube laboratory showed that DSBs in transcriptionally 
active chromatin are preferentially repaired by HR (Aymard et al, 2014). Since BRCA1 
has long been identified as a transcriptional factor in addition to its role in DNA repair, 
and it is preferentially recruited to gene promoters by other DNA sequence-specific 
transcriptional factors, it is possible that the BRCA1 protein is preferentially recruited to 
DSBs located in transcriptionally active chromatin and promotes resection at these sites 
(HR-prone DSBs), whereas it shows little effect on resection of DSBs located in 
transcriptionally inactive chromatin (NHEJ-prone DSBs). Therefore, BRCA1 depletion 
may show different effects on RPA foci formation depending on the level of transcription 
at the site of the break, leading to the inconsistent conclusions regarding the role of 
BRCA1 in DSB resection in the literature (Symington & Gautier, 2011). To test this idea, 
I have also examined the effect of BRCA1 depletion on DNA end resection at a few other 
DSB sites, including DSBs that have been shown to be HR-prone or NHEJ-prone 
(Aymard et al, 2014). However, I observed no effect of BRCA1 depletion on resection at 
any of the examined sites (data not shown).  
Based on the data I collected in this study using the in vivo resection assay, I 
suggest that BRCA1 has no direct effect on DSB end resection and that its function may 
be more similar to that of BRCA2, to mediate the formation of RAD51 filament. In 
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agreement with this conclusion, a recent study using high resolution techniques to 
measure resection suggests that BRCA1 accelerates, but not essential for, CtIP-dependent 
resection (Cruz-Garcia et al, 2014). In addition, recent studies show that microRNAs are 
implicated in regulation of DNA damage response and BRCA1 has been involved in 
regulation of microRNA biogenesis (Hu & Gatti, 2011; Kawai & Amano, 2012; Wan et 
al, 2011; Wang & Taniguchi, 2013), indicating that BRCA1 may actively regulate DNA 
repair through modulating the biogenesis of microRNAs, which is worth further 
investigation. 
 
Regulation of resection by DNA-PKcs 
The Ku70/80 heterodimer and DNA-PKcs are key regulators of NHEJ, but have 
also been implicated in regulation of HR (Allen et al, 2003; Convery et al, 2005; Cui et 
al, 2005; Neal et al, 2011; Shibata et al, 2011). Ku has been shown to inhibit resection in 
yeast and in vitro (Clerici et al, 2008; Krishna et al, 2007; Lee et al, 1998; Yang et al, 
2013; Zhang et al, 2007). However, it remains elusive whether the DNA-PKcs protein 
directly affects resection. By quantitatively measuring ssDNA intermediates of resection, 
I find that loss of DNA-PKcs or Ku protein leads to increased DSB end resection in 
human cells. This is not surprising considering the widely proposed model about the 
competition between NHEJ and HR factors for DNA ends (Allen et al, 2003; Neal et al, 
2011; Shrivastav et al, 2008). In addition, I observed increased accumulation of DSBs 
upon 4-OHT treatment in Ku or DNA-PKcs deficient cells, likely due to a failure of 
NHEJ repair, thus more DSB ends are available for resection in the absence of DNA-
PKcs or Ku. I also investigated the effects of chemical inhibition of DNA-PKcs and 
found that this also strongly simulates resection and increases the number of DSB ends in 
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cells after AsiSI translocation. However, it is hard to conclude whether DNA-PKcs 
directly inhibits resection based on these observations as depletion or chemical inhibition 
of DNA-PKcs also impairs the NHEJ pathway and leads to increased accumulation of 
DSB ends which can result in increased percentage of end resection.   
In contrast, my in vitro reconstituted resection assay clearly shows the DNA-PKcs 
protein directly represses Exo1-mediated DNA end resection in a Ku-dependent manner, 
which can be partially overcome by the MRN complex. Small-molecular inhibition of 
DNA-PKcs generates a strong barrier to resection, which cannot be relieved even in the 
presence of MRN but can be partially overcome by ATM. The end result of blocking 
DNA-PKcs activity is an inability to release DNA-PKcs from DSB ends and load Exo1 
onto the ends, which is consistent with the idea that autophosphorylation of DNA-PKcs 
promotes DNA-PKcs dissociation from DNA ends and allow access of other repair 
factors (Dobbs et al, 2010; Uematsu et al, 2007).  
 
Regulation of resection by MRN 
The mechanism by which MRN competes with Ku for DNA ends is not well 
understood. Ku is a very abundant protein with high affinity for DNA ends and it is 
recruited to break sites 1 s after DNA damage (Hartlerode et al, 2015). In contrast, the 
recruitment of MRN is relatively slower, about 5 s after damage (Hartlerode et al, 2015). 
The Ku70/80 heterodimer forms a ring-shaped structure that can slide on DNA (Cary et 
al, 1997; Walker et al, 2001). The localization of MRN and Ku to DSBs are independent 
from each other and it seems that MRN and Ku can be present at DSB sites 
simultaneously (Hartlerode et al, 2015), suggesting that MRN may push Ku inwards 
rather than removing Ku from DNA ends. In support of this conclusion, previous studies 
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in the Paull lab showed that that the DNA unwinding activity of Rad50, but not the 
nuclease activity of Mre11 in the MRN complex, is required for overcoming Ku 
inhibition of Exo1-mediated DNA end resection in vitro (Cannon et al, 2013; Yang et al, 
2013). MRN may function to push the Ku ring away from the extreme DNA ends by 
unwinding the ends to some extend via the Rad50 DNA unwinding activity and in this 
way promote the accessibility of the DNA ends to Exo1. Notably, in addition to 
antagonizing the initiation of resection, Ku also appears to reduce the extent of resection 
by Exo1, which is partially suppressed by MRN. It is possible that ring-shaped Ku70/80 
heterodimer accumulates internally on the DNA and serves as a block to the progression 
of Exo1 in vitro.  
My study here demonstrates that MRN can also partially overcome DNA-PKcs 
inhibition of resection in the presence of ATP, while it cannot restore resection blocked 
by DNA-PKcs in the absence of ATP or in the presence of DNA-PK inhibitor, suggesting 
that the autophosphorylation of DNA-PKcs is essential for releasing its inhibitory effect 
on resection and MRN may function to facilitate this process. Interestingly, I find that 
MRN directly stimulates DNA-PKcs autophosphorylation in vitro, possibly achieved 
through the end-tethering activity of MRN (de Jager et al, 2001). The DNA ends tethered 
together by MRN might promote DNA-PKcs in trans autophosphorylation which in turn 
facilitates DNA-PKcs dissociation from DNA ends (Meek et al, 2007), allowing the 
loading of Exo1.  
 
Regulation of resection by ATM 
It is well recognized that the ATM protein kinase actively regulates DSB end 
resection through phosphorylation of multiple proteins involved in resection. ATM-
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mediated phosphorylation of CtIP has been shown to be critical for CtIP-mediated end 
resection (Li et al, 2000; Makharashvili et al, 2014; Wang et al, 2013). ATM also 
promotes resection via phosphorylation and stabilization of hSSB1 (Richard et al, 2008), 
a component of the SOSS1 single-stranded DNA binding complex that has been shown to 
promote resection both in vitro (Yang et al, 2013) and in human cells (Zhou et al, 2014). 
In addition, ATM functions to prevent excessive resection through phosphorylation of 
Mre11 and Exo1 (Bolderson et al, 2010; Kijas et al, 2015). I show here that ATM 
promotes DSB resection via phosphorylation of DNA-PKcs, which enhances DNA-PKcs 
release and Exo1 recruitment. MRN alone cannot restore resection when DNA-PKcs 
catalytic activity is inhibited, while in this case ATM can function to rescue Exo1 
resection activity. Unlike the loss of DNA-PKcs protein which stimulates DNA end 
resection, blocking DNA-PKcs catalytic activity clearly is inhibitory to resection, but this 
block can be partially overcome by the substitute phosphorylation of DNA-PKcs by 
ATM. This data also suggests that ATM-mediated phosphorylation of DNA-PKcs, 
primarily at the T2609 cluster, is sufficient for promoting the dissociation of DNA-PKcs 
from DNA ends, although in this case the efficiency of DNA-PKcs dissociation is lower 
than when DNA-PKcs could be autophosphorylated.  
 
DNA-PKcs inhibits ATM kinase activity through phosphorylation 
Recent evidence shows that cross-talk occurs among ATM, DNA-PKcs and ATR 
and that these kinases may mutually regulate each other in response to DNA damage or 
replication stress. For instance, ATM-mediated phosphorylation of DNA-PKcs at 
Thr2609 is essential for DNA-PKcs function in DNA repair (Chen et al, 2007), while 
DNA-PKcs regulates the expression of ATM in cells (Peng et al, 2005), although the 
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underlying mechanism remains elusive. ATR is generally thought to function 
downstream of ATM in S/G2 phase cells, because ATM promotes DSB end resection and 
the generation of ssDNA intermediates which are required for ATR activation. However, 
it has been shown that the activation of ATM following replication fork stalling or UV 
treatment is dependent on ATR-mediated phosphorylation of ATM at Ser1981, a critical 
ATM autophosphorylation site in response to IR-induced DNA damage (Stiff et al, 
2006). Similarly, DNA-PKcs is also a target of ATR in response to UV-induced 
replication stress, and ATR-mediated DNA-PKcs phosphorylation at Thr2609 and 
Thr2647 is critical for cellular response to replication stress (Yajima et al, 2006). 
Conversely, DNA-PKcs promotes ATR activation by mediating phosphorylation of RPA 
and TopBP1 at collapsed replication forks (Vidal-Eychenie et al, 2013). In addition, 
MRN is also involved in the activation of ATR through recruitment of TopBP1 (Duursma 
et al, 2013; Lee & Dunphy, 2013). 
In this study I show that DNA-PKcs phosphorylates ATM at multiple sites and in 
this way repress ATM kinase activity. It should be noted that the inhibitory effect of 
DNA-PKcs on ATM kinase activity is stronger with limited amount of DNA ends than 
with excess DNA ends, which may not be surprising because DNA-PKcs needs to co-
localize with ATM at DNA ends in order to phosphorylate ATM, and the presence of 
excess DNA substrate is likely to reduce DNA-PK-ATM co-localization and DNA-PKcs-
mediated phosphorylation of ATM. A widely accepted model suggests that Ku and MRN, 
which recruit DNA-PKcs and ATM respectively, compete with each other for DSB 
binding (Paull, 2010). However, my study here seems to show that DNA-PKcs and ATM 
are simultaneously recruited and activated at the same DSB end. Pre-incubation of ATM 
with chemically inhibited DNA-PKcs results in normal ATM activation, suggesting that 
the presence of Ku/DNA-PKcs protein per se does not affect ATM kinase activity, and 
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the inhibition of ATM kinase activity by active DNA-PKcs is not simply an issue of 
DNA end competition between Ku/DNA-PKcs and MRN/ATM. This conclusion is 
supported by a recent study showing that MRN and Ku do not affect the recruitment of 
each other to DSBs (Hartlerode et al, 2015).  It is possible that both Ku/DNA-PKcs and 
MRN/ATM bind to DNA ends and form a large complex in which DNA-PKcs and ATM 
contact and phosphorylate each other.           
It is quite surprising that chemical inhibition of DNA-PKcs does not affect MRN-
dependent ATM activation in vitro. My previous study suggests that kinase-inhibited 
DNA-PKcs totally blocks Exo1-mediated DNA end resection even in the presence of 
MRN (Zhou & Paull, 2013). The ATPase activity of Rad50 in the MRN complex is also 
completely blocked by DNA-PKcs in the presence of DNA-PK inhibitor (Deshpande & 
Paull, unpublished data), indicating that kinase-inhibited DNA-PKcs blocks MRN-
mediated DNA end unwinding which requires energy generated through Rad50-mediated 
ATP hydrolysis. It remains to be investigated how ATM is fully activated by MRN in this 
case because the DNA end unwinding activity of MRN is essential for ATM activation 
(Lee & Paull, 2005). A possible explanation is that the recombinant ATM protein has 
some basal activity that can mildly phosphorylate the kinase-inhibited DNA-PKcs and 
remove the protein from extreme DNA ends. MRN can further push Ku inwards once 
DNA-PKcs is dissociated from the ends and unwind the DNA ends, leading to moderate 
ATM activation which may further stimulate DNA-PKcs phosphorylation and 
dissociation, exposing more DNA ends for unwinding and ATM recruitment, and hence 
fully activate ATM. 
ATM-mediated phosphorylation of DNA-PKcs leads to dissociation of DNA-
PKcs from DNA ends and inactivation of DNA-PKcs kinase activity. Interestingly, 
DNA-PKcs actively antagonizes this effect by phosphorylating ATM at multiple sites and 
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reducing ATM kinase activity. Numerous studies have revealed the importance of ATM 
phosphorylation for regulation of ATM activation. Except for autophosphorylation at 
four sites upon DNA damage, ATM is also phosphorylated by other kinases, including 
CDK5, EGFR and Aurora B, at various sites, and these phosphorylation events are 
critical for ATM activation upon DNA damage or mitosis (Lee et al, 2015; Tian et al, 
2009; Yang et al, 2011). However, no phosphorylation events that negatively regulate 
ATM kinase activity have been reported so far. In the current study, I identified seven 
ATM sites of interest, including S85, T86, T372, T373, T1985, S1987 and S1988. 
Phospho-mimetic mutations at these sites all reduce ATM catalytic activity by varying 
degrees and lead to impaired DNA damage response in cells. Notably, the phospho-
mimetic mutants bind normally to the intact MRN complex but show decreased affinity 
to MR, suggesting that ATM needs to interact with both Nbs1 and MR to be activated. 
This can also explain why the phospho-mimetic mutants are deficient in the MRN/DNA 
pathway but efficiently activated by oxidative stress. The transition from dimer to 
monomer is essential for ATM activation in response to DNA damage (Bakkenist & 
Kastan, 2003). It is possible that ATM phosphorylation at the identified sites may 
interfere with ATM monomerization upon DNA damage and hence inhibits ATM 
activation, which is an issue requires further investigation. The phospho-mimetic ATM 
mutants also exhibit dominant negative effects on endogenous ATM in cells, potentially 
because the ATM mutant and endogenous wild-type ATM form hybrid dimers that 
cannot convert to active monomer upon DNA damage.  
Previous studies in other groups have also identified phosphorylation of ATM at 
S85, T86, T373 and S1985 upon DNA damage in human cells (Kettenbach et al, 2011; 
Lee et al, 2015; Matsuoka et al, 2007; Sharma et al, 2014). The S85/T86 and T372/T373 
are both located in N-terminal HEAT repeats with similar amino acid pattern: STQ and 
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TTQ. The previous reported ATM phosphorylation sites that are involved in ATM 
activation, including Tyr370, Ser794 and Ser1403, are also located in the HEAT repeats, 
suggesting the importance of this region for regulation of ATM activity. The cluster of 
T1985/S1987/S1988 is localized in the FAT domain and sits very close to the ATM 
autophosphorylation site Ser1981, but mutations at these three sites do not seem to affect 
ATM Ser1981 autophosphorylation in vitro (data not shown). In cells expressing the 
phospho-mimetic ATM alleles the phosphorylation levels of ATM Ser1981 is reduced in 
the presence of DNA damage. But it remains to be investigated whether the phospho-
mimetic mutations directly inhibits Ser1981 autophosphorylation and hence represses 
ATM monomerization and activation, or whether they directly affect activation.  
Compared to cells expressing wild-type ATM, cells expressing the phospho-
mimic ATM mutants S85D/T86E, T1985E/S1987D/S1988D and T86E/T373E show 
decreased ATM activation and resection at DSB ends, impaired G2/M checkpoint 
activation, and increased sensitivity to DNA damage agents, suggesting that the 
phosphorylation of ATM at these sites plays an important role in regulation of DNA 
damage response. However, it is hard to determine under which situations these sites are 
phosphorylated or dephosphorylated without functional phospho-specific antibodies 
against these sites. It was proposed that in resting cells ATM kinase activity is inhibited 
by serine/threonine phosphorylation of certain sites, while PP5 phosphatase binds to 
ATM and removes these inhibitory phosphates from ATM upon DNA damage, leading to 
ATM activation (Ali et al, 2004). There is also evidence showing that some sites of ATM 
are dephosphorylated in response to DNA damage (Kozlov et al, 2003). It is possible that 
some of the sites identified in this study are constitutively phosphorylated in undamaged 
cells, but dephosphorylated by PP5 or other phosphatases in order to activate ATM in 
response to DNA damage. In addition, this modification may also serve as a new 
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mechanism to inactivate ATM after DSBs are repaired, promote cell cycle resumption 
(checkpoint adaptation) and keep the basal activity of ATM low in resting cells.  
My study reveals that multiple sites of ATM are phosphorylated in a DNA-PK-
dependent manner, such as T86, T373, T1985, S1987 and S1988. Interestingly, both 
T86A and T373A are not resistant to DNA-PK pre-incubation in vitro while 
T86A/T373A double mutant is, suggesting the necessity of phosphorylation at both sites 
for DNA-PK inhibition of ATM activity. In addition, T86A/T373A and 
T1985A/S1987A/S1988A both show resistance to DNA-PK, suggesting that 
phosphorylation of these two clusters can regulate ATM activity independently from each 
other.  
It remains to be examined whether DNA-PKcs-mediated phosphorylation blocks 
the activation of the inactive ATM dimer or whether it inactivates the already activated 
ATM monomer. The biological significance of DNA-PKcs-mediated phosphorylation of 
ATM is not clear as well. Considering that DNA-PKcs is a key NHEJ factor while ATM 
is essential for HR, these phosphorylation events, together with ATM-mediated 
phosphorylation of DNA-PKcs, may actively regulate DNA repair pathway choice in 
response to DNA damage. The phosphorylation of DNA-PKcs by ATM is likely to have 
multiple effects. 1) As reported previously (Chen et al, 2007), phosphorylation of DNA-
PKcs at the T2609 cluster by ATM is essential for DNA-PKcs-dependent NHEJ repair; 
2) I find that the 6A DNA-PKcs mutant in which all residues of the T2609 cluster have 
been mutated to alkaline is still able to be phosphorylated by ATM in vitro (data not 
shown), indicating that ATM phosphorylates DNA-PKcs at multiple sites, which may 
leads to the premature dissociation of DNA-PKcs from DNA ends and hence inhibits 
DNA-PKcs-dependent classical NHEJ; 3) DNA-PKcs inhibits resection while ATM-
mediated phosphorylation of DNA-PKcs overcomes this inhibition. Conversely, DNA-
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PKcs-mediated phosphorylation of ATM inhibits ATM activity. This may antagonize 
hyper-phosphorylation by ATM and promote NHEJ. In addition, the block in ATM 
activation inhibits DSB end resection and HR which require ATM kinase activity. 
 
Opposing effects of MRN on classical NHEJ and alternative NHEJ 
MRX has been shown to promote NHEJ via interactions with Ku and DNA 
Ligase IV in budding yeast (Boulton & Jackson, 1998; Moore & Haber, 1996), but the 
classical NHEJ does not seem to be dependent on the MRN complex in mammalian cells 
(Lewis & Resnick, 2000). Surprisingly, my study here suggests that instead of 
stimulating ligation, MRN dramatically inhibits end joining mediated by the DNA Ligase 
IV/XRCC4 complex in the presence of Ku/DNA-PKcs in vitro (Zhou & Paull, 2013). In 
contrast, MRN strongly stimulates DNA ligation by DNA Ligase III/XRCC1 by 
mediating DNA end tethering in vitro (Della-Maria et al, 2011). Thus, MRN shows 
opposite effects on classical NHEJ and alternative NHEJ. MRN was shown to tether the 
two DSB ends together in a synaptic complex (de Jager et al, 2001). It is quite likely that 
MRN-mediated end synapsis promotes the activity of Ligase III/XRCC1, but does not 
provide a configuration of ends that is favorable for the Ligase IV/XRCC4 complex. In 
addition, this synapsis might also promote the in trans autophosphorylation of DNA-
PKcs, which may lead to premature dissociation of DNA-PKcs and inhibit end rejoining. 
Moreover, MRN may promote the inwards translocation of Ku, and in this way may 
interfere with the formation of Ku/DNA-PKcs-mediated intermolecular DNA end 
synapsis which contributes to DNA ligation (Weterings et al, 2003). In contrast, in the 
alternative NHEJ pathway, MRN plays a positive role through interaction with Ligase 
III/XRCC1 and tether the DNA ends together for rejoining (Della-Maria et al, 2011).  
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I also find that the nuclease activity of MRN is essential for Ligase III/XRCC1-
mediated ligation of DNA with incompatible ends, suggesting MRN functions to process 
incompatible DNA ends in the alternative NHEJ pathway in addition to tethering the ends 
for ligation. It would be interesting to test whether the nuclease activity of MRN has any 
effect on the ligation of DNA substrate with incompatible ends in the classical NHEJ 
pathway. Since MRN unwinds DNA ends for ~15 nt, and in this way it may push Ku 
away from the ends and inhibits ligation, it might be worth exploring how the DNA 
unwinding activity of MRN Ligase IV/XRCC4-mediated ligation using a MRN mutant 
deficient in DNA unwinding activity (Cannon et al, 2013). Additionally, ATM likely 
leads to hyper-phosphorylation of DNA-PKcs. It would be interesting to test the effect of 
this modification on DNA end rejoining by Ligase IV/XRCC4. Compared with Ligase 
III/XRCC1, the ligation activity of Ligase IV/XRCC4 is very low even in the presence of 
Ku/DNA-PKcs in vitro. It might be helpful to further add other classical NHEJ factors, 
such as XLF, to the reactions. 
 
Summary 
In this study, I have developed a qPCR-based method to directly measure DSB 
end resection in human cells, providing a new tool for quantitative analysis of the actual 
resection products. I have demonstrated that the NHEJ factor DNA-PKcs directly inhibits 
DSB end resection, which can be overcome by ATM-mediated phosphorylation of DNA-
PKcs, and that the MRN complex promotes resection by recruiting Exo1 and enhancing 
DNA-PKcs autophosphorylation, but inhibits DNA ligase IV/XRCC 4-mediated end 
rejoining which is stimulated by Ku and DNA-PKcs. I have also shown that DNA-PKcs 
phosphorylates ATM at multiple sites, which inhibits ATM activation and ATM-
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dependent DSB end resection. Taken together, my studies have revealed a complex 
regulatory circuit in which Ku/DNA-PKcs and MRN/ATM antagonize each other for 
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